10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

Form 10-Q

þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended June 30, 2006.

Commission File Number 333-89756

Alion Science and Technology Corporation

(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction of
Incorporation of Organization)
54-2061691
(I.R.S. Employer
Identification No.)

10 West 35^th Street
Chicago, IL 60616
(312) 567-4000 1750 Tysons Boulevard, Suite 1300
McLean, VA 22102
(703) 918-4480

(Address, including Zip Code and Telephone Number with

Area Code, of Principal Executive Offices)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  þ Yes     o No

Indicate by check mark whether the registrant is a large accelerated filer, and accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Large Accelerated Filer o     Accelerated Filer o     Non-Accelerated Filer þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  o Yes     þ No

The number of shares outstanding of Alion Science and Technology Corporation Common Stock as of August 3, 2006, was: Common Stock 4,886,018

ALION SCIENCE AND TECHNOLOGY CORPORATION

FORM 10-Q

FOR THE THREE MONTHS AND NINE MONTHS ENDED JUNE 30, 2006

PART I — Financial Information			2
	Item 1.	Financial Statements	2
		Condensed Consolidated Balance Sheets	2
		Condensed Consolidated Statements of Operations	3
		Condensed Consolidated Statements of Cash Flows	4
		Notes to Financial Statements	5
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	35
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	53
	Item 4.	Controls and Procedures	54
PART II — Other Information			55
	Item 1.	Legal Proceedings	55
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	55
	Item 3.	Defaults Upon Senior Securities	55
	Item 4.	Submission of Matters to a Vote of Security Holders	55
	Item 5.	Other Information	55
	Item 6.	Exhibits	55
EX-4.13
EX-4.14
EX-10.73
EX-10.74
EX-10.75
EX-10.76
EX-10.77
EX-10.78
EX-31.1
EX-31.2
EX-32.1
EX-32.2

1

PART I — FINANCIAL INFORMATION

Item 1.   Financial Statements

ALION SCIENCE AND TECHNOLOGY CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30,			September 30,
	2006			2005
	(In thousands, except share and per share information)
	(Unaudited)
Current assets:
Cash and cash equivalents	$	2,754		$	37,778
Accounts receivable, less allowance of $3,854 and $3,539 at June 30, 2006 and September 30, 2005, respectively		112,034			80,898
Stock subscriptions receivable		—			1,733
Prepaid expenses		2,710			1,944
Other current assets		2,402			2,802
Total current assets		119,900			125,155
Property, plant and equipment, net		16,082			11,174
Intangible assets, net		75,348			30,198
Goodwill		390,132			163,419
Other assets		2,374			1,860
Deferred compensation assets		2,548			2,443
Total assets		606,384			334,249
Current liabilities:
Notes payable to bank		5,975			—
Current portion, Term B Senior Credit Facility note payable		2,573			1,404
Current portion, Acquisition obligations		8,198			3,616
Trade accounts payable and accrued liabilities		37,240			27,312
Accrued payroll and related liabilities		26,469			29,161
ESOP liabilities		1,991			274
Current portion of accrued loss on operating leases		963			1,054
Billings in excess of costs and estimated earnings on uncompleted contracts		1,810			2,559
Total current liabilities		85,219			65,380
Acquisition obligations, excluding current portion		4,029			7,100
Term B Senior Credit Facility note payable, excluding current portion		252,349			137,945
Bridge Loan note payable		164,680			—
Subordinated note payable		45,906			42,888
Deferred compensation liability		3,300			2,465
Accrued compensation, excluding current portion		15,229			6,356
Accrued postretirement benefit obligations		3,698			3,357
Non-current portion of lease obligations		4,412			3,694
Redeemable common stock warrants		32,396			44,590
Total liabilities		611,218			313,775
Shareholder’s equity:
Common stock $0.01 par value, 8,000,000 shares authorized; 4,920,133 shares and 5,149,840 shares issued and outstanding at June 30, 2006 and September 30, 2005, respectively		49			51
Additional paid-in capital		80,115			88,479
Accumulated deficit		(84,998	)		(68,056	)
Total shareholder’s equity		(4,834	)		20,474
Total liabilities and shareholder’s equity	$	606,384		$	334,249

See accompanying notes to condensed consolidated financial statements.

2

ALION SCIENCE AND TECHNOLOGY CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

	Three Months Ended						Nine Months Ended
	June 30,			June 30,			June 30,			June 30,
	2006			2005			2006			2005
	(In thousands, except share and per share information)
	(Unaudited)
Contract revenue	$	116,830		$	110,795		$	329,308		$	260,707
Direct contract expense		87,192			80,184			244,544			189,821
Gross profit		29,638			30,611			84,764			70,886
Operating expenses:
Indirect contract expense		7,212			10,539			19,370			19,668
Research and development		531			123			1,301			394
General and administrative		11,793			8,967			32,951			23,365
Rental and occupancy expense		5,390			3,578			15,443			8,530
Depreciation and amortization		2,543			5,459			9,734			12,718
Stock-based compensation(1)		3,260			3,402			8,282			7,604
Bad debt expense		292			114			507			529
Total operating expenses		31,021			32,182			87,588			72,808
Operating income (loss)		(1,383	)		(1,571	)		(2,824	)		(1,922	)
Other income (expense):
Interest income		108			136			569			192
Interest expense		(6,998	)		(9,418	)		(14,915	)		(32,303	)
Other		38			90			254			(9	)
Loss before income taxes		(8,235	)		(10,763	)		(16,916	)		(34,042	)
Income tax expense		(7	)		—			(26	)		(51	)
Net loss		(8,242	)		(10,763	)		(16,942	)		(34,093	)
Basic and diluted loss per share	$	(1.60	)	$	(2.21	)	$	(3.34	)	$	(8.84	)
Basic and diluted weighted average common shares outstanding		5,157,009			4,863,099			5,076,060			3,854,543

(1) Stock-based compensation is a separately reported component of general and administrative expense.

See accompanying notes to condensed consolidated financial statements.

3

ALION SCIENCE AND TECHNOLOGY CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	Nine Months Ended June 30,
	2006			2005
	(In thousands)
	(Unaudited)
Cash flows from operating activities:
Net loss	$	(16,942	)	$	(34,093	)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization		9,734			12,718
Accretion of debt to face value		689			2,835
Amortization of debt issuance costs		1,260			633
(Decrease) increase value of interest rate cap agreement		(364	)		73
Change in fair value of redeemable common stock warrants		1,450			20,618
Stock-based compensation		8,282			7,604
(Gain) loss on disposal of assets		(1	)		27
Gain on investments, net		(21	)		(37	)
Changes in assets and liabilities, net of effect of acquisitions:
Accounts receivable, net		(21,365	)		(1,856	)
Other assets		5,430			885
Trade accounts payable and accruals		2,669			7,064
Other liabilities		2,223			154
Net cash (used in) provided by operating activities		(6,956	)		16,625
Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired		(278,805	)		(70,644	)
Capital expenditures		(4,497	)		(1,762	)
Purchase of investment securities		—			(1,194	)
Net cash used in investing activities		(283,302	)		(73,600	)
Cash flows from financing activities:
Proceeds from Term B Senior Credit Facility		118,000			94,000
Proceeds from bridge loan		170,000			—
Payment of debt issuance costs		(7,758	)		(1,307	)
Repayment of Term B Credit Facility		(1,250	)		(720	)
Repayment of mezzanine note		—			(20,201	)
Repayment of mezzanine note warrants		(13,643	)		—
Payment of agreements with officers		—			(1,823	)
Borrowings under revolving credit facility		5,975			—
Purchase interest rate cap agreement		(44	)		—
Purchase common stock from ESOP Trust		(17,739	)		(2,281	)
Cash received from issuance of common stock to ESOP Trust		1,693			2,441
Net cash provided by financing activities		255,234			70,109
Net (decrease) increase in cash		(35,024	)		13,134
Cash at beginning of period		37,778			4,718
Cash at end of period	$	2,754		$	17,852
Supplemental disclosure of cash flow information:
Cash paid for interest		8,869			7,138
Cash paid for taxes		610			367
Non-cash financing activities:
Common stock issued to ESOP Trust in satisfaction of employer contribution liability		3,587			4,019
Common stock issued for acquisitions		—			37,250

See accompanying notes to condensed consolidated financial statements.

4

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(1)   Description and Formation of the Business

Alion provides scientific and engineering expertise to research and develop technological solutions for problems relating to national defense, homeland security, and energy and environmental analysis. The Company provides these research services primarily to agencies of the federal government and, to a lesser extent, to commercial and international customers.

Alion, a for-profit S Corporation, was formed in October 2001 for the purpose of purchasing substantially all of the assets and certain of the liabilities of IITRI, a not-for-profit membership corporation affiliated with and controlled by the Illinois Institute of Technology (IIT). On December 20, 2002, Alion acquired substantially all of the assets and liabilities of IITRI, excluding the assets and liabilities of IITRI’s Life Sciences Operation, for aggregate total proceeds of $127.3 million (the Transaction). Prior to that time, the Company’s activities were organizational in nature.

(2)   Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of Alion Science and Technology Corporation and its subsidiaries (collectively, the Company or Alion) and have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the audited condensed consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2005 (File No. 333-89756) filed with the SEC on January 31, 2006.

The statements are prepared on the accrual basis of accounting and include the accounts of Alion and its wholly-owned subsidiaries from the date of acquisition. All significant inter-company accounts have been eliminated in consolidation.

•  Human Factors Application, Inc. (HFA), acquired in the Transaction,

•  Innovative Technology Solution Corporation (ITSC) and Alion — IPS Corporation (IPS), which were acquired during the fiscal year ended September 30, 2004,

•  Alion — METI Corporation (METI), Alion — CATI Corporation (CATI), Alion Canada (U.S.), Inc., Alion Science and Technology (Canada) Corporation, and Alion — JJMA Corporation (JJMA), acquired or established during the fiscal year ended September 30, 2005,

•  Alion — BMH Corporation (BMH) and Washington Consulting, Inc. (WCI), acquired in February 2006, and

•  Alion — MA&D Corporation (MA&D) acquired in May 2006.

Fiscal and Quarter Periods

The Company’s fiscal year ends on September 30. The Company operates based on a three-month quarter, four-quarter fiscal year. Quarter end dates: December 31, March 31, June 30, and September 30.

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of financial statements and operating results reported for a given period. Actual results are likely to differ from those estimates; however, we do not believe such differences will materially affect the Company’s financial position, results of operations, or cash flows.

5

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Cash and Cash Equivalents

Cash in banks, and deposits with financial institutions with maturities of three months or less which can be liquidated without prior notice or penalty, are classified as cash and cash equivalents.

Revenue Recognition

Our revenue comes from contract research and other services under a variety of contracts, some of which provide for reimbursement of cost plus fees and others of which are fixed-price or time-and-material type contracts. The Company generally recognizes revenue when a contract has been executed, the contract price is fixed or determinable, delivery of the services or products has occurred and collectibility of the contract price is considered probable.

Revenue on cost-reimbursement contracts is recognized as costs are incurred and include estimates of applicable fees earned. Revenue on time-and-material contracts is recognized at contractually billable rates as labor hours and direct expenses are incurred. Under time-and-material contracts, labor and related costs are reimbursed at negotiated, fixed hourly rates.

Revenue on fixed price contracts is recognized on the percentage-of-completion method based on various performance measures. From time to time, facts develop that require the Company to revise its estimated total costs or revenues expected. The cumulative effect of revised estimates is recorded in the period in which the facts requiring revisions become known. The full amount of anticipated losses on any type of contract is recognized in the period in which they become known.

Contracts with agencies of the federal government are subject to periodic funding by the contracting agency concerned. Funding for a contract may be provided in full at inception of the contract or ratably throughout the term of the contract as the services are provided. If funding is not assessed as probable, revenue recognition is deferred until realization is probable.

Contract costs on federal government contracts are subject to audit by the federal government and adjustment pursuant to negotiations between the Company and government representatives. The government considers Alion to be a major contractor and maintains an office on site to perform its various audits throughout the year. All of the Company’s federal government contract indirect costs have been audited through fiscal year 2004. Indirect rates have been negotiated and settled through fiscal year 2001. The Company submitted its fiscal year 2005 indirect expense rates to the government on March 29, 2006. Contract revenue on federal government contracts has been recorded in amounts that are expected to be realized upon final settlement.

The Company recognizes revenue on unpriced change orders as expenses are incurred only to the extent that the Company expects it is probable that such costs will be recovered. The Company recognizes revenue in excess of costs on unpriced change orders only when management can also reliably estimate the amount of excess and experience provides a sufficient basis for recognition. The Company recognizes revenue on claims as expenses are incurred only to the extent that the Company expects it is probable that such costs will be recovered and the amount of recovery can be reliably estimated.

Software revenue is generated from licensing software and providing services. In general, professional services are considered essential to the functionality of the solution sold and revenue is recognized on the percentage of completion method, as prescribed by AICPA SOP 81-1, Accounting for Performance on Construction-Type and Certain Production-Type Contracts.

Income Taxes

The Company is an S corporation under the provisions of the Internal Revenue Code of 1986, as amended. For federal and certain state income tax purposes, the Company is not subject to tax on its income. All the Company’s income is allocated to its sole shareholder, the Alion Science and Technology Corporation Employee Stock

6

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Ownership, Savings and Investment Trust (the Trust). The Company may be subject to state income taxes in those states that do not recognize S corporations and to additional types of taxes including franchise and business taxes. All of the Company’s wholly-owned subsidiaries are qualified subchapter S or disregarded entities which, for federal income tax purposes, are not treated as separate taxpayers.

Accounts Receivable and Billings in Excess of Costs and Estimated Earnings on Uncompleted Contracts

Accounts receivable include billed accounts receivable, amounts currently billable and costs and estimated earnings in excess of billings on uncompleted contracts that represent accumulated project expenses and fees which have not been billed or are not currently billable as of the date of the consolidated balance sheet. The costs and estimated earnings in excess of billings on uncompleted contracts are stated at estimated realizable value and aggregated $31.6 million and $19.3 million at June 30, 2006 and September 30, 2005, respectively. At June 30, 2006, unbilled accounts receivable on uncompleted contracts included $6.8 million for customer-requested work performed by the Company on new and existing contracts for which the Company had not received contracts or contract modifications. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable losses in the Company’s existing billed and unbilled accounts receivable. The Company determines the allowance using specific identification and historical write-off experience based on the age of the population. Billings in excess of costs and estimated earnings and advance collections from customers represent amounts received from or billed to commercial customers in excess of project revenue recognized to date.

Goodwill and Other Intangibles

The Company adopted Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and Other Intangible Assets, which prohibits amortizing goodwill. SFAS 142 requires the Company to review goodwill at least annually for impairment or if events or changes in circumstances indicate goodwill might be impaired. The Company performs this review at the end of each fiscal year. An impairment loss is to be recognized to the extent that goodwill exceeds fair value. The Company estimates fair value by comparing the carrying amount of goodwill to an estimate of the fair value of Alion common stock based on a valuation performed by an independent third-party firm. If the carrying amount exceeds fair value, an impairment loss is recognized for any excess of recorded goodwill over its implied fair value as determined by allocating fair value similar to a purchase price allocation, under SFAS No. 141, Business Combinations. For the fiscal year ended September 30, 2005, the Company concluded that no goodwill impairment existed as of September 30, 2005. For the nine months ended June 30, 2006, there were no significant events that indicated the existence of goodwill impairment as of June 30, 2006. Intangible assets are amortized over their estimated useful lives of generally one to thirteen years primarily using the straight-line method.

Property, Plant and Equipment

Leasehold improvements, software and equipment are recorded at cost. Expenditures for maintenance and repairs that do not add significant value or significantly lengthen an asset’s useful life are charged to current operations. Software and equipment are depreciated over their estimated useful lives (2 to 15 years for the various classes of software and equipment) generally using the straight-line method. Leasehold improvements are amortized on the straight-line method over the shorter of the assets’ estimated useful life or the life of the lease. Upon sale or retirement of an asset, costs and related accumulated depreciation are deducted from the accounts, and any gain or loss is recognized in the consolidated statements of operations.

Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practicable to estimate fair value. It is impracticable for the Company to estimate the fair

7

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

value of its subordinated debt because the only market for this financial instrument consists of principal to principal transactions. For all of the following items, the fair value is not materially different than the carrying value.

Cash, cash equivalents, accounts payable and accounts receivable

The carrying amount approximates fair value because of the short maturity of those instruments.

Marketable securities

The fair values of these investments are estimated based on quoted or market prices for these or similar instruments.

Senior long-term debt

The carrying amount of the Company’s senior debt approximates fair value which is estimated on current rates offered to the Company for debt of the same remaining maturities.

Interest rate caps

The fair value of the Company’s financial instruments is estimated based on current rates offered to the Company for contracts with similar terms and maturities.

Redeemable common stock warrants

The Company uses an option pricing model to estimate the fair value of its redeemable common stock warrants.

Stock-based compensation

In December 2004, the Financial Accounting Standards Board issued SFAS 123(R), Share Based Payments.  For companies whose stock is not publicly traded on any exchange, this standard is not effective until the first annual reporting period beginning after December 15, 2005. Alion is required to adopt this standard with the Company’s next fiscal year starting October 1, 2006. SFAS 123(R) requires that share-based payments such as phantom stock and stock appreciation rights be recognized as compensation expense based on the fair value of the shares granted. The Company uses the intrinsic value method in APB Opinion No. 25 and FIN 28 to report stock-based compensation related to grants of phantom stock and stock appreciation rights. SFAS 123(R) does not apply to grants issued by the Company prior to the date of adoption. Management does not believe that adoption of SFAS 123(R) will have a material adverse impact on the Company’s results of operations or its cash flows.

8

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(3)   Accounts Receivable

Accounts receivable at June 30, 2006, and September 30, 2005, consist of the following:

	June 30,			September 30,
	2006			2005
	(In thousands)
Billed receivables	$	83,662		$	65,156
Unbilled receivables:
Amounts currently billable		18,193			13,376
Revenues recorded in excess of milestone billings on fixed price contracts		5,137			3,707
Revenues recorded in excess of estimated contract value or funding		6,825			1,323
Retainages and other amounts billable upon contract completion		2,071			875
Allowance for doubtful accounts		(3,854	)		(3,539	)
Total Accounts Receivable	$	112,034		$	80,898

Revenues recorded in excess of milestone billings on fixed price contracts consist of amounts not expected to be billed within the next month. Amounts currently billable consist principally of amounts to be billed within the next month. Indirect cost rates in excess of provisional billing rates on U.S. government contracts are generally billable at actual rates shortly after the end of each fiscal year. Any remaining unbilled balance including retainage is billable upon contract completion or completion of Defense Contract Audit Agency audits. Revenues recorded in excess of contract value or funding are billable upon receipt of contractual amendments or other modifications.

(4)   Employee Stock Ownership Plan (ESOP) and Stock Ownership Trust

On December 19, 2001, the Company adopted the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan (the Plan) and the Trust. The Plan, a tax qualified retirement plan, includes an ESOP component and a non-ESOP component. On August 9, 2005, the Internal Revenue Service issued a determination letter that the Trust and the Plan, as amended through the Ninth Amendment to the Plan, qualify under Sections 401(a) and 501(a) of the Internal Revenue Code of 1986 (the IRC), as amended. The Company believes that the Plan and Trust have been designed and are currently being operated in compliance with the applicable requirements of the IRC.

(5)   Postretirement Benefits

The Company sponsors a medical benefits plan providing certain medical, dental, and vision insurance benefits to eligible employees and former employees. The Company is self-insured and has a stop-loss limit under an insurance agreement.

The Company also provides postretirement medical benefits for employees who meet certain age and service requirements. Retiring employees may become eligible for those benefits at age 55 if they have 20 years of service, or at age 60 with 10 years of service. The plan provides benefits until age 65 and requires employees to pay one-quarter of their health care premiums. A small, closed group of employees is eligible for coverage after age 65. These retirees contribute a fixed portion of their health care premium. The estimated annual contribution to premiums from retirees is approximately $125,000.

There were no plan assets as of June 30, 2006 and September 30, 2005. The Company uses an October 1 measurement date.

9

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

In December 2003, the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the Act) was signed into law. The Act introduced a prescription drug benefit under Medicare Part D and a federal subsidy to sponsors of retirement health care plans that provide a benefit that is at least actuarially equivalent to Medicare Part D. Any measures of the accumulated postretirement benefit obligation or net periodic postretirement benefit cost in the Company’s financial statements do not reflect the effect of the Act. The Company has a small, closed group of retirees covered for medical benefits after age 65, thus the effect of the Act is not expected to be material.

(6)   Loss Per Share

Basic and diluted loss per share is computed by dividing net loss by the weighted average number of common shares outstanding excluding the impact of warrants, phantom stock and stock appreciation rights described herein as this impact would be anti-dilutive for all periods presented.

(7)   Shareholder’s Equity

The Company’s common stock is owned by the Trust. The Company provides a put option to any participant or beneficiary who receives a distribution of common stock which permits the participant or beneficiary to sell such common stock to the Company during certain periods, at the estimated fair value per share, which was $37.06 per share as of June 30, 2006. The estimated fair value per share is determined based upon a valuation performed by an independent, third-party firm. The Company may allow the Trust to purchase shares of common stock tendered to the Company under the put option.

Certain participants have the right to sell the shares distributed from their accounts that were acquired on the closing date of the Transaction at a value per share equal to the greater of the original purchase price or the estimated fair value price per share of the common stock.

(8)   Property, Plant and Equipment

Property, Plant and Equipment consist of the following:

	June 30,			September 30,
	2006			2005
	(In millions)
Leasehold improvements	$	2.7		$	2.3
Equipment and software		25.7			17.4
Total cost		28.4			19.7
Less accumulated depreciation and amortization		(12.3	)		(8.5	)
Net fixed assets	$	16.1		$	11.2

Depreciation and leasehold amortization expense for property, plant and equipment was approximately $1.2 million for each three-month period ended June 30, 2006 and 2005, respectively. Depreciation and leasehold amortization expense for property plant and equipment was approximately $3.6 million and $3.1 million for the nine months ended June 30, 2006 and 2005, respectively.

10

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(9)   Goodwill and Intangible Assets

As of June 30, 2006, the Company has recorded goodwill of approximately $390.1 million. Changes in the carrying amount of goodwill during the nine months ended June 30, 2006, in the aggregate, are summarized in the following table:

	Total
	(In millions)
Balance as of September 30, 2005	$	163.4
Goodwill acquired during the nine month period ended June 30, 2006		225.6
Adjustment to initial allocation made during the nine month period ended June 30, 2006		1.1
Balance as of June 30, 2006	$	390.1

For the acquisitions completed during the twelve-month period ended June 30, 2006, the purchase price allocations are preliminary and subject to change based upon the completion of the valuation of certain intangible assets and other items.

As of June 30, 2006, the Company has recorded gross intangible assets of approximately $113.3 million, accumulated amortization of $38.0 million and net intangible assets of approximately $75.3 million. Intangible assets consist primarily of contracts purchased in connection with the acquisitions of JJMA, IPS, METI, BMH, WCI, MA&D and the contracts the Company acquired from Anteon Corporation (Anteon Contracts) on June 30, 2006.

			Accumulated
	Gross		Amortization		Net
			(In millions)
Purchased contracts	$	110.4	$	37.4	$	73.0
Internal use software and engineering designs		2.2		0.3		1.9
Non-compete agreements		0.7		0.3		0.4
Total	$	113.3	$	38.0	$	75.3

The intangible assets have estimated useful lives of generally one to thirteen years and are being amortized primarily using the straight-line method. The weighted-average remaining amortization period of intangible assets was approximately four years at June 30, 2006. Amortization expense was approximately $6.1 million, and $4.8 million for the quarters ended June 30, 2006 and 2005, respectively. Estimated aggregate amortization expense for the remainder of fiscal year 2006 and for each of the next five years and thereafter is as follows:

		(In millions)
For the remaining three months:	2006	$	3.8
For the year ending September 30:	2007		15.3
	2008		14.8
	2009		14.6
	2010		14.5
	2011		8.6
	and thereafter		3.7
Total:		$	75.3

11

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(10)   Long-Term Debt

To fund the Transaction described in Note 1, the Company entered into various debt agreements (Senior Credit Agreement, Mezzanine Note, and Subordinated Note) on December 20, 2002. On August 2, 2004, the Company entered into a new Term B senior secured credit facility (the Term B Senior Credit Facility) with a syndicate of financial institutions for which Credit Suisse (CS) serves as arranger, administrative agent and collateral agent, and for which LaSalle Bank National Association serves as syndication agent. On April 1, 2005, the Company entered into an incremental term loan facility and an amendment to the Term B Senior Credit Facility (Amendment One), which added $72.0 million in term loans to the Company’s total indebtedness under the Term B Senior Credit Facility. On March 24, 2006, the Company entered into a second incremental term loan facility and second amendment to the Term B Senior Credit Facility (Amendment Two), which increased the term loan commitment under the Term B Senior Credit Facility by $68.0 million. Amendment Two also increased the revolving credit commitment under the senior revolving credit facility from $30.0 million to $50.0 million. On June 30, 2006, the Company entered into a third incremental term loan facility and amendment to the Term B Senior Credit Facility (Amendment Three), which added $50.0 million in term loans to our total indebtedness under the Term B Senior Credit Facility.

The discussion below describes the Term B Senior Credit Facility, as modified by Amendments One, Two and Three; certain of the initial debt agreements (and other related instruments) used to finance the Transaction; and the Bridge Loan Agreement used to finance part of the purchase price of the Anteon Contracts.

Term B Senior Credit Facility

The Term B Senior Credit Facility expires August 2, 2009 and consists of:

•  a senior term loan in the current approximate amount of $259.7 million;

•  a $50.0 million senior revolving credit facility approximately $6.0 million of which was actually borrowed and approximately $5.9 million of which was deemed borrowed as of June 30, 2006, for letters of credit; and

•  a $150.0 million uncommitted incremental term loan “accordion” facility in addition to the three incremental term loans the Company entered into as of April 1, 2005, March 24, 2006, and June 30, 2006.

The Term B Senior Credit Facility requires the Company to repay 1 percent of the principal balance of the senior term loan during each of the first four years (fiscal years 2005 through 2008) and 96 percent of the principal balance outstanding during the fifth and final year (2009). For the quarter ended June 30, 2006, the Company was obligated to pay a principal quarterly installment of $530,000. Through the quarter ending September 30, 2008, the Company is currently obligated to pay quarterly principal installments of $655,000. On December 31, 2008, March 31, 2009, June 30, 2009 and August 2, 2009, the Company is obligated to pay principal installments of approximately $63.4 million.

Under the senior revolving credit facility, the Company may request up to $40.0 million in letters of credit and may borrow up to $5.0 million in swing line loans for short-term borrowing needs. The Company must pay all principal obligations under the senior revolving credit facility in full no later than August 2, 2009.

The Company may prepay all or any portion of its Term B debt in minimum increments of $1 million, generally without penalty or premium, except for customary breakage costs associated with pre-payment of Eurodollar-based loans. If the Company issues certain permitted debt, or sells, transfers or disposes of certain assets, it must use all net proceeds to repay any Term B loan amounts outstanding. If the Company has excess cash flow for any fiscal year, it must use 50% of the excess cash flow to repay Term B loan amounts outstanding. If the Company’s leverage ratio is less than 2:00 to 1:00, it must use only 25% of excess cash flow to repay Term B loan amounts outstanding. Subject to certain exceptions, as long as the Bridge Loan is outstanding, its prepayment terms supersede the pre-payment terms of the Term B Senior Credit Facility. (See Bridge Loan Agreement below.)

12

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

If the Company borrows any additional term loan, including under the uncommitted incremental term loan facility, and certain terms of such loan are more favorable to the new lenders than existing terms under the Term B Senior Credit Facility, the applicable interest rate spread on the senior term loans can increase. As a result, additional term loans could increase the Company’s interest expense under its existing term loans. The Company’s significant subsidiaries (HFA, CATI, METI, JJMA, BMH, WCI and MA&D) guaranteed the Term B Senior Credit Facility.

Use of Proceeds.  On August 2, 2004, the Company borrowed $50.0 million through the senior term loan under the Term B Senior Credit Facility and used approximately $47.2 million to retire its then outstanding senior term loan and revolving credit facility administered by LaSalle Bank including principal and accrued unpaid interest and paid approximately $3.3 million in transaction fees. In October 2004, the Company borrowed approximately $22.0 million of the senior term loan to retire its existing $19.6 million mezzanine note and to pay approximately $2.4 million in accrued unpaid interest and prepayment premium. On April 1, 2005, the Company borrowed $72.0 million in an incremental term loan under the Term B Senior Credit Facility. The Company used approximately $58.7 million of the incremental term loan proceeds to pay a portion of the JJMA acquisition price, and approximately $1.25 million to pay transaction fees associated with the incremental term loan. The Company used approximately $12.0 million to pay a portion of the BMH acquisition price. On March 24, 2006, the Company entered into Amendment Two which made available to the Company $68.0 million in additional incremental term loans. The Company borrowed $32 million and used approximately $16.5 million of the proceeds to pay a portion of the WCI acquisition price, and approximately $13.6 million to redeem the mezzanine warrants held by IIT and the Company’s Chief Executive Officer. On May 15, 2006, the Company borrowed $15.0 million of the incremental term loans made available under Amendment Two in order to pay a portion of the MA&D acquisition price. On June 30, 2006, the Company borrowed $21.0 million of the incremental term loans made available under Amendment Two and $50.0 million in incremental term loans under Amendment Three in order to pay a portion of the acquisition price for the Anteon Contracts.

The Term B Senior Credit Facility permits the Company to use the remainder of its senior revolving credit facility for working capital needs, other general corporate purposes, and to finance permitted acquisitions. The Term B Senior Credit Facility permits the Company to use any proceeds from the uncommitted incremental term loan facility to finance permitted acquisitions and for any other purpose permitted by any future incremental term loan.

Security.  The Term B Senior Credit Facility is secured by a security interest in all of the Company’s current and future tangible and intangible property, as well as all of the current and future tangible and intangible property of the Company’s subsidiaries, HFA, CATI, METI, JJMA, BMH, WCI and MA&D.

13

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Interest and Fees.  Under the Term B Senior Credit Facility, the senior term loan and the senior revolving credit facility can each bear interest at either of two floating rates. The Company was entitled to elect that interest be payable on the Company’s $259.7 million senior term loan at an annual rate equal to either: 1) the applicable alternate base interest rate charged by CS plus 175 basis points or, 2) the Eurodollar rate plus 275 basis points. The Company was also entitled to elect that interest be payable on the senior revolving credit facility at an annual rate dependent on the Company’s leverage ratio and whether the borrowing is a Eurodollar or an alternate base rate (ABR) borrowing. Under the Term B Senior Credit Facility, if the Company were to elect a Eurodollar borrowing under its senior revolving credit facility, interest would be payable at an annual rate equal to the Eurodollar rate plus additional basis points as reflected in the table below under the column “Eurodollar Spread” corresponding to the Company’s leverage ratio at the time. Under the Term B Senior Credit Facility, if the Company were to elect an ABR borrowing under its senior revolving credit facility, the Company would pay interest at an alternate base interest rate based on the greater of CS’s prime rate or a federal funds effective rate, plus additional basis points reflected in the table below under the columns “Prime Rate ABR Spread” or “Federal Funds ABR Spread” corresponding to the Company’s leverage ratio at the time.

	Eurodollar		Federal Funds		Prime Rate
	Spread		ABR Spread		ABR Spread
Leverage Ratio	(in basis points)		(in basis points)		(in basis points)
Category 1		275		225		175
Greater than or equal to 3.00 to 1.00
Category 2		250		200		150
Greater than or equal to 2.50 to 1.00
but less than 3.00 to 1.00
Category 3		225		175		125
Greater than or equal to 2.00 to 1.00
but less than 2.50 to 1.00
Category 4		200		150		100
Less than 2.00 to 1.00

On April 1, 2005, the Company elected to have the senior term loan bear interest at the Eurodollar rate and the senior revolving credit facility bear interest at the ABR rate based on CS’s prime rate. As of June 30, 2006, the Eurodollar rate on the senior term loan was 8.25 percent (5.50 percent plus 2.75 percent Eurodollar spread) and the ABR rate was 10.0 percent (8.25 percent plus 1.75 percent spread).

Interest Rate Cap Agreements.  The Term B Senior Credit Facility requires the Company to maintain interest rate hedge agreements acceptable to CS to cap the Company’s interest expense on at least 40 percent of the Company’s long-term senior debt. The Company has three such agreements in place with its senior lenders.

The interest rate cap agreements cap the floating component of the total interest rate the Company pays, but do not affect spreads based on leverage ratio. The actual effective rate of interest that the Company pays on principal subject to each cap agreement is equal to the floating component in the cap plus the applicable spread. The interest rate spread in Term B Senior Credit Facility is added to the interest rate cap rate in each cap agreement in order to determine the effective interest rates under the cap agreements.

In August 2004, the Company paid approximately $319,000 to cap its interest rate at 6.64% (3.89% floating rate cap plus 2.75% spread) on $36.9 million in notional principal from September 2004 through September 2005 and 7.41% (4.66% floating rate cap plus 2.75% spread) from September 2005 through September 2007. The notional principal declines over time to $34.5 million at September 2007. In April 2005, Amendment One reduced the Eurodollar spread to 225 basis points, such that the total interest payable with respect to the principal amount covered by the first cap agreement was reset to 6.91% (4.66% floating rate cap plus 2.50% spread). In March 2006, Amendment Two increased the Eurodollar spread to 250 basis points, such that the total interest payable with

14

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

respect to the principal amount covered by the first cap agreement was reset to 7.16% (4.66% floating rate cap plus 2.50% spread). In June 2006, Amendment Three increased the Eurodollar spread to 275 basis points, such that the total interest payable with respect to the principal amount covered by the first cap agreement was reset to 7.41% (4.66% floating rate cap plus 2.75% spread).

In April 2005, the Company paid approximately $117,000 to cap its interest rate at 7.25% (5.00% floating rate cap plus 2.25% spread) on an additional $28.0 million in notional principal through September 2007. In March 2006, Amendment Two increased the Eurodollar spread to 250 basis points, such that the total interest payable with respect to the principal amount covered by the second cap agreement was reset to 7.50% (5.00% floating rate cap plus 2.50% spread). In June 2006, Amendment Three increased the Eurodollar spread to 275 basis points, such that the total interest payable with respect to the principal amount covered by the second cap agreement was reset to 7.75% (5.00% floating rate cap plus 2.75% spread).

In April 2006, the Company paid approximately $43,600 to cap its interest rate at 8.00% (5.50% floating rate cap plus 2.50% spread) on an additional $30.0 million in notional principal through September 2007. In June 2006, Amendment Three increased the Eurodollar spread to 275 basis points, such that the total interest payable with respect to the principal amount covered by the third cap agreement was reset to 8.25% (5.50% floating rate cap plus 2.75% spread).

As of June 30, 2006, approximately $94.8 million, or approximately 36.5 percent of the $259.7 million drawn under the Term B Senior Credit Facility was at a capped interest rate. The maximum effective interest rate on the $94.8 million that is currently under cap agreements is approximately 7.79 percent. The remaining outstanding aggregate balance under the Term B Senior Credit Facility over $94.8 million, which was approximately $164.9 million as of June 30, 2006, is not subject to any interest rate cap.

Other Fees and Expenses.  Each quarter the Company is required to pay a commitment fee equal to 50 basis points per year on the prior quarter’s daily unused balance of the revolving credit facility and the senior term loan. As of June 30, 2006, there was approximately $6.0 million outstanding on the revolving credit facility and there was no unused balance on the senior term loan. For the nine months ended June 30, 2006, the Company paid a commitment fee of approximately $0.1 million for the revolving credit facility and no commitment fee for the senior term loan.

In addition to issuance and administrative fees, the Company is required to pay a fronting fee not to exceed 25 basis points for each letter of credit issued under the revolving credit facility. Each quarter the Company is required to pay interest in arrears at the revolving credit facility rate for all outstanding letters of credit. In addition to other fees and expenses under the Term B Senior Credit Facility, the Company is required to pay an annual agent’s fee.

Financial Covenants.  The Term B Senior Credit Facility requires the Company to meet certain financial performance measures over the life of the facility. These financial measures are used by our lenders in evaluating our leverage capacity, debt service ability and liquidity that result from the calculation of leverage ratio and interest coverage ratio and are required by the terms of the Term B Senior Credit Facility. As defined below, both the leverage ratio and interest coverage refer to the non-GAAP term “EBITDA” and the term “Consolidated EBITDA” as defined in the Term B Senior Credit Facility. The definition, calculation and reconciliation of the differences between these non-GAAP financial measures to the most comparable financial measures calculated and presented in accordance with GAAP in this Form 10-Q are included in the schedules that follow.

a) Consolidated EBITDA — Definition

Consolidated EBITDA is defined in the Term B Senior Credit Facility as: (a) net income (or loss), as defined therein, plus (b) the following items, to the extent deducted from net income or included in the net loss, the sum of: (i) interest expense; (ii) provision for income taxes; (iii) depreciation and amortization, including amortization of other intangible assets; (iv) cash contributions to the ESOP in respect of the repurchase liability of the Company

15

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

under the ESOP Plan; (v) any non-cash charges or expenses including (A) non-cash expenses associated with the recognition of the difference between the fair market value of the remaining outstanding Warrants (see Note 11 “Redeemable Common Stock Warrants”) and the exercise price of those Warrants (B) non-cash expenses with respect to the stock appreciation rights and phantom stock plans, and the remaining outstanding Warrants and accretion of those Warrants and (C) non-cash contributions to the ESOP, (vi) any extraordinary losses and (vii) any nonrecurring charges and adjustments by the third-party valuation firm that prepares valuation reports in connection with the ESOP, minus (c) without duplication, (i) all cash payments made on account of reserves, restructuring charges and other non-cash charges added to net income (or included in net loss) pursuant to clause (b)(v) above in a previous period and (ii) to the extent included in net income (or net loss), any extraordinary gains and all non-cash items of income, in accordance with GAAP.

In addition, the Term B Senior Credit Facility adjusts consolidated EBITDA for purposes of calculating compliance with certain financial covenants in the event that the Company acquires another business pursuant to pre-approved procedures and requirements which the Term B Senior Credit Facility refers to as a “Permitted Acquisition” and in cases where the Company sells certain significant assets. In those cases, consolidated EBITDA will be adjusted for a particular accounting period so that consolidated EBITDA takes into account the pro forma effect of such acquisition or asset sale as if it had taken place at the beginning of that particular accounting period.

Consolidated EBITDA has limitations as an analytical tool, and is not to be considered in isolation or as a substitute for analysis of our financial performance or liquidity as reported under GAAP. Some of these limitations are:

•  Consolidated EBITDA does not reflect the Company’s cash expenditures, or future requirements for capital expenditures or contractual commitments;

•  Consolidated EBITDA does not reflect changes in, or cash requirements for, the Company’s working capital needs;

•  Consolidated EBITDA does not reflect interest expense, or the cash requirements necessary to service interest or principal payments, on the Company’s debt; and

•  although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Consolidated EBITDA does not reflect any cash requirements for such replacements.

The calculation and reconciliation to the most comparable financial measure calculated and presented in accordance with GAAP is included in the table below.

Alion Science and Technology Corporation
Non-GAAP Measures — EBITDA and Consolidated EBITDA
For the Twelve Months Ended June 30, 2006 and 2005

Calculation of EBITDA	2006			2005
	(Dollars in thousands) (Unaudited)
Net loss		(23,087	)	$	(38,670	)
Plus: Interest expense		21,309			39,718
Plus: Income tax expense		41			64
Plus: Depreciation and amortization expense		14,728			16,276
EBITDA	$	12,991		$	17,388

16

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Calculation of Consolidated EBITDA	2006		2005
EBITDA	$	12,991	$	17,388
Plus: Cash contributions to ESOP in respect of the repurchase liability		2,380		—
Plus: Non-cash expenses with respect to the stock appreciation rights and phantom stock plans (Stock-based compensation less cash settlements)		11,307		8,758
Plus: Non-cash contributions to the ESOP (including Company 401-k match)		6,839		4,914
Plus: Any nonrecurring charges and adjustments by third-party valuation firm that prepares valuation reports in connection with the ESOP		10,091		1,180
Plus: Acquisition-related pro forma adjustment to EBITDA attributable to the METI, CATI, JJMA, BMH WCI and Anteon Contracts acquisitions		28,974		—
Consolidated EBITDA	$	72,583	$	32,240

Leverage Ratio.  The Company’s leverage ratio is calculated by dividing the total outstanding amount of all of the Company’s consolidated indebtedness, but excluding the amount owed under the Company’s Subordinated Note and the aggregate amount of letters of credit issued on the Company’s behalf other than drawings which have not been reimbursed, by the Company’s Consolidated EBITDA for the previous four fiscal quarters on a rolling basis. The maximum total leverage ratio is measured as of the end of each of our fiscal quarters. For each of the following time periods, the Company is permitted to maintain a maximum leverage ratio not greater than the following:

Period	Ratio
June 30, 2006 through September 30, 2007		6.50 to 1.00
October 1, 2007 through June 30, 2008		6.00 to 1.00
July 1, 2008 through June 30, 2009		5.75 to 1.00
Thereafter		5.25 to 1.00

The calculation of the Company’s Leverage Ratio for the twelve months ended June 30, 2006 and 2005 is set forth in the table below.

Alion Science and Technology Corporation
Computation of Leverage Ratio
Under the Term B Senior Credit Facility
For the Twelve Months Ended June 30, 2006 and 2005

Numerator:	2006		2005
	(Dollars in thousands) (Unaudited)
Revolving credit facility	$	11,858	$	—
Term B Senior Credit facility debt outstanding, at face value		259,670		143,280
Bridge loan		170,000		—
Total debt outstanding	$	441,528	$	143,280

Denominator:
Consolidated EBITDA	$	72,583	$	32,240
Leverage ratio:		6.07		4.44

17

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Interest Coverage Ratio.  The Company’s interest coverage ratio is calculated by dividing the Company’s consolidated EBITDA, less amounts the Company spends attributable to property, plant, equipment and other fixed assets, by the Company’s consolidated interest expense. For each of the following time periods, the Company will be required to maintain a minimum interest coverage ratio not less than the following:

Period	Ratio
June 30, 2006 through September 30, 2007		1.65 to 1.00
October 1, 2007 through September 30, 2008		1.75 to 1.00
Thereafter		2.00 to 1.00

The calculation of the Company’s Interest Coverage Ratio for the twelve months ended June 30, 2006 and 2005 is set forth in the table below.

Alion Science and Technology Corporation
Computation of Interest Coverage Ratio
Under the Term B Senior Credit Facility
For the Twelve Months Ended June 30, 2006 and 2005

Numerator:	2006		2005
	(Dollars in thousands) (Unaudited)
Consolidated EBITDA	$	72,583	$	32,240
Less: Capital expenditures		4,968		2,654
Consolidated EBITDA less capital expenditures	$	67,615	$	29,586

Denominator:
Annual cash pay interest	$	10,777	$	7,354
Interest coverage ratio		6.27		4.02

The Term B Senior Credit Facility includes other covenants which, among other things, restrict the Company’s ability to do the following without the prior consent of syndicate bank members that have extended more than 50 percent or more of the aggregate amount of all loans then outstanding under the Term B Senior Credit Facility:

•  incur additional indebtedness other than permitted additional indebtedness;

•  consolidate, merge or sell all or substantially all of the Company’s assets;

•  make certain loans and investments including acquisitions of businesses, other than permitted acquisitions;

•  pay dividends or distributions other than distributions needed for the ESOP to satisfy its repurchase obligations and for certain payments required under the Company’s equity based incentive plans;

•  enter into transactions with the Company’s shareholders and affiliates;

•  enter into certain transactions not permitted under ERISA;

•  grant certain liens and security interests;

•  enter into sale and leaseback transactions;

•  change lines of business;

•  repay subordinated indebtedness and redeem or repurchase certain equity;

18

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

•  pay certain earn outs in connection with permitted acquisitions or

•  use the proceeds of the Company’s borrowings other than as permitted by the Term B Senior Credit Facility.

Events of Default.  The Term B Senior Credit Facility contains customary events of default including, without limitation:

•  payment default;

•  breach of representations and warranties;

•  uncured covenant breaches;

•  default under certain other debt exceeding an agreed amount;

•  bankruptcy and insolvency events;

•  notice of debarment, suspension or termination under a material government contract;

•  certain ERISA violations;

•  unstayed judgments in excess of an agreed amount;

•  failure of the subordinated note to be subordinated to the Term B Senior Credit Facility;

•  failure of any guarantee of the Term B Senior Credit Facility to be in effect;

•  failure of the security interests to be valid, perfected first priority security interests in the collateral;

•  failure of the Company to remain an S-corporation;

•  imposition on the Trust of certain taxes in excess of an agreed amount;

•  final determination that the ESOP is not a qualified plan;

•  incurrence of a civil or criminal liability in excess of $5 million of the Company or any subsidiary arising from a government investigation;

•  the actual termination of a material contract due to alleged fraud,, willful misconduct, negligence, default or any other wrongdoing; or

•  change of control (as defined below).

For purposes of the Term B Senior Credit Facility, a change of control generally occurs when, before the Company lists its common stock to trade on a national securities exchange or the NASDAQ National Market quotation system and obtains net proceeds from an underwritten public offering of at least $30.0 million the Trust fails to own at least 51 percent of the Company’s outstanding equity interests, or, after the Company has such a qualified public offering, any person or group other than IIT or the Trust owns more than 37.5 percent of the Company’s outstanding equity interests. A change of control may also occur if a majority of the seats (other than vacant seats) on the Company’s board of directors shall at any time be occupied by persons who were neither nominated by our board nor were appointed by directors so nominated. A change of control may also occur if a change of control occurs under any of the Company’s material indebtedness including the Company’s subordinated note and the warrants issued with the Company’s subordinated note.

For the three and nine months ended June 30, 2006 and 2005, the Company was in compliance in all material respects with the covenants set forth in the Term B Senior Credit Facility.

19

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Mezzanine Note

On December 20, 2002, the Company issued a $20.3 million note to IITRI (Mezzanine Note) as part of the consideration for the Transaction. On July 1, 2004, the Illinois Institute of Technology (IIT) acquired all of IITRI’s rights and interests in the Mezzanine Note and the related Warrant Agreement. On October 1, 2004, the Company redeemed the Mezzanine Note for approximately $19.6 million, and paid a prepayment penalty of approximately $1.8 million and approximately $0.6 million in accrued interest. On extinguishment of the Mezzanine Note, the Company recognized approximately $2.1 million of unamortized original issue discount in addition to the $1.8 million prepayment penalty.

Subordinated Note

On December 20, 2002, the Company issued a $39.9 million note to IITRI (Subordinated Note) as part of the consideration for the Transaction. On July 1, 2004, the Illinois Institute of Technology (IIT) acquired all of IITRI’s rights and interests in the Subordinated Note and the related Warrant Agreement. On June 30, 2006, the Company and IIT entered into an agreement, which increased interest payable on the Subordinated Note from December 21, 2006 through December 20, 2008.

The Subordinated Note bears interest at (i) 6% through December 20, 2006, (ii) approximately 6.4% from December 21, 2006 through December 20, 2007, and (iii) 6.7% from December 21, 2007 through December 20, 2008. Interest is payable quarterly by the issuance of paid-in-kind or PIK notes maturing at the same time as the Subordinated Note. The issuance of the PIK notes has the effect of deferring the underlying cash interest expense on the Subordinated Note. Commencing December 2008, the Subordinated Note will bear interest at 16% per year payable quarterly in cash through the time of repayment in full of the Subordinated Note. Principal on the Subordinated Note will be payable in equal installments of $19.95 million in December 2009 and December 2010; the PIK notes are also due in equal installments of approximately $7.4 million on these same dates.

Bridge Loan Agreement

On June 30, 2006, the Company entered into a Bridge Loan Agreement with Credit Suisse and borrowed $170 million (the Bridge Loan, also called the Initial Loan). Certain of the Company’s subsidiaries have guaranteed the Bridge Loan Agreement. The Initial Loan is due December 31, 2007 and automatically converts to an Extended Loan maturing December 31, 2011, if it has not been repaid by December 31, 2007. Aggregate outstanding principal under the Bridge Loan is due and payable on December 31, 2011, together with accrued and unpaid interest and applicable premiums, unless it is repaid and satisfied before then.

If the Company issues certain permitted debt (excluding the Term B Senior Credit Facility), or sells, transfers or disposes of certain assets other than in the normal course of business, or issues or sells certain kinds of equity interests, it must use all net proceeds to repay any Bridge Loan amounts outstanding.

Use of Proceeds.  The Company used the proceeds from the Bridge Loan to pay part of the cost of acquiring the Anteon Contracts.

20

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Interest and Prepayment.  The Bridge Loan bears interest at a floating rate based on the Eurodollar Rate plus the applicable spread reflected in the table below which varies over four time periods: July 1 — December 31, 2006; January 1, 2007 — June 30, 2007; July 1 — December 31, 2007; and January 1, 2008 — December 31, 2011. The first interest payment is due September 30, 2006. Interest is payable quarterly in arrears in cash except that the Company may elect to pay any interest payable in excess of 700 basis points over the applicable Eurodollar floating rate in the form of PIK notes or it may elect to add the excess to the principal amount of the Bridge Loan. The Company may prepay all or any portion of the Bridge Loan in minimum increments of $100,000, as long as the Company repays an aggregate of at least $1.0 million plus applicable premium (described below) and customary breakage costs associated with pre-payment of Eurodollar-based loans. Bridge Loan prepayments are subject to an applicable premium percentage (in basis points) of the principal amount being repaid based on the prepayment date. Applicable margins for interest rates based on the Eurodollar rate and prepayment premium percentages are disclosed in the table below.

		Eurodollar
		Spread		Prepayment
		Basis		Premium in
From	Through	Points		Basis Points
July 1, 2006	December 31, 2006		550		-0-
January 1, 2007	June 30, 2007		625		100
July 1, 2007	December 31, 2007		700		200
January 1, 2008	December 31, 2008		900		100
January 1, 2009	December 31, 2009		900		200
January 1, 2010	December 31, 2011		900		300

Financial Covenants.  The Bridge Loan Agreement requires the Company to meet certain financial performance measures. Our lenders use these measures to evaluate our leverage capacity, debt service ability and liquidity. The Company’s financial covenants are based on the non-GAAP terms EBITDA and Consolidated EBITDA which are calculated in the same manner as under the Term B Senior Credit Facility. The limitations of Consolidated EBITDA as an analytical tool and a calculation of the Company’s Consolidated EBITDA are set forth above in “Consolidated EBITDA Definition” and “Calculation of EBITDA.”

Leverage Ratio.  The leverage ratio is calculated in the same manner as the leverage ratio for the Term B Senior Credit Facility. For each of the following time periods, the Company is required to maintain a maximum leverage ratio not greater than the following:

Period	Ratio
June 30, 2006 through September 30, 2007		7.00 to 1.00
October 1, 2007 through June 30, 2008		6.50 to 1.00
July 1, 2008 through June 30, 2009		6.25 to 1.00
July 1, 2009 through September 30, 2010		5.75 to 1.00
Thereafter		4.75 to 1.00

21

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Interest Coverage Ratio.  The interest coverage ratio is calculated in the same manner as the interest coverage ratio for the Term B Senior Credit Facility. For each of the following time periods, the company is required to maintain a minimum interest coverage ratio not less than the following:

Period	Ratio
July 1, 2006 through September 30, 2007		1.40 to 1.00
October 1, 2007 through September 30, 2008		1.50 to 1.00
October 1, 2008 through September 30, 2009		1.75 to 1.00
October 1, 2009 through September 30, 2010		1.90 to 1.00
Thereafter		2.00 to 1.00

The Bridge Loan Agreement includes other covenants which, among other things, restrict the Company’s ability to do the following without the prior consent of those Bridge Loan lenders that have extended more than 50 percent of the aggregate amount of the outstanding principal amount of the Bridge Loan:

•  incur additional indebtedness other than permitted additional indebtedness;

•  consolidate, merge or sell all or substantially all of the Company’s assets;

•  make certain loans and investments including acquisitions of businesses, other than permitted acquisitions;

•  pay dividends or distributions other than distributions needed for the ESOP to satisfy its repurchase obligations and for certain payments required under the Company’s equity based incentive plans;

•  enter into transactions with the Company’s shareholders and affiliates;

•  enter into certain transactions not permitted under ERISA;

•  grant certain liens and security interests;

•  enter into sale and leaseback transactions;

•  change lines of business;

•  repay subordinated indebtedness and redeem or repurchase certain equity;

•  use the proceeds other than as permitted by the Bridge Loan; and

•  pay certain earn-outs in connection with permitted acquisitions.

Events of Default.  The Bridge Loan Agreement contains customary events of default including, without limitation:

•  payment default;

•  breach of representations and warranties;

•  uncured covenant breaches;

•  default under certain other debt exceeding an agreed amount;

•  bankruptcy and insolvency events;

•  notice of debarment, suspension or termination under a material government contract;

•  incurrence of a Government investigation resulting in a criminal or civil liability of the Company, or any subsidiary, in excess of $10.0 million;

•  the actual termination of a material contract due to alleged fraud, misconduct or any other wrongdoing;

•  certain ERISA violations;

•  failure of the subordinated note to be subordinated to the Bridge Loan Agreement;

•  failure of the Company to remain an S-corporation

22

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

•  imposition on the Trust of certain taxes in excess of an agreed amount; or

•  final determination that the ESOP is not a qualified plan.

As of June 30, 2006, the Company was in compliance in all material respects with the covenants set forth in the Bridge Loan.

Other Notes and Agreements

On December 20, 2002, the Company entered into a $0.9 million deferred compensation agreement with Dr. Bahman Atefi, its President, CEO and Chairman, as a condition to completing the Transaction, with payment terms substantially equivalent to those of the Mezzanine Note. The Company issued detachable warrants representing the right to buy approximately 22,062 shares of Alion common stock at an exercise price of $10.00 per share, with put rights similar to those contained in the warrants accompanying the Mezzanine Note. On October 29, 2004, the Company paid Dr. Atefi approximately $1.1 million, including $0.2 million in accrued interest under his deferred compensation agreement.

On February 11, 2004, the Company borrowed $750,000 from an officer of the Company and issued a promissory note with interest at a rate of 15% per year, payable quarterly, effective February 11, 2004. On December 9, 2004, the Company paid the officer $750,000 plus accrued interest of $21,635 to extinguish the Promissory Note.

As of June 30, 2006, the remaining fiscal year principal repayments (at face amount before debt discount) for outstanding indebtedness are as follows:

	2006		2007		2008		2009		2010		2011		Total
Senior Secured Term B Loan(1)	$	0.7	$	2.6	$	2.6	$	253.8	$	—	$	—	$	259.7
Bridge Loan(2)		—		—		—		—		—	$	175.1		175.1
Subordinated Seller Note(3)		—		—		—		19.9		19.9	$	—		39.8
Subordinated Paid in Kind Note(4)		—		—		—		7.4		7.4	$	—		14.8
Total principal payments	$	0.7	$	2.6	$	2.6	$	281.1	$	27.3	$	175.1	$	489.4

(1)	The table reflects the balance drawn of $259.7 million as of June 30, 2006, expected annual principal payments of approximately $0.7 million for the remainder of fiscal year 2006 and $2.6 million for fiscal years 2007 and 2008. During 2009, we expect to pay approximately $253.8 million in principal. The table does not reflect any prepayments of the Term B Senior Credit Facility based on excess cash flow or other conditions as the timing and amount of any such payments are uncertain. The approximate $254.9 million on the face of the balance sheet includes, as of June 30, 2006, approximately $10.1 million of unamortized debt issue costs which totaled approximately $12.3 million.
(2)	The table reflects the balance drawn of $170.0 million as of June 30, 2006. The principal amount, plus applicable prepayment premium, is due and payable on December 31, 2011. The principal amount of $175.1 million includes $170.0 million principal at par value plus prepayment premium of $5.1 million (3% of par). The approximate $164.7 million on the face of the balance sheet includes, as of June 30, 2006, approximately zero unamortized debt issue costs which totaled approximately $5.3 million.
(3)	Repayment of $39.9 million for the face value of the Subordinated Seller Note in two equal payments of $19.95 million in years 2009 and 2010. The $39.9 million includes, as of June 30, 2006, approximately $4.6 million of unamortized debt discount assigned to fair value of the detachable warrants. On the date of issuance, December 20, 2002, approximately $7.1 million was assigned as the fair value of the warrants in accordance with Emerging Issues Task Force Issue No. 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially settled in, a Company’s Own Stock.”
(4)	During the eight-year term of the Subordinated Note, approximately $14.8 million of principal accretes to the note and is included in the principal payments in fiscal years 2009 and 2010. The principal, together with the outstanding balance of the PIK notes will be paid in equal amounts at the end of fiscal years 2009 and 2010.

23

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(11)   Redeemable Common Stock Warrants

In connection with the issuance of the Mezzanine Note, Subordinated Note, and the Deferred Compensation Agreement described in Note 10, the Company issued 524,229 (an amount which was subsequently reduced by repurchase of 19,327 warrants), 1,080,437, and 22,062, respectively, detachable redeemable common stock warrants (the Warrants) to IITRI and Dr. Atefi. As of July 1, 2004, IITRI transferred all of its rights, title and interest in the warrants to the Illinois Institute of Technology (IIT). On March 28, 2006, the Company redeemed all of the outstanding warrants issued in connection with the Mezzanine Note and Deferred Compensation Agreements, 504,902 and 22,062 warrants, respectively. The Company paid approximately $13.1 million to redeem the warrants issued in connection with the Mezzanine Note, and paid approximately $0.57 million to redeem the warrants issued in connection with the Deferred Compensation Agreement. The Subordinated Note Warrants have an exercise price of $10 per share and are exercisable until December 20, 2010. The Warrants permit the holders to sell the warrants back to the Company, at predetermined times, at the then current fair value of the common stock less the exercise price. The Warrants are classified as debt instruments in accordance with Emerging Issues Task Force Issue No. 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock”. The estimated fair value of the Warrants of approximately $10.3 million on the date of issuance was recorded as a discount to the face value of the notes issued and as a liability in the accompanying consolidated balance sheet. The estimated fair value of the Warrants remaining outstanding as of June 30, 2006 was $32.4 million. Changes in the estimated fair value of the Warrants are recorded as interest expense in the accompanying consolidated statements of operations.

(12)   Leases

Future minimum lease payments under non-cancelable operating leases for buildings, equipment and automobiles at June 30, 2006 are set out below. Under these operating leases, the Company subleased some excess capacity to subtenants under non-cancelable operating leases. In connection with the IPS, METI, and JJMA acquisitions, the Company assumed operating leases at above-market rates and recorded a loss accrual of approximately $5.2 million based on the estimated fair value of the lease liabilities assumed. The loss is being amortized over the lease terms; the remaining unamortized balance was $2.6 million at June 30, 2006. In connection with the IPS acquisition, the Company also acquired a related sub-lease pursuant to which it receives above-market rates. Based on the estimated fair value of the sublease, the Company recognized an asset of $0.6 million which is being amortized over the lease term. The remaining asset value was $0.3 million at June 30, 2006.

Fiscal Years Ending	(In millions)
2006 (for the remainder of fiscal year)	$	6.5
2007		25.4
2008		21.9
2009		17.8
2010		12.9
2011		10.0
and thereafter		12.5
Gross lease payments	$	107.0
Less: non-cancelable subtenant receipts		6.7
Net lease payments	$	100.3

Rent expense under operating leases was $4.6 million and $3.6 million for the three months ended June 30, 2006 and 2005, respectively, and $18.3 million and $9.2 million for the nine months ended June 30, 2006 and 2005, respectively. Sublease rental income under operating leases was $0.5 million and $0.4 million for the three months ended June 30, 2006 and 2005, respectively, and $2.1 million and $1.3 million for the nine months ended June 30, 2006 and 2005, respectively.

24

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(13)   Stock Appreciation Rights

In November 2002, the board of directors adopted the Alion Science and Technology Corporation 2002 Stock Appreciation Rights (SAR) Plan (the “2002 SAR Plan”), which is administered by the compensation committee of the board or its delegate. On November 9, 2004, the board of directors amended the 2002 SAR Plan to provide that, on or after October 3, 2004, no further grants would be made under the 2002 SAR Plan. Existing grants made under the plan before October 3, 2004, remain in force. The 2002 SAR Plan has a term of ten years. Awards were granted under the plan to directors, officers, and employees. Outstanding SAR awards cannot exceed the equivalent of 10% of the Company’s outstanding shares of common stock on a fully diluted basis. A grantee has the right to receive payment upon exercise equal to the difference between the appraised value of a share of Alion common stock as of the grant date and the appraised value of a share of Alion common stock as of the exercise date based on the most recent valuation of the shares of common stock held by the ESOP. Under the 2002 SAR Plan, awards vest at 20% per year for employees. Awards to members of the Company’s board of directors vest ratably over each member’s then-current term of office. From December 2002 through November 2003, the Company granted 236,400 SARs to directors and employees.

In November 2005, the board of directors approved an amendment to the 2002 SAR plan to permit employees to make two separate one-time elections, 1) to receive payment for SARs as they vest each year or when fully-vested and 2) to receive payment for SARs already vested. The board of directors also amended the 2002 SAR plan to eliminate the requirement to timely exercise in order for an employee to receive payment for vested SARs.

On January 13, 2005, the Company’s board of directors adopted a second SAR plan, the Alion Science and Technology Corporation 2004 Stock Appreciation Rights Plan (the “2004 SAR Plan”), to comply with the deferred compensation provisions of the American Jobs Creation Act of 2004.

The 2004 SAR Plan has a 10-year term. Awards may be granted under the plan to Alion directors, officers, employees and consultants. Under the Plan, the chief executive officer has the authority to grant awards as he deems appropriate; however, awards to executive officers are subject to the approval of the administrative committee of the Plan. Outstanding SAR awards cannot exceed the equivalent of 12% of the Company’s outstanding shares of common stock on a fully diluted basis. Awards to employees vest ratably over four years and awards to directors vest ratably over each director’s term of service. The 2004 SAR Plan contains a provision for accelerated vesting in the event of death, disability or a change in control of the Company.

A grantee has the right to receive payment for vested SARs equal to the difference between the appraised value of a share of Alion common stock as of the grant date and the appraised value of a share of Alion common stock as of the exercise date per the most recent valuation of the common stock held by the ESOP. For SARs granted under the 2004 SAR Plan before November 9, 2005 and outstanding when a change in control of the Company occurs, payment is based on the number of SARs multiplied by the share price at the date of the change in control (or earlier valuation, if higher).

In November 2005, the board of directors approved an amendment to the 2004 SAR Plan to permit employees to make a one-time election to receive payment for SARs as they vest each year or when fully vested. The board of directors also approved an amendment to the 2004 SAR Plan to eliminate the requirement to timely exercise in order for an employee to receive payment for vested SARs. As of June 30, 2006, the Company has granted 689,325 SARs under the 2004 SAR Plan.

For the quarters ended June 30, 2006 and 2005, the Company recognized approximately $1.0 million, and $1.6 million, respectively, in compensation expense associated with the two SAR plans.

25

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The table below sets out the disclosures required by SFAS No. 123 and the assumptions used to value a share of Alion common stock and the Company’s grants of stock appreciation rights as of June 30, 2006 and September 30, 2005. The Company uses the intrinsic value method to recognize stock-based compensation expense. There is no established public trading market for Alion’s common stock. The ESOP is the only holder of our common stock. The Company uses an independent third party valuation firm to determine the fair market value of a share of Alion common stock. Alion does not expect to pay any dividends on its common stock. The terms of the senior credit facility and the subordinated note prohibit us from paying dividends without the consent of the respective lenders. We currently intend to retain future earnings, if any, for use in the operation of our business.

Alion Science and Technology Corporation
Stock-based Compensation Disclosures per FAS 123
Stock Appreciation Rights
As of June 30, 2006

	Shares		Shares		Total																									Remaining
Date of	Granted to		Granted to		Shares		Exercise		Outstanding		Outstanding								Vested		Exercisable		Risk Free					Expected		Life
Grant	Employees		Directors		Granted		Price		at 10/1/05		6/30/06		Forfeited		Exercised		Expired		6/30/06		at 6/30/06		Interest Rate		Volatility			Life		(months)
December 2002		64,250		29,400		93,650	$	10.00		53,450		47,325		140		5,985		—		26,825		860		4.06%-4.49%		60	%		5 yrs		16.4
May 2003		300				300	$	11.13		300		240		—		60		—		60		—		2.70%-3.30%		55	%		5 yrs		21.8
June 2003		300				300	$	11.13		300		300		—		—		—		120		—		2.70%-3.30%		55	%		5 yrs		22.6
November 2003		129,550		12,600		142,150	$	14.71		127,920		109,850		3,530		14,540				45,680		4,120		4.06%-4.49%		60	%		5 yrs		28.3
November 2004		—		12,600		12,600	$	19.94		12,600		12,600		—		—		—		4,200		4,200		3.10%-3.60%		45	%		3 yrs		16.5
February 2005		164,750				164,750	$	19.94		152,400		144,475		263		7,663				30,175		—		3.10%-3.60%		45	%		4 yrs		30.9
March 2005		2,000				2,000	$	19.94		2,000		2,000		—		—		—		500		—		3.10%-3.60%		45	%		4 yrs		32.0
April 2005		33,000				33,000	$	29.81		30,250		24,750		2,750		2,750		—		4,125		—		4.10%-4.20%		45	%		4 yrs		32.9
June 2005		2,000				2,000	$	29.81		2,000		2,000		—		—		—		500		—		4.10%-4.20%		45	%		4 yrs		35.1
December 2005		272,675				272,675	$	35.89		267,075		261,475		5,600		—		—		—		—		4.20%-4.20%		40	%		4 yrs		41.7
February 2006		13,000				13,000	$	35.89		13,000		13,000		—		—		—		—		—		4.20%-4.20%		40	%		4 yrs		43.4
February 2006		7,500				7,500	$	35.89		7,500		7,500		—		—		—		—		—		4.20%-4.20%		40	%		4 yrs		43.8
Total		689,325		54,600		743,925				668,795		625,515		12,283		30,998		—		112,185		9,180
Wtd Avg Exercise Price	$	25.31	$	13.38	$	24.43			$	25.47	$	25.87	$	27.81	$	16.43	$	—	$	15.83	$	16.66									34.1

26

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(14)   Phantom Stock Plans

Phantom stock refers to hypothetical shares of Alion common stock. Recipients, upon vesting, are generally entitled to receive cash equal to the product of the number of hypothetical shares vested and the then-current value of Alion common stock, based on the most recent valuation of the shares of common stock held by the ESOP. The Company’s phantom stock plans are administered by the compensation committee of the board of directors which is authorized to grant key management employees and outside directors awards of phantom stock.

Grants of phantom stock do not confer voting or any other rights associated with ownership of our common stock. References to shares of common stock under the plan are for accounting and valuation purposes only.

The Company is authorized to issue up to 2.0 million shares of Phantom Stock in the aggregate for all Phantom Stock plans.

Initial Phantom Stock Plan

In February 2003, the compensation committee of Alion’s board of directors approved, and the board of directors subsequently adopted, the Alion Science and Technology Phantom Stock Plan (the “Initial Phantom Stock Plan”).

The Initial Phantom Stock plan has a term of ten years. The Initial Phantom Stock Plan contains provisions for acceleration of vesting and payouts in connection with an employee’s death, disability, involuntary termination of employment without cause or a change in control of the Company. The phantom stock awards vest according to the following:

	The Vested Amount
	for Grant in
	February			November
Anniversary from Grant Date	2003			2003
1st		—			20	%
2nd		—			20	%
3rd		50	%		20	%
4th		25	%		20	%
5th		25	%		20	%

As of June 30, 2006, under the Initial Phantom Stock Plan, the Company had granted 223,685 shares of phantom stock.

Second Phantom Stock Plan

On November 9, 2004, the Company’s compensation committee approved, and the full board adopted, the Alion Science and Technology Corporation Performance Shares and Retention Phantom Stock Plan (the “Second Phantom Stock Plan”) to comply with the requirements of the American Jobs Creation Act.

The Second Phantom Stock Plan permits awards of retention share phantom stock and performance share phantom stock. A retention award is for a fixed number of shares determined at the date of grant. A performance award is for an initial number of shares subject to change at the vesting date. Performance phantom shares are subject to forfeiture for failure to achieve a specified threshold value for a share of the Company’s common stock as of the vesting date. If the value of a share of the Company’s common stock equals the threshold value but does not exceed the target value, the number of performance shares in a given grant may be decreased by a specified percentage (generally up to 50 percent). If the value of a share of the Company’s common stock exceeds a pre-established target price on the vesting date, the number of performance shares in a given grant may be increased by a specified percentage (generally up to 20%).

27

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Awards of performance share phantom stock vest three years from date of grant (unless otherwise provided in an individual award agreement) and awards of retention share phantom stock vest as specified in each individual award agreement, provided that the grantee is still employed by the Company. Under limited circumstances, a grantee may defer an award payout beyond the original date. The Second Phantom Stock Plan contains provisions for acceleration of vesting and payouts in connection with an employee’s death, disability, involuntary termination of employment without cause or a change in control of the Company.

In November 2005, the board of directors approved amendments to the Initial Phantom Stock Plan and the Second Phantom Stock Plan to permit employees to make a one-time election for either or both plans to receive payment for phantom shares as they vest each year or when fully vested.

As of June 30, 2006, the Company has granted 233,708 shares of retention phantom stock and 202,763 shares of performance phantom stock under the Second Phantom Stock Plan.

Director Phantom Stock Plan

On November 9, 2005, the Company’s compensation committee approved, and the full board adopted, the Alion Science and Technology Corporation Board of Directors Phantom Stock Plan (Director Phantom Stock Plan).

The Director Phantom Stock Plan provides for annual awards of shares of phantom stock to non-employee directors of the Company. The number of shares of phantom stock granted each year to each non-employee director is equal to the quotient obtained by dividing $35,000 by the fair market value of one share of the Company’s stock as of the date of the award rounded up to the next highest whole number. Fair market value is determined by the Administrative Committee in its sole discretion using the most recent valuation of the Company’s common stock made by an independent appraisal that meets the requirements of Code Section 401(a)(28)(C), as of a date that is no more than 12 months before the date of the award.

Grants under the Director Phantom Stock Plan vest in one-third increments each year for three years from the date of the award. Vesting of an award accelerates upon a grantee’s death or disability or upon a change of control of the Company. Before each award is granted (or within 30 days of the grant date for individuals who become a director on the grant date), a director may elect whether to receive payment for phantom shares as they vest, or when the award is fully vested. A director who elects to receive payment when an award has fully vested, may elect to defer the proceeds of the award into the Alion Science and Technology Director Deferred Compensation Plan provided the election is made no later than one year before the award fully vests. All payments made under the awards shall be in cash.

As of June 30, 2006, the Company had granted 7,808 shares of phantom stock under the Director Phantom Stock Plan.

For the quarters ended June 30, 2006 and 2005, the Company recognized approximately $2.3 million and $2.0 million, respectively, in compensation expense associated with all three phantom stock plans.

28

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The table below sets out the disclosures required by SFAS No. 123 and the assumptions used to value a share of Alion common stock and the Company’s grants of phantom stock as of June 30, 2006 and September 30, 2005. The Company uses the intrinsic value method to recognize stock-based compensation expense. There is no established public trading market for Alion’s common stock. The ESOP is the only holder of the Company’s common stock. The Company uses an independent third party valuation firm to determine the fair market value of a share of Alion common stock. Alion does not expect to pay any dividends on its common stock. The terms of the senior credit facility and the Subordinated Note prohibit paying dividends without the consent of the respective lenders. The Company intends to retain future earnings, if any, for use in the business.

Alion Science and Technology Corporation
Stock-based Compensation Disclosures per FAS 123
Phantom Stock
as of June 30, 2006

	Shares		Shares		Total		Grant Date																		Free							Remaining
	Granted to		Granted to		Shares		Price		Outstanding		Outstanding		Outstanding								Vested at		Exercisable		Interest					Expected		Life
Date of Grant	Employees		Directors		Granted		per Share		at 10/1/04		at 9/30/05		at 6/30/06		Forfeited		Exercised		Expired		6/30/06		at 6/30/06		Rate		Volatility			Life		(months)
February 2003		171,000				171,000	$	10.00		171,000		171,000		85,000		6,232		79,768		—		16,500		—		4.06%-4.49%		60	%		5 yrs		18.8
November 2003		52,685				52,685	$	14.71		52,685		52,685		32,971		2,107		17,607		—		3,331		—		4.06%-4.49%		60	%		5 yrs		28.3
January 2005		202,763				202,763	$	19.94		—		202,763		202,763		—		—		—		—		—		3.10%-3.60%		45	%		3 yrs		18.6
January 2005		103,414				103,414	$	19.94				103,414		103,414								—		—		3.10%-3.60%		45	%		3 yrs		18.6
January 2005		5,015				5,015	$	19.94		—		5,015		5,015		—		—				1,254		—		3.10%-3.60%		45	%		4 yrs		30.6
August 2005		2,960				2,960	$	33.78		—		2,960		2,960		—		—		—		—		—		3.72%-3.77%		45	%		3 yrs		25.0
November 2005		66,592		7,808		74,400	$	35.89		—		—		74,400		—		—				—		—		4.20%-4.20%		40	%		3 yrs		28.2
November 2005		55,726				55,726	$	35.89		—		—		55,726		—		—		—		—		—		4.20%-4.20%		40	%		5 yrs		52.2
Total		660,156		7,808		667,964				223,685		537,838		562,249		8,340		97,375		—		21,085		—
Wtd Avg Grant Date Fair Value Price per Share	$	19.97	$	35.89	$	20.15			$	11.11	$	16.34	$	21.89	$	11.19	$	10.85	$	—	$	11.34	$	—									23.9

29

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(15)   Segment Information and Customer Concentration

The Company operates in one segment, delivering a broad array of scientific and engineering expertise to research and develop technological solutions for problems relating to national defense, public health and safety, and nuclear safety and analysis under contracts with the federal government, state and local governments, and commercial customers. The Company’s federal government customers typically exercise independent contracting authority, and even offices or divisions within an agency or department may directly, or through a prime contractor, use the Company’s services as a separate customer so long as that customer has independent decision-making and contracting authority within its organization.

Contract receivables from agencies of the federal government represented approximately $104.0 million, or 91%, of accounts receivable at June 30, 2006 and $79.0 million, or 94%, of accounts receivable at September 30, 2005. Contract revenues from agencies of the federal government represented approximately 94.7% of total contract revenues during the nine months ended June 30, 2006 and 98% of total contract revenues during the nine months ended June 30, 2005. Two prime contracts with the Department of Defense represented approximately 14.6% and 10.6% of revenue for the nine months ended June 30, 2006. Two prime contracts with the Department of Defense represented approximately 18.8% and 12.4% of revenue for the year ended September 30, 2005.

(16)   Business Combinations

Fiscal Year 2005 Acquisitions

Acquisition of Assets of Countermeasures, Inc.

On October 28, 2004, Alion purchased substantially all of the assets of Countermeasures, Inc. for approximately $2.4 million. As of June 30, 2006, the Company has recorded approximately $1.4 million in goodwill relating to this acquisition. The results of operations for Countermeasures, Inc. are included in Alion’s operations from the date of acquisition. No pro forma disclosures are required as the acquisition was not significant to the Company’s operations.

Acquisition of ManTech Environmental Technology, Inc.

On February 11, 2005, Alion acquired 100 percent of the outstanding stock of METI, an environmental and life sciences research and development company for approximately $7.0 million in cash. As of June 30, 2006, the Company has recorded $5.6 million in goodwill related to this acquisition. The results of operations for METI are included in Alion’s operations from the date of acquisition. No pro forma disclosures are required as the acquisition was not significant to the Company’s operations.

Acquisition of Carmel Applied Technologies, Inc.

On February 25, 2005 Alion acquired 100 percent of the outstanding stock of CATI, a flight training software and simulator development company, for approximately $7.3 million in cash. The transaction is subject to an earn-out provision not-to-exceed a cumulative amount of $9.0 million based on attaining certain cumulative revenue goals for fiscal years 2006 and 2007, and a second earn-out provision not-to-exceed $1.5 million for attaining certain revenue goals in the commercial aviation industry. As of June 30, 2006, the Company has recorded $13.9 million in goodwill related to this acquisition. The results of operations for CATI are included in Alion’s operations from the date of acquisition. No pro forma disclosures are required as the acquisition was not significant to the Company’s operations.

30

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Investment in VectorCommand Ltd.

On March 22, 2005, Alion acquired approximately 12.5 percent of the A ordinary shares in VectorCommand Ltd. for $1.5 million which is accounted for at cost. No pro forma disclosures are required as the acquisition was not significant to the Company’s operations.

Acquisition of John J. McMullen Associates, Inc.

On April 1, 2005, the Company acquired 100 percent of the issued and outstanding stock of JJMA pursuant to a Stock Purchase Agreement by and among Alion, JJMA, Marshall & Ilsley Trust Company N.A. as trustee of the JJMA Employee Stock Ownership Trust, and holders of JJMA stock options and JJMA stock appreciation rights. The Company paid approximately $52.9 million, issued 1,347,197 shares of Alion common stock to the JJMA Trust valued at approximately $37.3 million, and agreed to make $8.3 million in future payments in addition to acquisition costs. The Company valued its common stock issued to the JJMA Trust at $27.65 per share based on an independent valuation conducted by Houlihan Lokey Howard Zukin, an unrelated third party. The estimated total purchase price is as follows. No new pro forma disclosures are required. Disclosures were previously made in fiscal year 2005.

Form of Consideration	Fair Value
	(In millions)
Cash paid, net of cash acquired	$	52.9
Stock issued		37.3
Future payments		8.3
Acquisition costs		1.3
Total consideration	$	99.8

The Company allocated the purchase price of JJMA to the estimated fair value of the assets acquired and liabilities assumed in the purchase as follows (in millions):

Accounts receivable	$	21.5
Property and equipment		1.0
Other assets		1.4
Identifiable intangible assets		29.6
Goodwill		57.8
Accounts payable and other accrued liabilities		(11.5	)
Total	$	99.8

The acquired identifiable intangibles assets in these transactions were as follows:

					Weighted Average
	Estimated		Residual		Remaining
Amounts in Millions	Fair Value		Value		Amortization Period
Purchased contracts	$	28.0	$	—		5 years
Internal use software and designs		0.9		—		3 years
Not to Compete Agreements		0.7		—		1 years
Total	$	29.6	$	—		5 years

As of June 30, 2006, the net intangible values for acquired contracts, internal use software, and non-compete agreements were $22.7 million, $0.7 million and $0.4 million, respectively.

31

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Except for JJMA, none of the 2005 fiscal year acquisitions was material individually or in the aggregate and therefore no pro forma information is required to be provided. The results of JJMA are included in the third quarter results reported for fiscal year 2005 and 2006 and therefore no pro forma information for JJMA is necessary.

Fiscal Year 2006 Acquisitions

Acquisition of BMH Associates, Inc.

On February 10, 2006, the Company acquired 100 percent of the issued and outstanding stock of BMH, a provider of advanced software, systems engineering and distributed interactive simulations for military training and experimentation, for $20.0 million (less a $1.5 million hold back plus additional contingent earn-out obligations over a two year period which can not exceed $6.0 million. As of June 30, 2006, the Company has recorded approximately $18.2 million in goodwill relating to this acquisition. The purchase price allocation is preliminary and subject to change based upon the completion of the valuation of certain intangible assets and other items.

Acquisition of Washington Consulting, Inc.

On February 27, 2006, the Company acquired 100 percent of the issued and outstanding stock of WCI, a provider of enterprise IT and management consulting solutions and services to commercial and government customers, for $18.0 million (less a $1.5 million hold back) plus additional contingent earn-out obligations over a two year period which can not exceed $2.5 million. As of June 30, 2006, the Company has recorded approximately $18.2 million in goodwill relating to this acquisition. The purchase price allocation is preliminary and subject to change based upon the completion of the valuation of certain intangible assets and other items.

Acquisition of Micro Analysis and Design, Inc.

On May 22, 2006, the Company acquired 100 percent of the issued and outstanding stock of MA&D, a provider of human factors engineering, modeling and simulation and software development for $15.0 million (less a $2.0 million hold back) plus additional contingent earn-out obligations over a two year period which can not exceed $2.5 million. As of June 30, 2006, the Company has recorded approximately $15.8 million in goodwill relating to this acquisition. The purchase price allocation is preliminary and subject to change based upon the completion of the valuation of certain intangible assets and other items.

Acquisition of certain assets of Anteon Corporation

On June 30, 2006, the Company acquired from Anteon a group of assets consisting primarily of customer contracts for approximately $221.4 million. As of June 30, 2006, the Company has recorded approximately $50.0 million for purchased contracts and approximately $173.3 million in goodwill relating to this acquisition. The purchase price allocation is preliminary and subject to change based upon the completion of the valuation of certain intangible assets and other items.

Except for Anteon Contract acquisition, none of the 2006 fiscal year acquisitions was material individually or in the aggregate and therefore no pro forma information is required to be provided. The Company acquired the Anteon Contracts on the last day of the current quarter. There was no effect on operating results for the quarter and therefore no pro forma information for this acquisition is necessary.

(17)   Commitments and Contingencies

Earn Out Commitments

The Company has earn out commitments related to the following acquisitions:

AB Technologies (AB Tech) — The earn out was based on an agreed-upon formula applied to net income of the business units that formerly comprised AB Tech. For the nine months ended June 30, 2006 and 2005, the

32

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Company recognized zero and approximately $1.4 million, respectively, in earn out obligation associated with this agreement. The earn out obligation expired on February 7, 2005, the fifth anniversary of the original acquisition date.

ITSC — The earn out was based on a portion of the gross revenue of the business units that formerly comprised ITSC. For the nine months ended June 30, 2006 and 2005, the Company recognized zero and approximately $0.3 million, respectively, in earn out obligation associated with this agreement. The obligation expired September 30, 2005.

CATI — There is an earn out provision not to exceed $8.25 million based on the revenue of the business units that formerly comprised CATI. There is a second earn out provision not to exceed $1.5 million based on attaining certain revenue goals in the commercial aviation industry. The obligations continue until September 2007. For the nine months ended June 30, 2006 and 2005, the Company recognized approximately $2.0 million and zero, respectively, in earn out obligation related to CATI.

BMH — There is an earn out provision not to exceed a total of $6.0 million based on the revenue of the business units that formerly comprised BMH. The obligation continues until December 2007. For the nine months ended June 30, 2006 and 2005, the Company recognized no earn out obligation related to BMH.

WCI — There is an earn out provision not to exceed a total of $2.5 million based on the revenue of the business units that formerly comprised WCI. The obligation continues until September 2007. For the nine months ended June 30, 2006 and 2005, the Company recognized no earn out obligation related to WCI.

MA&D — There is an earn out provision not to exceed a total of $2.5 million based on the revenue of the business units that formerly comprised MA&D. The obligation continues until September 2007. For the nine months ended June 30, 2006 and 2005, the Company recognized no earn out obligation related to MA&D.

Legal Proceedings

AB Tech Settlement

On July 22, 2005, the Company settled the dispute with the former owners of AB Tech and subsequently paid $4.8 million to the owners.

Joseph Hudert vs. Alion; Frank Stotmeister vs. Alion

On December 23, 2004, the estate of Joseph Hudert filed an action against Grunley-Walsh Joint Venture, L.L.C. (Grunley-Walsh) and the Company in the District of Columbia Superior Court for damages in excess of $80 million. On January 6, 2005, the estate of Frank Stotmeister filed an action against the Company in the same court on six counts, some of which are duplicate causes of action, claiming $30 million for each count. Several other potential defendants may be added to these actions in the future.

The suits arose in connection with a steam pipe explosion that occurred on or about April 23, 2004 on a construction site at 17th Street, N.W. in Washington, D.C. The plaintiffs died, apparently as a result of the explosion. They were employees of the prime contractor on the site, Grunley-Walsh, and the subcontractor, Cherry Hill Construction Company Inc., respectively. Grunley-Walsh had a contract with the U.S. General Services Administration (GSA) for construction on 17th Street N.W. near the Old Executive Office Building in Washington, D.C. Sometime after the award of Grunley-Walsh’s construction contract, Alion was awarded a separate contract by GSA. Alion’s responsibilities on this contract were non-supervisory monitoring of Grunley-Walsh’s activities and reporting to GSA of any deviations from contract requirements.

The Company intends to defend these lawsuits vigorously. Based on the facts underlying the lawsuits known to the Company at this time, and the Company’s non-supervisory monitoring role at the project site, the Company’s management believes that the potential for Alion to incur a material loss as a result of the lawsuits is remote.

33

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Therefore, the Company’s management does not believe that these lawsuits will have a material adverse effect upon the Company, its operations or its financial condition.

Alion’s primary provider of general liability insurance, St. Paul Travelers, has assumed defense of these lawsuits. However, since there is some uncertainty as to whether St. Paul Travelers received timely notice of a potential claim by Alion in connection with these lawsuits under its general liability insurance policy, St. Paul Travelers indicated when it assumed defense of the lawsuits, that it was doing so subject to a reservation of rights to deny coverage. Nevertheless, even if St. Paul Travelers is ultimately able to properly deny coverage as a result of late notice of the lawsuits, the Company’s management does not believe that the lawsuits will have a materially adverse effect upon the Company, its operations or its financial condition. American International Group, the Company’s excess insurance carrier, has also been notified regarding these lawsuits.

The Company is involved in various claims and legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect upon the financial position, results of operations, or liquidity of the Company.

Government Audits

Contract costs on federal government contracts, including indirect costs, are subject to audit by the federal government and adjustment pursuant to negotiations between the Company and government representatives. The government considers Alion a major contractor and maintains an office on site to perform its various audits throughout the year. All of the Company’s federal government contract indirect costs have been audited through 2004. Indirect rates have been negotiated through fiscal year 2001. The Company submitted its fiscal year 2005 indirect expense rates to the government on March 29, 2006. Contract revenue on federal government contracts has been recorded in amounts that are expected to be realized upon final settlement.

34

Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read together with the condensed consolidated financial statements and the notes to those statements. This discussion contains forward-looking statements that involve risks and uncertainties. These statements relate to our future plans, objectives, expectations and intentions and are for illustrative purposes only. These statements may be identified by the use of words such as “believe,” “expect,” “intend,” “plan,” “anticipate,” “likely,” “will,” “pro forma,” “forecast,” “projections,” “could,” “estimate,” “may,” “potential,” “should,” “would,” and similar expressions.

The factors that could cause actual results to differ materially from those anticipated include, but are not limited to, the following: changes to the ERISA laws related to the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan; changes to the tax laws relating to the treatment and deductibility of goodwill, the Company’s subchapter S status, or any change in the Company’s effective tax rate; additional costs associated with compliance with provisions of the Sarbanes-Oxley Act of 2002, including any changes in the SEC’s rules, and other corporate governance requirements; failure of government customers to exercise options under contracts; funding decisions relating to U.S. Government projects; government contract procurement (such as bid protest) and termination risks; competitive factors such as pricing pressures and/or competition to hire and retain employees; the results of current and/or future legal proceedings and government agency proceedings which may arise out of our operations (including our contracts with government agencies) and the attendant risks of fines, liabilities, penalties, suspension and/or debarment; undertaking acquisitions that could increase our costs or liabilities or be disruptive; taking on additional debt to fund acquisitions; failure to adequately integrate acquired businesses; material changes in laws or regulations applicable to the Company’s businesses; as well as other risk factors discussed in the Company’s annual report on Form 10-K for the year ended September 30, 2005 (File No. 333-89756) filed with the SEC on January 31, 2006.

Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s view only as of August 14, 2006. The Company undertakes no obligation to update any of the forward-looking statements made herein, whether as a result of new information, future events, changes in expectations or otherwise. This discussion addresses only our continuing operations.

Critical Accounting Estimates and Policies

Our significant accounting policies are described in Note 2 to the condensed consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2005.

Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties, which potentially result in materially different results under different assumptions and conditions. Application of these policies is a critical element in the portrayal of our financial condition and results of operations. The discussion and analysis of our financial condition and results of operations are based on our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these quarterly condensed consolidated financial statements requires management to make estimates and judgments that affect the reported amount of assets, liabilities, revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.

Our critical accounting policies are set forth below:

Revenue Recognition, Cost Estimation and Payment

We recognize revenue when persuasive evidence of an arrangement exists, services have been rendered, the contract price is fixed or determinable, and collectibility is reasonably assured. We use a standard internal process to determine whether all required criteria for revenue recognition have been met. This process includes a monthly review of contract revenues and expenses by several levels of management covering among other matters, progress against schedule, project staffing and levels of effort, risks and issues, subcontract management, incurred and estimated costs, and disposition of prior action items. This monthly internal review is designed to determine whether the overall progress on a contract is consistent with the effort expended and revenue recognized to date.

35

Our revenues consist primarily of payments for the work of our employees, and to a lesser extent, related costs for materials and subcontract efforts under contracts with our customers. Cost of services consists primarily of compensation expenses for program personnel, the fringe benefits associated with this compensation, and other direct expenses incurred to complete programs, including cost of materials and subcontract efforts.

The Company’s revenue results from contract research and other services under a variety of contracts, some of which provide for reimbursement of cost plus fees and others of which are fixed-price or time-and-material type contracts. Absent evidence to the contrary, we recognize revenues as follows:

•  Cost-reimbursement contracts — revenue is recognized as costs are incurred and include an estimate of applicable fees earned.

•  Fixed-price contracts — revenue is recognized using the percentage-of-completion method based on various performance measures. From time to time, facts develop that require the Company to revise its estimated total costs or revenues expected. The cumulative effect of revised estimates is recorded in the period in which the facts requiring revisions become known. The full amount of anticipated losses on any type of contract is recognized in the period in which they become known.

•  Time-and-material contracts — revenue is recognized at contractually billable rates as labor hours and direct expenses are incurred. Labor and related costs are reimbursed at negotiated, fixed hourly rates.

The following table summarizes the percentage of revenues attributable to each contract type for the periods indicated.

	For the Nine Months Ended June 30,
Contract Type	2006				2005
	(In thousands)
Cost-reimbursement	$	199,532	61	%	$	155,445	60	%
Fixed-price		65,626	20	%		49,639	19	%
Time-and-material		64,150	19	%		55,623	21	%
Total	$	329,308	100	%	$	260,707	100	%

Contracts with agencies of the federal government are subject to periodic funding by the contracting agency concerned. Funding for a contract may be provided in full at inception of the contract or ratably throughout the term of the contract as the services are provided. If funding is not assessed as probable, revenue recognition is deferred until realization is probable.

Contract costs on federal government contracts, including indirect costs, are subject to audit by the federal government and adjustment pursuant to negotiations between the Company and government representatives. The government considers Alion to be a major contractor and maintains an office on site to perform various audits throughout the year. All of the Company’s federal government contract indirect costs have been audited through fiscal year 2004. Indirect rates have been negotiated and settled through 2001. The Company submitted its fiscal year 2005 indirect expense rates to the government in March 2006. Contract revenues on federal government contracts have been recorded in amounts that are expected to be realized upon final settlement.

The Company recognizes revenue on unpriced change orders as expenses are incurred only to the extent that the Company expects it is probable that such costs will be recovered. The Company recognizes revenue in excess of costs on unpriced change orders only when management can also reliably estimate the amount of excess and experience provides a sufficient basis for recognition. The Company recognizes revenue on claims as expenses are incurred only to the extent that the Company expects it is probable that such costs will be recovered and the amount of recovery can be reliably estimated.

Contract revenue recognition inherently involves estimation. Examples of estimates include the contemplated level of effort to accomplish the tasks under contract, the cost of the effort, and the ongoing assessment of our progress towards completing the contract. From time to time, as part of our standard management processes, facts develop that require us to revise our estimated total costs or revenues. In most cases, these revisions relate to changes in the contractual scope of our work. To the extent that a revised estimate affects contract profit or revenue

36

previously recognized, we record the cumulative effect of the revision in the period in which the facts requiring the revision become known. Anticipated losses are recognized in the accounting period in which they are first determined. For all periods presented herein, the effects, if any, of revised estimates were not material, nor did the Company recognize any anticipated losses on contracts.

Our most significant expense is our cost of services, which consists primarily of direct labor costs for program personnel and direct expenses incurred to complete contracts, including cost of materials and subcontract efforts. Our ability to accurately predict personnel requirements, salaries and other costs, as well as to manage personnel levels and successfully redeploy personnel, can have a significant impact on our cost of services. Overhead costs principally include facility lease expenses, indirect labor expenses, supplies and other office expenses in support of our direct contract activities. General and administrative expenses consist primarily of costs associated with our management, finance personnel and administrative groups; sales and marketing expenses including bid and proposal efforts; and travel and other corporate costs.

We earn the majority of our revenue from contracts with various departments and agencies, or prime contractors, of the federal government. Much of the revenue and payments we receive are based on provisional billings that are subject to audit adjustment. Federal government agencies and departments have the right to challenge our cost estimates and allocations on government contracts. Contracts with such agencies are subject to audit and possible adjustment to account for unallowable costs under cost-type contracts or other regulatory requirements that affect both cost-type and fixed-price contracts.

The following table sets forth, for each period indicated, the percentage of our revenues from our major types of customers.

	For the Nine Months Ended June 30,
Customer Type	2006				2005
	(In thousands)
U.S. Department of Defense (DoD)	$	287,919	88	%	$	239,904	92	%
Other Federal Civilian Agencies		24,063	7	%	$	13,924	5	%
Commercial/State/Local and International		17,326	5	%	$	6,879	3	%
Total	$	329,308	100	%	$	260,707	100	%

The increase in percentage of fiscal year 2006 revenue for the categories of Other Federal Civilian Agencies and the Commercial/State/Local and International is primarily a result of the work performed by METI (customer: U.S. Environmental Protection Agency) and CATI and WCI (commercial customers), respectively, as integrated business units of Alion.

We generate a minimal amount of software revenue from licensing software. In general, we provide professional services essential to the functionality of the solution sold and recognize revenue on the percentage of completion method, as prescribed by AICPA SOP 81-1, Accounting for Performance on Construction-Type and Certain Production-Type Contracts.

Goodwill and Identifiable Intangible Assets

The Company accounts for goodwill and other intangible assets in accordance with the provisions of SFAS No. 142. The Company does not amortize goodwill; it reviews goodwill for impairment at least annually at the end of each fiscal year. The Company assesses the impairment of goodwill and identifiable intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors that could trigger an impairment review include:

•  Significant underperformance relative to expected historical or projected future operating results;

•  Significant changes in the manner of use of acquired assets or overall business strategy;

•  Significant negative industry or economic trends; and

•  Significant decline in Alion’s stock price for a sustained period.

37

If the Company determines the carrying value of intangibles or goodwill may not be recoverable, management measures any impairment using a projected discounted cash flow or other appropriate measure of fair value, including independent valuation.

As of June 30, 2006, the Company has goodwill of approximately $390.1 million and approximately $75.3 million of net intangible assets primarily purchased contracts. The intangible assets have an estimated useful life of generally one to thirteen years and are amortized primarily using the straight-line method.

Stock-Based Compensation

In December 2004, the Financial Accounting Standards Board issued SFAS 123(R), Share Based Payments.  For companies whose stock is not publicly traded on any exchange, this standard is not effective until the first annual reporting period beginning after December 15, 2005. Alion is required to adopt this standard with the Company’s next fiscal year starting October 1, 2006. SFAS 123(R) requires that share-based payments such as phantom stock and stock appreciation rights be recognized as compensation expense based on the fair value of the shares granted. The Company uses the intrinsic value method in APB Opinion No. 25 and FIN 28 to report stock-based compensation related to grants of phantom stock and stock appreciation rights. SFAS 123(R) does not apply to grants issued by the Company prior to the date of adoption. Management does not believe that adoption of SFAS 123(R) will have a material adverse impact on the Company’s results of operations or its cash flows.

Comparison of Results of Operations

Alion completed the acquisitions of METI and CATI in February 2005, JJMA in April 2005, BMH and WCI in February 2006, MA&D in May 2006 and the Anteon Contracts in June 2006. For the three months ended June 30, 2006, the Company’s operating results include the operating results for these acquisitions (however, the Anteon Contracts acquisition occurred on June 30, 2006 and, therefore, had no material impact on the operating results of Alion). Operating results for three months ended June 30, 2005, do not include operating results for the BMH, WCI, MA&D and Anteon Contracts acquisitions. For the nine months ended June 30, 2005, the operating results include only approximately sixteen weeks of operating results for the METI and CATI acquisitions and only twelve weeks of operating results for the JJMA acquisition. Significant differences in the Company’s results of operations for the periods presented arise from the effects of these acquisitions.

38

The following discussion and analysis includes references to selected financial information in the table below in conjunction with the Company’s condensed consolidated financial statements provided elsewhere in the document.

Quarter Ended June 30, 2006 Compared to Quarter Ended June 30, 2005

For purposes of comparability, the selected financial information provided in the table below reflects the relative financial impact of the METI, CATI, JJMA, BMH, WCI and MA&D acquisitions, which we refer to as the “acquired operations” of Alion, as they relate to the financial performance of Alion for the quarter ended June 30, 2006, compared to the financial performance for quarter ended June 30, 2005. All operations of Alion, other than those acquired through the above-noted acquisitions are referred to as “non-acquired operations.”

	Quarter Ended June 30, 2006																	Quarter Ended June 30, 2005
												Consolidated																	Consolidated
	Consolidated											Operations Less						Consolidated											Operations Less
	Operations						Acquired					Acquired						Operations of						Acquired					Acquired
	of Alion						Operations*					Operations						Alion						Operations*					Operations
	(Dollars in millions)																	(Dollars in millions)
				%					%						%						%					%						%
Financial information				revenue					revenue						revenue						revenue					revenue						revenue
Total revenue	$	116.8					$	46.0				$	70.8					$	110.8					$	30.7				$	80.1
Material and subcontract revenue		38.0			32.5	%		16.0		34.8	%		22.1			31.1	%		29.9			26.9	%		8.1		26.5	%		21.7			27.1	%
Total direct contract expenses		87.2			74.6	%		33.8		73.5	%		53.4			75.4	%		80.2			72.4	%		22.2		72.4	%		58.0			72.4	%
Major components of direct contract expense
Direct labor expense		47.8			40.9	%		17.6		38.2	%		30.2			42.6	%		47.6			43.0	%		12.9		41.9	%		34.7			43.4	%
Other direct expense (ODC)		3.1			2.6	%		0.8		1.7	%		2.3			3.3	%		3.4			3.1	%		1.3		4.4	%		2.0			2.6	%
Material and subcontract (M&S) expense		36.3			31.1	%		15.5		33.6	%		20.9			29.5	%		29.2			26.4	%		8.0		26.1	%		21.2			26.5	%
Gross profit		29.6			25.3	%		12.2		26.5	%		17.4			24.6	%		30.6			27.6	%		8.5		26.1	%		22.1			26.5	%
Total operating expense		31.0			26.6	%		11.5		25.0	%		19.5			27.6	%		32.2			29.0	%		7.7		25.2	%		24.5			30.5	%
Major components of operating expense
Indirect personnel and facilities		12.6			10.8	%		5.5		12.0	%		7.1			10.0	%		14.1			12.7	%		3.2		10.4	%		10.9			13.6	%
General and administrative		11.8			10.1	%		5.4		11.7	%		6.4			7.0	%		9.0			8.1	%		2.9		9.6	%		6.0			7.5	%
Depreciation and amortization		2.5			2.2	%		0.9		2.0	%		1.6			2.3	%		5.5			4.9	%		1.6		5.2	%		3.9			4.8	%
Stock-based compensation		3.3			2.8	%		—		0.0	%		3.3			4.6	%		3.4			3.1	%		—		0.0	%		3.4			4.2	%
Income (loss) from operations	$	(1.4	)		(1.2	)%	$	0.7		1.6	%	$	(2.1	)		(2.9	)%	$	(1.6	)		(1.4	)%	$	0.8		2.5	%	$	(2.3	)		(2.9	)%

* For the quarters ended June 30, 2006 and 2005, METI, CATI, JJMA, BMH ,WCI and MA&D have been fully integrated within Alion on a consolidated basis.

Revenues.  Revenues increased $6.0 million, or 6.0%, to $116.8 million for the quarter ended June 30, 2006, from $110.8 million for the quarter ended June 30, 2005. This increase is attributable to the following:

•	Increase in revenue generated by the activities of the acquired operations	$	15.3	million
•	Decrease in revenue generated by the activities of the non-acquired operations	$	(9.3	) million
	Total:	$	6.0	million

For the quarter ended June 30, 2006, approximately $14.5 million came from the activities of BMH, WCI and MA&D. The $9.3 million decrease in revenue was attributable to the following: 1) reduced funding under the DoD Joint Spectrum Center (JSC) accounted for approximately $3.2 million, 2) our unsuccessful bid for the follow-on contract to support the U.S. Navy for Guam Ordnance Services accounted for approximately $1.8 million, and 3) discontinued funding of the Mobile Parts Hospital and related services for the Department of Defense accounted for approximately $1.8 million. Many contracts experienced reduced or delayed funding for current contract tasks

39

and delays or cancellations of anticipated new tasks (under existing contracts) because of the delay in congressional approval of the Federal budget for fiscal year 2006. On the balance of our contracts, revenue decreased by $2.5 million.

Material and subcontract (M&S) revenue increased approximately $8.1 million, or 27.1%, to $38.0 million for the quarter ended June 30, 2006 from $29.9 million for the quarter ended June 30, 2005. The acquired operations generated approximately $7.9 million of the increase. M&S revenue increased to 32.5% of revenue from 26.9% of revenue for the quarters ended June 30, 2006 and 2005, respectively. This was due partially to the increase in content of M&S revenue to total revenue from acquired operations and partially to decreased total contract revenue from non-acquired operations. In particular, the content of M&S revenue for work provided by JSC and Guam Ordnance Services contracts was lower in the quarter ended June 30, 2006, than in the quarter ended June 30, 2005.

Direct Contract Expenses.  Direct contract expenses increased $7.0 million, or 8.7%, to $87.2 million for the quarter ended June 30, 2006 from $80.2 million for the quarter ended June 30, 2005. Approximately $11.6 million in increased expenses from acquired operations was offset by a decrease of approximately $4.6 million attributable to non-acquired operations. BMH, WCI and MA&D generated approximately $9.9 million in increased expenses. Direct contract expenses were 74.6% and 72.4% of revenue for the quarters ended June 30, 2006 and 2005, respectively.

•  Direct labor expense for the quarter ended June 30, 2006 increased by $0.2 million, or 0.4%, to $47.8 million from $47.6 million for the quarter ended June 30, 2005. Direct labor expense declined to 40.9% from 43.0% of revenue for the quarters ended June 30, 2006, and 2005. This decrease was due partially to the decrease in content of direct labor expense from acquired operations and partially to decreased total contract revenue from non-acquired operations. Direct labor expense under the JSC and Guam Ordnance Services contracts was higher in the quarter ended June 30, 2006, than in the quarter ended June 30, 2005.

•  M&S expense increased approximately $7.1 million, or 24.3%, to $36.3 million for the quarter ended June 30, 2006, compared to $29.2 million for the quarter ended June 30, 2005. M&S expense increased to 31.1% from 26.4% of revenue for the quarters ended June 30, 2006 and 2005. The percent increase in M&S expense was due partially to the increase in content of M&S expense to total direct contract expense of the acquired operations and partially to decreased total contract revenue from non-acquired operations. M&S expense under the JSC and Guam Ordnance Services contracts was lower in the quarter ended June 30, 2006, than in the quarter ended June 30, 2005. M&S expense was approximately 95.6% and 97.7% of M&S revenue for the quarters ended June 30, 2006 and 2005.

M&S work has been increasing relative to direct labor, as a result of contracts obtained in connection with our acquired operations as well as higher levels of M&S related work on contracts in the non-acquired operations. This trend is expected to continue for at least the next two fiscal years or until backlog on these contracts is expended.

Gross Profit.  Gross profit was $29.6 million and $30.6 million for the quarters ended June 30, 2006 and June 30, 2005, respectively. Gross profit was 25.3% and 27.6% of revenue for the quarters ended June 30, 2006 and 2005, respectively. Gross profit for acquired and non-acquired operations was 26.5% and 24.6% for the quarter ended June 30, 2006, and 26.1% and 26.5% for the quarter ended June 30, 2005. Gross profit margins decreased due to the relative increase in M&S contract work. M&S contract work typically generates lower profit margins than contract direct labor work.

Operating Expenses.  Operating expenses decreased $1.2 million, or 3.7%, to $31.0 million for the quarter ended June 30, 2006, from $32.2 million for the quarter ended June 30, 2005. Acquired operations generated $3.8 million more in operating expenses offsetting a $5.0 million decrease in operating expenses for non-acquired operations. Operating expenses were 26.6% and 29.0% of revenue for the quarters ended June 30, 2006 and 2005.

•  Operating expenses for indirect personnel and rental and occupancy expenses decreased approximately $1.5 million, or 11.9%, to $12.6 million from $14.1 million for the quarter ended June 30, 2006, compared to the quarter ended June 30, 2005. Operating expenses for indirect personnel and facilities declined to 10.7% from 12.7% of revenue for the quarters ended June 30, 2006 and 2005, respectively.

40

•  General and administrative (G&A) expense increased approximately $2.8 million, or 31.1%, to $11.8 million for the quarter ended June 30, 2006, compared to $9.0 million for the quarter ended June 30, 2005. G&A expenses were 10.1% and 8.1% of revenue for the quarters ended June 30, 2006 and 2005, respectively. Approximately $1.4 million of the $2.8 million increase is due to increased fringe benefit expenses and approximately $0.5 million was due to third-party legal and accounting fees associated with acquisitions. These additional expenses represent approximately 1.5% of revenue. The remaining $0.9 million increase in G&A expense is associated to infrastructure costs to accommodate recent acquisitions.

•  Depreciation and amortization expense decreased approximately $3.0 million, or 54.6%, to $2.5 million for the quarter ended June 30, 2006, compared to $5.5 million for the quarter ended June 30, 2005, principally related to amortization of purchased contracts. For the quarters ended June 30, 2006 and 2005, there were zero and approximately $2.5 million in amortization expense associated with the contracts purchased from IITRI. Depreciation and amortization expense was 2.1% and 4.9% of revenue for the quarters ended June 30, 2006 and 2005, respectively.

•  Stock-based compensation expense relates to the SAR and phantom stock plans. This expense decreased approximately $0.1 million, or 2.9% to $3.3 million for the quarter ended June 30, 2006, compared to approximately $3.4 million for the quarter ended June 30, 2005.

Income (loss) from Operations.  There was an operating loss of $1.4 million for the quarter ended June 30, 2006, compared to an operating loss of $1.6 million for the quarter ended June 30, 2005. Operating loss decreased by $0.2 million because of the factors discussed above.

Other Income (Expense).  Other income (expense) decreased approximately $2.3 million, or 25.5%, to $6.9 million for the quarter ended June 30, 2006 as compared to $9.2 million for the quarter ended June 30, 2005. Interest expense decreased approximately $2.4 million, or 25.5%, to $7.0 million for the quarter ended June 30, 2006 from approximately $9.4 million for the quarter ended June 30, 2005. The $2.5 million decrease in interest expense is attributable to the following:

	Quarter Ended
	June 30,
	2006		2005
	(In millions)
Revolving facility	$	0.4	$	—
Senior term loan		4.1		2.6
Bridge loan		0.1		—
Subordinated Note		1.0		1.0
Accretion of warrants(a)		1.2		5.8
Other		0.2		—
Total	$	7.0	$	9.4

(a) Reflects change in value assigned to the detachable warrants associated with Mezzanine and Subordinated notes based on the change in the value of Alion common stock and the number of warrants outstanding.

Income Tax (Expense) Benefit.  The Company has filed qualified subchapter S elections for all of its wholly-owned subsidiaries to treat them as disregarded entities for federal income tax purposes. Some states do not recognize the effect of these elections or Alion’s S corporation status. For our Canadian subsidiary, Alion Science and Technology (Canada) Corporation, we accrue a tax liability, as required. The Company recorded $7,000 and zero income tax expense for the quarters ended June 30, 2006 and 2005, respectively.

Net Loss.  The net loss decreased approximately $2.6 million, or 25.0%, to $8.2 million for the quarter ended June 30, 2006 as compared to $10.8 million for the quarter ended June 30, 2005. The $2.7 million decrease is associated with factors discussed above.

41

Nine Months Ended June 30, 2006 Compared to Nine Months Ended June 30, 2005

For purposes of comparability, the selected financial information provided in the table below reflects the relative financial impact of the METI, CATI, JJMA, BMH, WCI and MA&D acquisitions, which we refer to as the “Acquired Operations” of Alion, as they relate to the financial performance of Alion for the nine months ended June 30, 2006 compared to the financial performance for the nine months ended June 30, 2005. All of the operations of Alion are referred to as “non-acquired operations.”

	Nine Months Ended June 30, 2006																	Nine Months Ended June 30, 2005
												Consolidated																	Consolidated
												Operations Less						Consolidated											Operations Less
	Consolidated						Acquired					Acquired						Operations of						Acquired					Acquired
	Operations of Alion						Operations*					Operations						Alion						Operations*					Operations
	(Dollars in millions)																	(Dollars in millions)
				%					%						%						%					%						%
Financial information				revenue					revenue						revenue						revenue					revenue						revenue
Total revenue	$	329.3					$	112.2				$	217.1					$	260.7					$	32.9				$	227.8
Material and subcontract revenue		103.9			31.6	%		35.7		31.8	%		68.2			31.4	%		68.5			26.3	%		8.4		25.5	%		60.1			26.4	%
Total direct contract expenses		244.2			74.2	%		81.5		72.7	%		162.8			75.0	%		189.8			72.8	%		23.7		71.9	%		166.1			72.9	%
Major components of direct contract expense
Direct labor expense		136.4			41.4	%		45.2		40.3	%		91.3			42.0	%		115.2			44.2	%		14.1		42.7	%		101.2			44.4	%
Other direct expense (ODC)		8.3			2.5	%		2.0		1.8	%		6.2			2.8	%		7.2			2.8	%		1.4		4.1	%		5.8			2.5	%
Material and subcontract (M&S) expense		99.5			30.2	%		34.3		30.6	%		65.2			30.0	%		67.4			25.8	%		8.3		25.1	%		59.1			25.9	%
Gross profit		85.1			25.8	%		30.8		27.4	%		54.3			25.0	%		70.9			27.2	%		9.2		28.1	%		61.7			27.1	%
Total operating expense		87.9			26.7	%		30.3		27.0	%		57.5			26.5	%		72.8			27.9	%		8.3		25.2	%		64.5			28.3	%
Major components of operating expense
Indirect personnel and facilities		34.8			10.6	%		13.8		12.3	%		21.0			9.7	%		28.2			10.8	%		3.5		10.8	%		24.7			10.8	%
General and administrative		32.9			10.0	%		13.3		11.8	%		19.6			9.0	%		23.4			9.0	%		3.2		9.6	%		20.2			8.9	%
Depreciation and amortization		9.7			3.0	%		3.2		2.9	%		6.5			3.0	%		12.7			4.9	%		1.6		4.8	%		11.1			4.9	%
Stock-based compensation		8.3			2.5	%		—		0.0	%		8.3			3.8	%		7.6			2.9	%		—		0.0	%		7.6			3.3	%
Income (loss) from operations	$	(2.8	)		(0.8	)%	$	0.5		0.4	%	$	(3.1	)		(1.4	)%	$	(1.9	)		(0.7	)%	$	0.9		2.9	%	$	(2.8	)		(1.2	)%

* For the nine month periods ended June 30, 2006 and 2005, the operations of the acquired entities, METI, CATI, JJMA, BMH, WCI and MA&D, respectively, have been fully integrated within Alion on a consolidated basis.

Revenues.  Revenues increased $68.6 million to $329.3 million for the nine months ended June 30, 2006, or 26.3%, from $260.7 million for the nine months ended March 31, 2005. The acquired operations generated approximately $79.3 million of the approximate $68.6 million in increased revenue. The non-acquired operations generated decreased revenue of $10.7 million attributable to the following: 1) reduced funding under the Department of Defense Joint Spectrum Center (JSC) accounted for approximately $8.3 million, 2) our unsuccessful bid for the follow-on contract to support the U.S. Navy for Guam Ordnance Services accounted for $5.1 million, and 3) discontinued funding of the Mobile Parts Hospital and related services for the Department of Defense accounted for approximately $5.1 million. Many contracts experienced reduced or delayed funding for current contractual tasks and delays or cancellations of anticipated new tasks (under existing contracts) because of the delays in congressional approval of the Federal budget for fiscal year 2006. On the balance of our contracts, revenue increased by approximately $7.8 million.

42

M&S revenue increased approximately $35.7 million to $104.2 million for the nine months ended June 30, 2006, or 52.1%, from $68.5 million for the nine months ended June 30, 2005. The acquired operations generated approximately $27.7 million of the increase. M&S revenue increased approximately 5.3% to 31.6% from 26.3% for the nine months ended June 30, 2006 and 2005, respectively. This was due partially to the increase in content of M&S revenue from acquired operations and partially to decreased total contract revenue from non-acquired operations (related to the issues described above). M&S revenue for the JSC and Guam Ordnance Services contracts was lower in the nine months ended June 30, 2006 than in the nine months ended June 30, 2005. To a lesser extent, M&S revenue from acquired operations increased due to higher profit margins on work performed.

Direct Contract Expenses.  Direct contract expenses increased approximately $54.7 million to $244.5 million, or 28.8%, from $189.8 million for the nine months ended June 30, 2006, and 2005, respectively. Approximately $58.2 million in increased direct contract expenses attributable to the acquired operations was offset by a decrease of approximately $3.4 million attributable to non-acquired operations. Direct contract expenses were 74.3% of revenue for the nine months ended June 30, 2006, as compared to 72.8% for the nine months ended June 30, 2005.

•  Direct labor expense for the nine months ended June 30, 2006 increased by $21.2 million, or 18.4%, to $136.4 million from $115.2 million for the nine months ended June 30, 2005. Direct labor expense decreased to 41.4% from 44.2% of revenue for the nine-month periods ended June 30, 2006 and 2005 due to a shift from direct labor to M&S expense. This was partially due to the decrease in content of direct labor expense from acquired operations and partially due to decreased total contract revenue from non-acquired operations. Direct labor expense under the JSC and Guam Ordnance Services contracts was higher in the months ended June 30, 2006 than in the nine months ended June 30, 2005.

•  M&S expense increased approximately $32.4 million, or 48.1%, to $99.8 million for the nine months ended June 30, 2006, compared to $67.4 million for the nine months ended June 30, 2005. M&S expense was 30.3% and 25.9% of revenue for the nine months ended June 30, 2006 and 2005, respectively. The percent increase in M&S expense was due partially to the increase in content of M&S expense to total direct contract expense for acquired operations and partially to decreased total contract revenue from non-acquired operations (related to the issues described above). M&S expense, as a percentage of M&S revenue, declined to approximately 95.8% from 98.4% for the nine months ended June 30, 2006 and 2005, primarily due to increased profit margins on M&S work by acquired operations.

Gross Profit.  Gross profit increased $13.9 million, or 19.6%, to $84.8 million for the nine months ended June 30, 2006, from $70.9 million for the nine months ended June 30, 2005. Gross profit as a percentage of revenue declined to 25.7% from 27.2% for the nine months ended June 30, 2006 and 2005, principally due to increased M&S revenue which is less profitable than direct labor revenue. M&S work has been increasing relative to direct labor, as a result of contracts obtained with acquired operations as well as higher levels of M&S work on contracts in non-acquired operations. This trend is expected to continue for at least the next two fiscal years or until backlog on these contracts is expended. M&S effort typically generates lower profit margins than contract direct labor work.

Operating Expenses.  Operating expenses increased $14.8 million, or 20.3% to $87.6 million for the nine months ended June 30, 2006, from $72.8 million for the nine months ended June 30, 2005. Acquired operations generated $21.7 million in increased expenses offsetting a decrease in expenses from non-acquired operations of approximately $7.0 million. Operating expense was 26.6% and 28.3% of revenue for the nine months ended June 30, 2006 and 2005.

•  Operating expenses for indirect personnel and rental and occupancy expenses increased approximately $6.6 million, or 23.4%, to $34.8 million for the nine months ended June 30, 2006, from $28.2 million for the nine months ended June 30, 2005. Operating expenses for indirect personnel and facilities were 10.6% and 10.8% of revenue for the nine months ended June 30, 2006 and 2005. The increase is partially attributable costs associated with integrating the BMH, WCI and MA&D.

•  G &A expense increased approximately $9.6 million, or 41.3%, to $33.0 million for the nine months ended June 30, 2006, compared to $23.4 million for the nine months ended June 30, 2005. G&A expenses were 10.0% and 9.0% of revenue for the nine months ended June 30, 2006 and 2005. Approximately $1.4 million

43

of the $9.6 million increase is due to increased fringe benefit expense. Approximately $2.2 million was for third-party legal and accounting fees associated with acquisitions. Approximately $1.3 million is due to external accounting and legal fees for an independent investigation relating to an anonymous letter to the Company alleging, among other things, illegal activities in one of the Company’s business units. The independent investigators concluded there was no material basis for the allegations. These additional expenses represent approximately 1.5% of revenue.

•  Depreciation and amortization expense decreased approximately $3.0 million, or 23.6%, to $9.7 million for the nine months ended June 30, 2006, compared to $12.7 million for the nine months ended June 30, 2005. Depreciation expense primarily arises from fixed assets while amortization expense derives primarily from purchased contracts. Amortization expense decreased because amortization of contracts purchased from IITRI ended in December 2005. For the nine months ended June 30, 2006 and 2005, approximately $1.5 million and $7.5 million in amortization expense was associated with the contracts purchased from IITRI. This decrease of approximately $6.0 million was offset by an increase of approximately $3.0 million for amortization of METI, CATI, and JJMA purchased contracts. Depreciation and amortization expense was 3.0% and 4.9% of revenue for the nine months ended June 30, 2006 and 2005.

•  Stock-based compensation expense relates to the SAR and phantom stock plans. This expense increased approximately $0.7 million, or 9.2% to $8.3 million for the nine months ended June 30, 2006, compared to approximately $7.6 million for the nine months ended June 30, 2005. The increase in stock-based compensation expense results from the relative change in price of a share of Alion common stock in the nine months ended June 30, 2006 and 2005 and, to a lesser extent, the increase in awards granted. Stock-based compensation was approximately 2.5% and 2.9% of revenue for the nine months ended June 30, 2006 and 2005, respectively.

Operating Loss.  Operating losses increased to $2.8 million from $1.9 million for the nine months ended June 30, 2006 and 2005, respectively, due to the factors described above.

Other Income (Expense).  Other income (expense) decreased approximately $18.0 million to approximately $14.1 million, or 68.6%, for the nine months ended June 30, 2006, from $32.1 million for the nine months ended June 30, 2005. As a component of other income (expense), interest expense decreased approximately $17.4 million, or 53.8%, to $14.9 million for the nine months ended June 30, 2006 from $32.3 million for the nine months ended June 30, 2005 and is summarized in the following table:

	For Nine Months Ended
	June 30,
	2006		2005
Revolving facility	$	0.7	$	0.3
Senior term loan		9.4		4.7
Bridge loan		0.1		—
Mezzanine note — cash pay interest		—		1.8
- accretion of debt discount		—		2.2
Subordinated note — PIK interest		1.8		1.8
- accretion of long-term deferred interest		0.5		0.4
- accretion of debt discount		0.7		0.7
Accretion of warrant liability(a)		1.5		20.4
Other		0.2		0.0
	$	14.9	$	32.3

(a) Reflects change in value assigned to the outstanding detachable warrants associated with the Mezzanine and Subordinated notes based on the change in the value of Alion common stock.

44

Income Tax (Expense) Benefit.  The Company has filed qualified subchapter-S elections for all of its subsidiaries to treat them as disregarded entities for federal income tax purposes. Some states do not recognize the effect of these elections or Alion’s S-corporation status. The Company recorded $0.03 million and $0.05 million in state income tax expense for the nine months ended June 30, 2006 and 2005, respectively.

Net Loss.  The Company’s net loss decreased approximately $17.2 million or 50.4% to $16.9 million for the nine months ended June 30, 2006, from $34.1 million for the nine months ended June 30, 2005, due to the factors discussed above.

Liquidity and Capital Resources

The Company’s primary liquidity requirements are for debt service, working capital, capital expenditures, and acquisitions. The Company’s principal working capital need is to fund accounts receivable, which increases with the growth of the business. The Company is funding present operations, and intends to fund future operations, primarily through cash provided by operating activities and through use of a revolving credit facility.

The following discussion relates to the cash flow of Alion for the nine months ended June 30, 2006 and 2005.

Operating activities used approximately $7.0 million and provided approximately $16.6 million in net cash for the nine months ended June 30, 2006 and 2005, respectively. The $23.6 million increase in use of cash is primarily attributable to the approximate $21.8 million increase in use of cash to fund growth in accounts receivable.

Net cash used in investing activities was approximately $282.7 million and $73.6 million for the nine months ended June 30, 2006 and 2005, respectively. During the nine months ended June 30, 2006, the Company used cash of approximately $278.8 million to acquire BMH, WCI, MA&D and the Anteon Contracts. The Company spent approximately $3.9 million for capital expenditures unrelated to acquisitions. During the nine months ended June 30, 2005, the Company paid approximately $18.2 million to acquire CATI — $7.3 million; METI — $7.0 million; the assets of Countermeasures, Inc. — $2.4 million; and the investment in VectorCommand Ltd. — $1.5 million. The Company paid approximately $58.7 million in cash as part of the purchase price for JJMA.

Net cash provided by financing activities was approximately $255.2 million for the nine month period ended June 30, 2006, compared to net cash provided by financing activities of approximately $70.1 million for the nine month period ended June 30, 2005. During the nine months ended June 30, 2006, Alion borrowed approximately $118.0 million in proceeds under the Term B Senior Credit Facility and borrowed $170.0 million pursuant to the Bridge Loan Agreement. The borrowed proceeds of approximately $288.0 million were used to fund acquisitions ($278.8 million), to pay certain debt issuance costs of approximately $7.8 million and to repay approximately $1.3 million of principal under the Term B note payable. The Company used cash of approximately $13.6 million to redeem of the mezzanine warrants held by IIT and Dr. Atefi, and purchased approximately $17.7 million in common stock from the ESOP Trust. During the nine months ended June 30, 2005, Alion borrowed $94.0 million in proceeds under the Term B Senior Credit Facility. The Company used approximately $58.7 million for the JJMA acquisition, approximately $22.0 to redeem its Mezzanine Note and approximately $18.0 million to finance other acquisitions.

Discussion of Debt Structure

On August 2, 2004, the Company entered into a new Term B senior secured credit facility (the Term B Senior Credit Facility) with a syndicate of financial institutions for which Credit Suisse (CS) serves as arranger, administrative agent and collateral agent, and for which LaSalle Bank National Association serves as syndication agent. On April 1, 2005, the Company entered into an incremental term loan facility and an amendment to the Term B Senior Credit Facility (Amendment One), which added $72 million in term loans to the Company’s total indebtedness under the Term B Senior Credit Facility. On March 24, 2006, the Company entered into a second incremental term loan facility and second amendment to the Term B Senior Credit Facility (Amendment Two), which increased the term loan commitment under the Term B Senior Credit Facility by $68.0 million. Amendment Two also increased the revolving credit commitment under the senior revolving credit facility from $30.0 million to $50.0 million. On June 30, 2006, the Company entered into a third incremental term loan facility and amendment to

45

the Term B Senior Credit Facility (Amendment Three), which added $50 million in term loans to our total indebtedness under the Term B Senior Credit Facility.

The discussion below describes the Term B Senior Credit Facility, as modified by Amendments One, Two and Three; certain of the initial debt agreements (and other related instruments) used to finance the Transaction; and Bridge Loan Agreement used to finance part of the Company’s acquisition on June 30, 2006, of the Anteon Contracts and other assets for approximately $221.4 million.

Term B Senior Credit Facility

The Term B Senior Credit Facility expires August 2, 2009 and consists of the following balances at June 30, 2006 and September 30, 2005:

	2006			2005
Senior term loan	$	259.7		$	142.9
Less: Unamortized debt issuance costs		(4.8	)		(3.6	)
Term B Senior Credit Facility Note Payable	$	254.9		$	139.3
Less current maturities, net of unamortized debt issue costs		(2.6	)		(1.4	)
Term B Senior Credit Facility Note Payable, less current maturities	$	252.3		$	137.9

The Term B Senior Credit Facility has a term expiring August 2, 2009 and consists of:

•  senior term loan in the current approximate amount of $259.7 million including the incremental term loans of which approximately $259.7 million had been drawn down as of June 30, 2006;

•  a $50.0 million senior revolving credit facility, approximately $6.0 of which was actually borrowed and approximately $5.9 million of which was deemed borrowed as of June 30, 2006, for letters of credit; and

•  a $150.0 million uncommitted incremental term loan “accordion” facility in addition to the three incremental term loan facilities we entered into as of April 1, 2005, March 24, 2006 and June 30, 2006.

The Term B Senior Credit Facility requires the Company to repay 1 percent of the principal balance of the senior term loan during each of the first four years (fiscal years 2005 through 2008) and 96 percent of the principal balance outstanding during the fifth and final year (2009). For the quarter ended June 30, 2006, the Company was obligated to pay a principal quarterly installment of $530,000 on the senior term loan. Beginning with the quarter ending June 30, 2006 and through the quarter ending September 30, 2008, the Company is currently obligated to pay quarterly principal installments of $655,000. On each of December 31, 2008, March 31, 2009, June 30, 2009 and August 2, 2009, the Company is obligated to pay principal installments of approximately $63.4 million.

Under the senior revolving credit facility, the Company may request up to $40.0 million in letters of credit and may borrow up to $5.0 million in swing line loans for short-term borrowing needs. The Company must pay all principal obligations under the senior revolving credit facility in full no later than August 2, 2009.

The Company may prepay all or any portion of its Term B debt in minimum increments of $1 million, generally without penalty or premium, except for customary breakage costs associated with pre-payment of Eurodollar-based loans. If the Company issues certain permitted debt, or sells, transfers or disposes of certain assets, it must use all net proceeds to repay any Term B loan amounts outstanding. If the Company issues certain kinds of equity or has excess cash flow for any fiscal year, it must use 50% of the net proceeds or excess cash flow to repay Term B loan amounts outstanding. If the Company’s leverage ratio is less than 2:00 to 1:00, it must use only 25% of net proceeds or excess cash flow to repay Term B loan amounts outstanding. As long as the Bridge Loan is outstanding, its prepayment terms supercede the prepayment terms of the Term B Senior Credit Facility (see Bridge Loan Agreement below).

If the Company borrows any additional term loan, including under the uncommitted incremental term loan facility, and certain terms of such loan are more favorable to the new lenders than existing terms under the Term B Senior Credit Facility, the applicable interest rate spread on the senior term loans can increase. As a result, additional term loans could increase the Company’s interest expense under its existing term loans. The Company’s significant subsidiaries (HFA, CATI, METI, JJMA, BMH, WCI and MA&D) guaranteed Company’s obligations under the Company’s Term B Senior Credit Facility.

46

Use of Proceeds.  On August 2, 2004, the Company borrowed $50.0 million through the senior term loan under the Term B Senior Credit Facility and used approximately $47.2 million to retire its then outstanding senior term loan and revolving credit facility administered by LaSalle Bank including principal and accrued unpaid interest and paid approximately $3.3 million in transaction fees. In October 2004, the Company borrowed approximately $22.0 million of the senior term loan to retire our existing $19.6 million mezzanine note and to pay approximately $2.4 million in accrued unpaid interest and prepayment premium. On April 1, 2005, the Company borrowed $72.0 million in an incremental term loan under the Term B Senior Credit Facility. The Company used approximately $58.7 million of the incremental term loan proceeds to pay a portion of the JJMA acquisition price, and approximately $1.25 million to pay transaction fees associated with the incremental term loan. The Company used approximately $12.0 million to pay a portion of the BMH acquisition price. On March 24, 2006, the Company entered into Amendment Two which made available to the Company $68.0 million in additional incremental term loans. The Company used approximately $16.5 million of these incremental term loan proceeds to pay a portion of the WCI acquisition price, and approximately $13.6 million to redeem the mezzanine warrants held by IIT and the Company’s Chief Executive Officer. On May 15, 2006, the Company borrowed $15.0 million of the incremental term loans made available under Amendment Two in order to pay a portion of the MA&D acquisition price. On June 30, 2006, the Company borrowed $21.0 million of the incremental term loans made available under Amendment Two and $50.0 million in incremental term loans under Amendment Three in order to pay a portion of the acquisition price for the Anteon Contracts.

The Term B Senior Credit Facility permits the Company to use the remainder of its senior revolving credit facility for working capital needs, other general corporate purposes, and to finance permitted acquisitions. The Term B Senior Credit Facility permits the Company to use any proceeds from the uncommitted incremental term loan facility to finance permitted acquisitions and for any other purpose permitted by any future incremental term loan.

Security.  The Term B Senior Credit Facility is secured by a security interest in all of the Company’s current and future tangible and intangible property, as well as all of the current and future tangible and intangible property of the Company’s subsidiaries, HFA, CATI, METI, JJMA, BMH, WCI and MA&D.

Interest and Fees.  Under the Term B Senior Credit Facility, the senior term loan and the senior revolving credit facility can each bear interest at either of two floating rates. The Company was entitled to elect that interest be payable on the Company’s $259.7 million senior term loan at an annual rate equal to either: 1) the applicable alternate base interest rate charged by CS plus 175 basis points or, 2) the Eurodollar rate plus 275 basis points. The Company was also entitled to elect that interest be payable on the senior revolving credit facility at an annual rate dependent on the Company’s leverage ratio and whether the borrowing is a Eurodollar or an alternate base rate (ABR) borrowing. Under the Term B Senior Credit Facility, if the Company were to elect a Eurodollar borrowing under its senior revolving credit facility, interest would be payable at an annual rate equal to the Eurodollar rate plus additional basis points as reflected in the table below under the column “Eurodollar Spread” corresponding to the Company’s leverage ratio at the time. Under the Term B Senior Credit Facility, if the Company were to elect an ABR borrowing under its senior revolving credit facility, the Company would pay interest at an alternate base interest rate based on the greater of CS’s prime rate or a federal funds effective rate, plus additional basis points reflected in the table below under the columns ‘‘Prime Rate ABR Spread or “Federal Funds ABR Spread” corresponding to the Company’s leverage ratio at the time.

47

	Eurodollar		Federal Funds		Prime Rate ABR
	Spread		ABR Spread		Spread
Leverage Ratio	(in basis points)		(in basis points)		(in basis points)
Category 1		275		225		175
Greater than or equal to 3.00 to 1.00
Category 2		250		200		150
Greater than or equal to 2.50 to 1.00 but less than 3.00 to 1.00
Category 3		225		175		125
Greater than or equal to 2.00 to 1.00 but less than 2.50 to 1.00
Category 4		200		150		100
Less than 2.00 to 1.00

On April 1, 2005, the Company elected to have the senior term loan bear interest at the Eurodollar rate and the senior revolving credit facility bear interest at the ABR rate based on CS’s prime rate. As of June 30, 2006, the Eurodollar rate on the senior term loan was 8.25 percent (5.50 percent plus 2.75 percent Eurodollar spread) and the ABR rate was 10.00 percent (8.25 percent plus 1.75 percent spread).

Interest Rate Cap Agreements.  The Term B Senior Credit Facility requires the Company to maintain interest rate hedge agreements acceptable to CS to cap the Company’s interest expense on at least 40 percent of the Company’s long-term senior debt. The Company has three such agreements in place with its senior lenders.

The interest rate cap agreements cap the floating component of the total interest rate the Company pays, but do not affect spreads based on leverage ratio. The actual effective rate of interest that the Company pays on principal subject to each cap agreement is equal to the floating component in the cap plus the applicable spread. The interest rate spread in Term B Senior Credit Facility is added to the interest rate cap rate in each cap agreement in order to determine the effective interest rates under the cap agreements.

In August 2004, the Company paid approximately $319,000 to cap its interest rate at 6.64% (3.89% floating rate cap plus 2.75% spread) on $36.9 million in notional principal from September 2004 through September 2005 and 7.41% (4.66% floating rate cap plus 2.75% spread) from September 2005 through September 2007. The notional principal declines over time to $34.5 million at September 2007. In April 2005, Amendment One reduced the Eurodollar spread to 225 basis points, such that the total interest payable with respect to the principal amount covered by the first cap agreement was reset to 6.91% (4.66% floating rate cap plus 2.50% spread). In March 2006, Amendment Two increased the Eurodollar spread to 250 basis points, such that the total interest payable with respect to the principal amount covered by the first cap agreement was reset to 7.16% (4.66% floating rate cap plus 2.50% spread). In June 2006, Amendment Three increased the Eurodollar spread to 275 basis points, such that the total interest payable with respect to the principal amount covered by the first cap agreement was reset to 7.41% (4.66% floating rate cap plus 2.75% spread).

In April 2005, the Company paid approximately $117,000 to cap its interest rate at 7.25% (5.00% floating rate cap plus 2.25% spread) on an additional $28.0 million in notional principal through September 2007. In March 2006, Amendment Two increased the Eurodollar spread to 250 basis points, such that the total interest payable with respect to the principal amount covered by the second cap agreement was reset to 7.50% (5.00% floating rate cap plus 2.50% spread). In June 2006, Amendment Three increased the Eurodollar spread to 275 basis points, such that the total interest payable with respect to the principal amount covered by the second cap agreement was reset to 7.75% (5.00% floating rate cap plus 2.75% spread).

In April 2006, the Company paid approximately $43,600 to cap its interest rate at 8.00% (5.50% floating rate cap plus 2.50% spread) on an additional $30.0 million in notional principal through September 2007. In June 2006, Amendment Three increased the Eurodollar spread to 275 basis points, such that the total interest payable with respect to the principal amount covered by the third cap agreement was reset to 8.25% (5.50% floating rate cap plus 2.75% spread).

48

As of June 30, 2006, approximately $94.8 million, or approximately 36.5 percent of the $259.7 million drawn under the Term B Senior Credit Facility was at a capped interest rate. The maximum effective interest rate on the $94.8 million that is currently under cap agreements is approximately 7.79 percent. The remaining outstanding aggregate balance under the Term B Senior Credit Facility over $94.8 million, which was approximately $164.9 million as of June 30, 2006, is not subject to any interest rate cap.

Other Fees and Expenses.  Each quarter the Company is required to pay a commitment fee equal to 50 basis points per year on the prior quarter’s daily unused balance of the revolving credit facility and the senior term loan. As of June 30, 2006, there was approximately $6.0 million outstanding on the revolving credit facility and there was no unused balance on the senior term loan. For the nine months ended June 30, 2006, the Company paid a commitment fee of approximately $0.1 million for the revolving credit facility and no commitment fee for the senior term loan.

In addition to issuance and administrative fees, the Company is required to pay a fronting fee not to exceed 25 basis points for each letter of credit issued under the revolving credit facility. Each quarter the Company is required to pay interest in arrears at the revolving credit facility rate for all outstanding letters of credit. In addition to other fees and expenses under the Term B Senior Credit Facility, the Company is required to pay an annual agent’s fee.

Covenants.  Under the terms of the Term B Credit Facility, the Company is required to comply with certain covenants. As of June 30, 2006, the Company was in compliance in all material respects with the covenants set forth in the Term B Credit Facility.

Bridge Loan Agreement

On June 30, 2006, the Company entered into a Bridge Loan Agreement with Credit Suisse and borrowed $170 million (the Bridge Loan, also called the Initial Loan). Certain of the Company’s subsidiaries have guaranteed the Bridge Loan Agreement. The Initial Loan is due December 31, 2007 and automatically converts to an Extended Loan maturing December 31, 2011, if it has not been repaid by December 31, 2007. Aggregate outstanding principal under the Bridge Loan is due and payable on December 31, 2011, together with accrued and unpaid interest and applicable premiums, unless it is repaid and satisfied before then.

If the Company issues certain permitted debt (excluding the Term B Senior Credit Facility), or sells, transfers or disposes of certain assets other than in the normal course of business, or issues or sells certain kinds of equity interests, it must use all net proceeds to repay any Bridge Loan amounts outstanding.

Use of Proceeds.  The Company used the proceeds from the Bridge Loan to pay part of the cost of acquiring the Anteon Contracts.

Interest and Prepayment.  The Bridge Loan bears interest at a floating rate based on the Eurodollar Rate plus the applicable spread reflected in the table below which varies over four time periods: July 1 — December 31, 2006; January 1, 2007 — June 30, 2007; July 1 — December 31, 2007; and January 1, 2008 — December 31, 2011. The first interest payment is due September 30, 2006. Interest is payable quarterly in arrears in cash except that the Company may elect to pay any interest payable in excess of 700 basis points over the applicable Eurodollar floating rate in the form of PIK notes or it may elect to add the excess to the principal amount of the Bridge Loan. The Company may prepay all or any portion of the Bridge Loan in minimum increments of $100,000, as long as the Company repays an aggregate of at least $1.0 million plus applicable premium (described below) and customary breakage costs associated with pre-payment of Eurodollar-based loans. Bridge Loan prepayments are subject to an applicable premium percentage (in basis points) of the principal amount being repaid based on the prepayment date. Applicable margins for interest rates based on the Eurodollar rate and prepayment premium percentages are disclosed in the table below.

49

		Eurodollar
		Spread		Prepayment
		Basis		Premium in
From	Through	Points		Basis Points
July 1, 2006	December 31, 2006		550		-0-
January 1, 2007	June 30, 2007		625		100
July 1, 2007	December 31, 2007		700		200
January 1, 2008	December 31, 2008		900		100
January 1, 2009	December 31, 2009		900		200
January 1, 2010	December 31, 2011		900		300

Covenants.  Under the terms of the Bridge Loan Agreement, the Company’s required to comply with certain covenants. As of June 30, 2006, the Company was in compliance in all material respects with the covenants set forth in the Bridge Loan Agreement.

During the remainder of fiscal year 2006 and the next six fiscal years, at a minimum, we expect that we will have to make the estimated interest and principal payments set forth below.

	7-Fiscal Year Period
	2006*		2007		2008		2009		2010		2011		2012
	($ In thousands)
Bank revolving credit facility
- Interest(1)	$	99	$	250	$	250	$	250	$	250	$	250	$	250
Senior Secured Term B Loan
- Interest(2)		5,306		20,634		20,772		10,491		—		—		—
- Principal(3)		655		2,620		2,620		253,775		—		—		—
Bridge Loan
- Interest(4)		4,702		19,803		23,618		24,681		24,961		25,250		1,597
- Principal(4)		—		—		—		—		—		—		175,100
Subordinated note
- Interest(5)		—		—		—		6,384		3,192		—		—
- Principal(5)		—		—		—		27,352		27,352		—		—
Total cash — Pay interest		10,107		40,687		44,640		41,806		28,403		25,500		1,847
Total cash — Pay principal		655		2,620		2,620		281,127		27,352		0		175,100
Total	$	10,762	$	43,307	$	47,260	$	322,933	$	55,755	$	25,500	$	176,947

*	Estimated interest expense for the remainder of fiscal 2006
(1)	We anticipate accessing, from time to time, our $50.0 million bank revolving credit facility to finance our ongoing working capital needs. The remaining term of the revolving credit facility is approximately three years; however, we expect to review the revolving credit facility as an on-going requirement to fund working capital. For the remainder of fiscal year 2006, we anticipate the balance drawn on the revolving credit facility will be approximately $3.3 million, which will decline during the remainder of fiscal year 2006 as we anticipate improved collections on outstanding accounts receivable. For the fiscal years 2007 through 2009, we anticipate the balance drawn on the revolving credit facility will be minimal. Interest expense value includes an estimate for the unused balance fee on the $50.0 million revolving credit facility.
(2)	The projected average annual balance we estimate will be drawn under the Senior Secured Term B Loan is as follows: $259.3 million, $257.7 million, $255.1 million, and $126.9 million for the remainder of fiscal year 2006 and for fiscal years ending September 30, 2007, 2008, and 2009, respectively. The Company expects it will need to refinance the Term B Senior Credit Facility before the end of fiscal year 2008 and expects interest expense to continue at levels similar to prior years. Based on an estimated LIBOR rate plus the CS Eurodollar spread, the effective annual interest rate for the remainder of fiscal year 2006 and for fiscal years 2007, 2008,

50

	and 2009 is estimated to be approximately 7.9%, 7.8%, 7.9%, and 8.0%, respectively. The effective interest rate takes into account the interest rate cap agreements which limit the interest rate on a portion, but not all, of the outstanding principal balance of the Term B Senior Credit Facility. The current cap agreements expire in September 2007. Outstanding principal balances not under the cap agreements had interest based on the Eurodollar rate. The term of the Senior Secured Term B Loan is five years. The approximate impact of a 1% increase in the interest rate, as applied to principal balances drawn under the Senior Secured Term B Loan not covered by the current interest rate cap agreements would be $0.4 million, $1.7 million, $2.6 million, and $1.3 million for the remainder of fiscal year 2006 and for fiscal years ending September 30, 2007, 2008, and 2009, respectively. Estimated interest expense includes an estimate for the commitment fee on the Senior Secured Term B Loan.
(3)	The Term B Senior Credit Facility requires us to repay 1 percent of the principal balance outstanding under the senior term loan during each of the fiscal years 2006 through 2008 and 96 percent of the principal balance outstanding during fiscal year 2009 of the term. The table reflects the balance drawn of $259.67 million as of June 30, 2006, resulting in expected annual principal payments of approximately $0.6 million for the remainder of fiscal year 2006 and $2.62 million in each of fiscal years 2007, and 2008. During the fifth year, or 2009, we are scheduled to pay principal in the amount of $253.8 million. The Term B Senior Credit Facility also requires us to make mandatory prepayments of principal depending upon whether we generate certain excess cash flow in a given fiscal year, we issue certain equity, we issue or incur certain debt or we sell certain assets. As of June 30, 2006, no mandatory prepayments are due.
(4)	The table reflects the balance drawn under the Bridge Loan of $170.0 million as of June 30, 2006 with the principal amount, plus applicable prepayment premium, due and payable on December 31, 2011. The principal amount of $175.1 million includes $170.0 million at par value plus prepayment premium of $5.1 million (3% of par). Based on an estimated Eurodollar rate plus the CS Eurodollar spread, the effective annual interest rate for the remainder of fiscal year 2006 and for fiscal years 2007, 2008, 2009, 2010, 2011 and 2012 is estimated to be approximately 11.1%, 11.6%, 13.9%, 14.5%, 14.7%, 14.8% and 15.0%, respectively. The approximate impact of a 1% increase in the interest rate, as applied to principal balance drawn under the Bridge Loan, would be $0.4 million for the remainder of fiscal year 2006, $1.7 million for each fiscal year 2007 through 2011, and $0.4 million for the partial period of fiscal year 2012.
(5)	Interest expense on the subordinated note during the four fiscal years from 2006 to 2008 is 6% simple interest, paid-in-kind by the issuance of PIK notes. These interest amounts accrue to principal increasing the principal value of the subordinated note. PIK notes do not bear interest. Interest obligations paid by issuance of the PIK notes does not compound. In the years 2006 through 2008, the PIK interest on the Subordinated Note will be approximately $2.4 million in each year. During the eight-year term of the Subordinated Note, approximately $14.2 million of principal accretes to the note through the PIK notes. These amounts are included in the principal payments in fiscal years 2009 and 2010. In years 2009 and 2010, interest will be 16% paid quarterly in cash on the original principal of $39.9 million. The principal, together with the outstanding balance of the PIK notes, will be paid in equal amounts at the end of fiscal years 2009 and 2010.

Other Obligations

Earn-outs

The Company has earn out commitments related to the following acquisitions:

CATI — There is an earn out provision not to exceed a total of $8.25 million based on the revenue of the business units that formerly comprised CATI for fiscal years 2005 through 2007. There is a second earn out provision not to exceed $1.5 million based on attaining certain revenue goals in the commercial aviation industry. The obligations continue until September 2007. For the nine months ended June 30, 2006 and 2005, the Company recognized approximately $2.0 million and zero, respectively, in earn out obligation related to CATI.

BMH — There is an earn out provision not to exceed a total of $6.0 million based on the revenue of the business units that formerly comprised BMH. The obligation continues until December 2007. For the nine months ended June 30, 2006 and 2005, the Company recognized no earn out obligation related to BMH.

51

WCI — There is an earn out provision not to exceed a total of $2.5 million based on the revenue of the business units that formerly comprised WCI. The obligation continues until September 2007. For the nine months ended June 30, 2006 and 2005, the Company recognized no earn out obligation related to WCI.

MA&D — There is an earn out provision not to exceed a total of $2.5 million based on the revenue of the business units that formerly comprised MA&D. The obligation continues until September 2007. For the nine months ended June 30, 2006 and 2005, the Company recognized no earn out obligation related to MA&D.

Lease Payments

The Company’s remaining minimum lease payment obligations under non-cancelable operating leases for the remainder of fiscal year 2006 and for fiscal years ending 2007, 2008, 2009, 2010 and 2011 are $9.6 million, $16.4 million, $15.0 million, $11.9 million $7.5 million and $4.6 million respectively. The remaining aggregate obligations on these leases thereafter are approximately $1.9 million. Commercial facility lease expenses are included in these amounts. These commercial facility lease obligations are currently reimbursable costs under the Company’s government contracts.

Other Obligations

Other contingent obligations which will impact the Company’s cash flow include:

•  Repurchase obligations under the KSOP;

•  Obligations related to the holder’s put rights associated with the Subordinated Note warrants; and

•  Obligations relating to our stock based compensation plans.

As of June 30, 2006, the Company has spent a cumulative total of $27.6 million to repurchase shares of its common stock from the Trust to satisfy obligations under the KSOP to terminated employees.

	Number of Shares				Total Value
Date	Repurchased		Share Price		Purchased
June 2003		5,248	$	11.13	$	58,412
July 2003		2,696	$	11.13	$	30,000
December 2003		50,031	$	14.71	$	735,956
May 2004		117	$	16.56	$	1,945
June 2004		727	$	16.56	$	12,039
June 2004		743	$	16.56	$	12,297
July 2004		48,309	$	16.56	$	799,997
December 2004		46,816	$	19.94	$	933,505
March 2005		5,691	$	19.94	$	113,486
June 2005		45,846	$	29.81	$	1,366,674
August 2005		1,090	$	33.78	$	36,803
September 2005		170,657	$	33.78	$	5,764,784
December 2005		211,537	$	35.89	$	7,592,079
June 2006		273,800	$	37.06	$	10,147,043
Total					$	27,605,031

The Company believes that cash flow from operations and cash available under its revolving credit facility will provide it with sufficient capital to fulfill its current business plan and to fund its working capital needs for at least the next 27 months. Although the Company expects to have positive cash flow from operations, it will need to generate significant additional revenues beyond its current revenue base and to earn net income in order to repay principal and interest on the indebtedness it assumed under the Term B Senior Credit Facility, the Bridge Loan and the remaining outstanding indebtedness it incurred to fund the Transaction.

52

The Company’s business plan calls for it to continue to acquire companies with complementary technologies. The Term B Senior Credit Facility allows the Company to make certain permitted acquisitions, and the Company intends to use a portion of the financing available to it under the Term B Senior Credit Facility to make permitted acquisitions.

The Company expects to refinance the Bridge Loan Agreement before the end of fiscal year 2006 through the issuance of up to $200.0 million of unsecured senior subordinated notes. The Company intends to use the proceeds to repay the Bridge Loan and a portion of the Senior Term B Credit loan. The Company also expects that it will need to refinance the Term B Senior Credit Facility before the end of fiscal year 2008. The Company’s cash from operations will be insufficient to satisfy all of its obligations and it cannot be certain that it will be able to refinance on terms that will be favorable to the Company, if at all. Moreover, if the Company’s plans or assumptions change, if its assumptions prove inaccurate, if it consummates additional or larger investments in or acquisitions of other companies than are currently planned, if it experiences unexpected costs or competitive pressures, or if its existing cash and projected cash flow from operations prove insufficient, it may need to obtain greater amounts of additional financing and sooner than expected. While it is the Company’s intention only to enter into new financing or refinancing that it considers advantageous, it cannot be certain that such sources of financing will be available to the Company in the future, or, if available, that financing could be obtained on terms favorable to the Company.

Contract performance — Joint Spectrum Center Contract

The Company did not win the re-compete for its existing contract with the JSC. The Company filed a protest against the award of the contract to one of its competitors. The Company’s principal argument was that the successful bidder had an organizational conflict of interest with respect to its proposed performance of the contract. In its decision dated January 9, 2006, the GAO sustained the protest and recommended that the contracting agency take certain corrective action in order to address the awardee’s organizational conflict of interest. On June 12, 2006, the contracting agency re-awarded the contract to the original awardee. On June 16, 2006, the Company filed another formal bid protest. The Company’s principal argument was that the original awardee continues to have an organizational conflict of interest with respect to its proposed performance of the contract. The Company is awaiting a decision from the GAO. The Company continues to support the JSC customer under its existing contract until the issues involved in its protest are resolved.

Item 3.   Quantitative and Qualitative Disclosures About Market Risk

The Company’s exposure to interest rate risk is primarily due to the debt it incurred to finance the Transaction, the subsequent refinancing of a portion of that debt in August 2004 and additional financing undertaken by the Company in October 2004, April 2005, March 2006 and June 2006. The Subordinated Note has a stated fixed interest rate, and therefore presents no risk of change to interest charges as a result of an increase in market interest rates.

The balance drawn under the $50.0 million senior revolving credit facility bears interest at variable rates based on CS’s prime rate plus a maximum spread of 225 basis points. The balance on the Senior Secured Term B Loan bears interest at variable rates tied to the Eurodollar rate. Such variable rates increase the risk that interest charges will increase materially if market interest rates increase. As of June 30, 2006, the Company has reduced, in part, the maximum total amount of variable interest rate risk on the Senior Secured Term B Loan by entering into three interest rate cap agreements that cover the first $92.5 million, or approximately 35.6% of currently outstanding principal borrowed. See the Discussion of Debt Structure in Item 2 for a discussion of the three interest rate cap agreements. The approximate impact of a 1% increase in the interest rate, as applied to principal balances drawn under the Senior Term B Credit Facility that are not covered by the current interest rate cap agreement, would be approximately $0.2 million, $1.7 million, $2.6 million, and $1.3 million for the remainder of fiscal year 2006 and for fiscal years ending September 30, 2007, 2008, and 2009, respectively.

The balance drawn under the Bridge Loan Agreement bears interest at variable rates tied to the Eurodollar rate plus a maximum CS Eurodollar spread of 900 basis points. Such variable rates increase the risk that interest charges will increase materially if market interest rates increase. The approximate impact of a 1% increase in the interest rate, as applied to the principal balance drawn under the Bridge Loan Agreement, would be $0.4 million for the

53

remainder of fiscal year 2006, $1.7 million for each fiscal year 2007 through 2011, and $0.4 million for fiscal year 2012.

The Company does not use derivatives for trading purposes. It invests its excess cash in short-term, investment grade, and interest-bearing securities.

Foreign currency risk

The Company’s expenses and revenues from its international contracts are generally denominated in U.S. dollars. The Company does not believe that its operations are subject to material risks associated with currency fluctuations.

Risk associated with the value of Alion common stock

The Company has exposure to change in the fair market value of Alion’s common stock as the economic basis for the estimate of contingent obligations relating to the holder’s put rights associated with the Subordinated Note warrants. The value of this obligation would increase by approximately $1.1 million if the price of the Company’s stock were to increase by 10% and would decrease by approximately $1.4 million if the price of the Company’s stock were to decrease by 10%.

The Company also has exposure to change in the fair market value of Alion’s stock as the economic basis for the estimate of contingent obligations relating to its repurchase obligations under the KSOP and obligations relating to stock appreciation rights and phantom stock programs. The amount of such exposure will depend upon a number of factors including but not limited to, the number of employees who might exercise their rights under the stock appreciation and phantom stock programs during any particular time period.

Item 4.   Controls and Procedures

(a) Disclosure Controls and Procedures.  The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this quarterly report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports that the Company files or submits under the Exchange Act.

(b) Internal Control Over Financial Reporting.  There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rule 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

54

PART II — OTHER INFORMATION

Item 1.   Legal Proceedings

See Footnote 17 to the Condensed Consolidated Financial Statements.

Other than the actions discussed in Footnote 17, the Company is not involved in any legal proceeding other than routine legal proceedings occurring in the ordinary course of business. The Company believes that these routine legal proceedings, in the aggregate, are not material to its financial condition and results of operations.

As a government contractor, the Company may be subject from time to time to federal government inquiries relating to its operations and audits by the Defense Contract Audit Agency. Contractors found to have violated the False Claims Act, or which are indicted or convicted of violations of other federal laws, may be suspended or debarred from federal government contracting for some period. Such an event could also result in fines or penalties.

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds

None, other than sales of securities already reported by the Company in current reports on Form 8-K.

Item 3.   Defaults Upon Senior Securities

None.

Item 4.   Submission of Matters to a Vote of Security Holders

None.

Item 5.   Other Information

None.

Item 6.   Exhibits

Exhibit No.			Description
	4	.13	Twelfth Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.
	4	.14	Thirteenth Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.
	10	.69	Asset Purchase Agreement dated as of June 4, 2006, by and between Anteon Corporation, Alion Technical Services Corporation and Alion Science and Technology Corporation. (1)
	10	.73	Separation Agreement between Alion Science and Technology Corporation and Barry Watson.
	10	.74	Second Addendum to Employment Agreement between Alion Science and Technology Corporation and James Fontana.
	10	.75	Commitment letter by and between Alion Science and Technology Corporation, Credit Suisse and Credit Suisse Securities (USA) LLC.
	10	.76	Amendment to Offer of Promotion between Alion Science and Technology Corporation and Leroy R. Goff III.
	10	.77	Offer Letter between Alion Science and Technology Corporation and Scott A. Fry.
	10	.78	Addendum to Offer Letter between Alion Science and Technology Corporation and Scott A. Fry.
	31	.1	Certification of Chief Executive Officer of Alion Science and Technology Corporation pursuant to Rule 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
	31	.2	Certification of Chief Financial Officer of Alion Science and Technology Corporation pursuant to 15d-14a) promulgated under the Securities Exchange Act of 1934, as amended.
	32	.1	Certification of Chief Executive Officer of Alion Science and Technology Corporation, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
	32	.2	Certification of Chief Executive Officer of Alion Science and Technology Corporation, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(1) Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s Form 8-K filed with the Securities and Exchange Commission on June 7, 2006 (File no. 333-89756).

55

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ALION SCIENCE AND TECHNOLOGY CORPORATION

By:  /s/  John M. Hughes

Name: John M. Hughes

Title: Chief Financial Officer

(Principal Financial and Accounting Officer

and Duly Authorized Officer)

Date: August 14, 2006

56

EX-4.13

Exhibit 4.13

Twelfth Amendment to
Alion Science and Technology Corporation
Employee Ownership, Savings and Investment Plan

     WHEREAS, Alion Science and Technology Corporation maintains an Employee Ownership, Savings and Investment Plan (the “Plan”) for the benefit of its Employees and Employees of other Adopting Employers, which Plan was last amended and restated as of December 19, 2001; and

     WHEREAS, the Board of Directors of the Company, pursuant to Section 15.1 of the Plan, has delegated authority to amend the Plan to the undersigned officer, provided he determines that the amendment would not materially increase costs of the Plan to the Company or any Adopting Employer; and

     WHEREAS, the undersigned officer has determined that this Twelfth Amendment would not materially increase costs of the Plan to the Company or any Adopting Employer;

     NOW, THEREFORE, pursuant to the powers of amendment reserved under Section 15.1 of the Plan, the Plan is hereby amended by the Company, effective February 10, 2006, unless otherwise provided, by the addition of Supplement No. 2, attached hereto, at the end of the Plan.

     FURTHER RESOLVED, that Exhibit A of the Plan – Adopting Employers and Special Plan Provisions for Certain Adopting Employers shall be amended by the addition of Washington Consulting, Inc., a wholly-owned subsidiary of the Company, effective as of February 25, 2006.

     IN WITNESS WHEREOF, Alion Science and Technology Corporation has caused this Twelfth Amendment to the Plan to be executed on its behalf by the Chief Executive Officer as of the ___3___ day of ___April___, 2006.

Alion Science and Technology Corporation
By:	/s/ Bahman Atefi
	Its: Chief Executive Officer

Supplement No. 2

BMH Associates, Inc. Profit Sharing 401(k) Plan

     1.1 Purpose. The purpose of this Supplement No. 2 is to set forth provisions applicable to individuals (“Former BMH Participants”) who were previously participants in the BMH Associates, Inc. Profit Sharing 401(k) Plan (“BMH Plan”) immediately before the acquisition of BMH Associates, Inc. by the Company and who became participants in the Plan on February 11, 2006 as provided in Section 1.4. Except to the extent expressly modified by this Supplement No. 2, the provisions of the Plan shall apply to the participation of such Former BMH Participants as of the date assets are transferred from the BMH Plan to this Plan.

     1.2 Former BMH Participants. A Participant shall include any former employee whose account under the BMH Plan was transferred to the Plan.

     1.3 Employment Commencement Date. In no event shall a Former BMH Participant’s Employment Commencement Date be before February 11, 2006.

     1.4 Participation. A Former BMH Participant who is an Eligible Employee on February 11, 2006 shall become a Participant in the Plan as of such date. Such a Former BMH Participant shall become eligible to contribute to the Plan as of the first day of the first payroll period beginning on or after February 11, 2006. For purposes of determining eligibility for Matching Contribution and any Profit Sharing Contribution, a Former BMH Participant’s Period of Service shall include his or her service with BMH as of February 10, 2006. For purposes of determining the amount of any Matching Contribution and any Profit Sharing Contribution for the Plan Year ending September 30, 2006, a Former BMH Participant’s Compensation shall only include amounts paid by the Company after the later of February 10, 2006 or the date on which such person satisfies the eligibility requirements for such contribution.

     1.5 Mapping of Investments. Except as provided in Section 5.1(j) of the Plan, a Former BMH Participant’s account under the BMH Plan which is transferred to this Plan shall be invested in the Non ESOP Component Funds that the ESOP Committee, or its delegate, determines most closely resemble the investment funds under the BMH Plan in which such account was invested immediately before the transfer.

     1.6 Diversification. For purposes of Plan Section 5.2, a Former BMH Participant’s Period of Participation shall not include the period of time during which he or she participated in the BMH Plan. For purposes of Plan Section 5.2, a Former BMH Participant’s “years of employment” shall not include his or her employment with BMH Associates, Inc.

     1.7 Vesting. A Former BMH Participant who is an Employee on February 11, 2006 shall be fully vested in his or her Profit Sharing Contributions under the Plan.

     1.8 In-Service Withdrawals. Subject to Plan Sections 8.1(a)(2) and 8.3, a Former BMH Participant may withdraw from the Non ESOP Component any portion or all of his or her account under the BMH Plan which is transferred to this Plan on or after attainment of age fifty-nine and one-half (59¹/2). In addition, a Former BMH Participant may withdraw all or a portion of his or her (1) BMH Pre-Tax Contributions Account (excluding earnings), (2) BMH Profit

2

Sharing Account, and (3) BMH Rollover Account, in the event of a hardship in accordance with the terms and conditions prescribed in Sections 8.1(b) and 8.3.

     1.9 Merger of BMH Plan. Effective as of February 10, 2006, all accrued benefits under the BMH Plan shall become accrued benefits under this Plan.

3

EX-4.14

Exhibit 4.14

Thirteenth Amendment to
Alion Science and Technology Corporation
Employee Ownership, Savings and Investment Plan

     WHEREAS, Alion Science and Technology Corporation (the “Company”) maintains an Employee Ownership, Savings and Investment Plan (the “Plan”) for the benefit of its Employees and Employees of other Adopting Employers, which Plan was last amended and restated as of December 19, 2001; and

     WHEREAS, under Section 15.1 of the Plan, the Company has reserved the right to amend the Plan at any time, in whole or in part, by action of its Board of Directors; and

     WHEREAS, the Board of Directors of the Company, pursuant to Section 15.1 of the Plan, has delegated authority to amend the Plan to the undersigned officer, provided he determines that the amendment would not materially increase costs of the Plan to the Company or any Adopting Employer; and

     WHEREAS, the undersigned officer has determined that this Thirteenth Amendment to Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan would not materially increase costs of the Plan to the Company or any Adopting Employer; and

     WHEREAS, capitalized terms used and not defined herein shall have the meanings assigned to such terms in the Plan.

     NOW THEREFORE, pursuant to the powers of amendment reserved under Section 15.1 of the Plan, the Plan is hereby amended, as follows:

     1. Section 4.1(a) of the Plan is amended, effective as of May 6, 2006, by deleting the entirety of Section 4.1(a) of the Plan, and substituting the following in lieu thereof:

“Except as otherwise provided herein and in Exhibit A to this Plan, a Participant may authorize an Adopting Employer to reduce his or her Compensation on a pre-tax basis by an amount equal to any whole percentage of Compensation that does not exceed twenty percent (20%) and to have such amount contributed to the Plan as an Elective Deferral. Effective October 1, 2002, the Elective Deferral contributions percentage is sixty percent (60%) for each Pay Period. At the time amounts are contributed to the Plan as an Elective Deferral, the Participant will designate the percentage (in increments of 1%) to be (i) held for investment in the Participant’s ESOP Elective Deferral Account in accordance with Section 5.1(c) and (ii) otherwise invested in the Participants’ Non ESOP Elective Deferral Account in accordance with Section 5.1(a). A Participant may elect to defer no more than eleven percent (11%) of Compensation into the Participant’s ESOP Elective Deferral Account for each Pay Period.”

     2. Section 5.1(c) of the Plan is amended, effective as of May 6, 2006, by deleting the entirety of Section 5.1(c) of the Plan, and substituting the following in lieu thereof:

“Each Participant shall be entitled to designate the percentage (in multiples of one percent) of his Elective Contributions that shall be invested in Common Stock under the ESOP Component of this Plan, subject to the eleven percent (11%) limitation set forth in

Section 4.1(a). To the extent a Participant directs his Elective Contributions to be invested under the ESOP Component, such contributions shall be accumulated in a short term interest fund in the ESOP Component of the Plan and shall be converted to Common Stock on a semi-annual basis using the Common Stock value as of the Valuation Date preceding or as of the conversion date (whichever is lower), and shall then be allocated to the participant’s ESOP Elective Deferral Account. Notwithstanding the foregoing, for the period of April 1, 2005 through September 30, 2005, to the extent a Participant directs his Elective Contributions to be invested under the ESOP Component, such contributions shall be accumulated in a short term interest fund in the ESOP Component of the Plan and shall be converted to Common Stock as of the Valuation Date coincident with or next following the date of receipt based on the Current Market Value of Common Stock as of the Valuation Date coincident with or next following the date of receipt based on the Current Market Value of Common Stock as of such Valuation Date or as of the preceding Valuation Date (whichever is lower), and shall then be allocated to the participant’s ESOP Elective Deferral Account. Notwithstanding the above, in the event the total Elective Deferrals directed to the ESOP Component exceed five (5%) of the aggregate payroll expenses since December 20, 2002 (measured as of the end of each Plan Year) of the Company and each of the subsidiaries of the Company (a) that is an Adopting Employer, and (b) substantially all of whose employees are eligible to participate in the ESOP Component, the ESOP Committee may choose pursuant to uniform and nondiscriminatory policies to redirect a portion of each Participant’s Elective Deferrals that have been directed to the ESOP Component, and any interest credited to such amounts, to the Participant’s non-ESOP Accounts. Such a reduction would be applied on a pro rata basis to Elective Deferrals intended to be invested in the ESOP Component during such period.”

[Signature follows on next page]

2

     IN WITNESS WHEREOF, the Company has caused this Thirteenth Amendment to Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan to be executed on its behalf by the Chief Executive Officer of the Company as of the 28^th day of April, 2006.

Alion Science and Technology Corporation
 

/s/ Bahman Atefi  

By: Bahman Atefi 

Its: Chief Executive Officer 

3

EX-10.73

Exhibit 10.73

SEPARATION AGREEMENT AND GENERAL RELEASE

          This Separation Agreement and General Release (“Agreement”) is entered into by and between Barry S. Watson (“Employee”) and Alion Science and Technology Corporation (“Alion” or the “Company”) as of the latest date of execution by the parties to this Agreement. This Agreement supersedes and cancels any prior employment agreements or arrangements Employee may have entered into with Alion or its subsidiaries, affiliates, successors, assigns or predecessors in interest, including without limitation the Employment Agreement between Employee and Alion dated December 20, 2002 (the “Employment Agreement”), except as otherwise provided in this Agreement; provided, however, that the Employee Intellectual Property Agreement between Employee and Alion dated December 18, 2002, shall remain in full force and effect.

          In consideration of the mutual covenants, agreements and representations contained herein, the adequacy of which is hereby acknowledged, the parties hereto expressly and intentionally bind themselves as follows:

     1. SEPARATION OF EMPLOYEE

     Employee hereby agrees that he will announce his retirement from Alion and has notified Alion as of April 21, 2006 (the “Notification Date”) that his employment as Sector Senior Vice President and Sector Manager for the Systems Technology Sector of Alion will cease. Alion and Employee agree that Employee shall remain an employee with Alion in an untitled position until April 28, 2006 (the “Separation Date”). Employee voluntarily resigns from employment with the Company effective upon the Separation Date, or, if earlier, upon death or the date Employee accepts alternative employment, and the Company hereby accepts Employee’s resignation. Employee expressly acknowledges that, upon the occurrence of the Separation Date, he will no longer be an employee of Alion. Except as provided in Paragraph 2 below, effective as of the Notification Date, Employee shall not be eligible for further pay or benefits, including without limitation any benefits under any severance pay plan applicable to him as an employee of Alion, except as provided in this Agreement. From the period of the Notification Date through the Separation Date, and except as otherwise expressly permitted by Alion’s Chief Executive Officer, Employee shall not perform any work for Alion, shall cease all of his activities in connection with his duties at Alion, shall have no authority to act on behalf of or bind Alion and shall not represent to any third party or to any employee, agent or representative of Alion that he has any title, role or authority to act for or on behalf of Alion; provided, however, that, up to the Separation Date, Employee shall provide reasonable assistance and cooperation to Alion at such times as Alion may reasonably request. In addition, effective on the Notification Date, Employee expressly resigns from all offices, directorships and fiduciary positions with the Company or any related entities, including without limitation as a director of METI, Inc., a subsidiary of Alion.

     2. PAYMENTS BY ALION

          (a) For the period from the Notification Date through the Separation Date (the “Salary Continuance Period”), Employee shall remain on the Company’s payroll at his current prorated annual base salary (the “Salary Continuance Payments”). If Employee signs and does not revoke this Agreement, then, within eight (8) business days from the seven day period set forth in Paragraph 4(c)(ii), Alion shall make a lump sum severance payment to Employee in the amount of $486,449.62.

          (b) In addition to the Salary Continuance Payments and lump sum severance payment set forth above, the Company shall pay to Employee, within sixty (60) days from the Separation Date, a lump sum amount equal to $1,164,933.70 representing all amounts due for the vested and prorated unvested shares of phantom stock under the Alion Phantom Stock Plan (the “Plan”) and the Phantom Stock Agreements executed between the Company and Employee pursuant to the Plan for the Dates of Grants, as defined in the Plan, of February 11, 2003 and November 3, 2003. Such amount, computed as [x shares] times [share price] shall be increased or decreased as necessary to reflect the “Fair Market Value” assigned to shares under the Plan as of the March 31 “Valuation Date” (as such terms are defined in the Plan).

          (c) In addition to the above payments, the Company shall pay to Employee, contemporaneously with the payments set forth in Paragraph 2(a) above, an amount of $24,236.45 for outstanding accrued Paid Time Off (“PTO”).

          (d) Employee shall be permitted to continue the use of the automobile under the Company’s current automobile lease for Employee until the Separation Date. On or before close of business on the Separation Date, Employee shall return the automobile, along with all accessories purchased or reimbursed by the Company, to the Company’s Director of Human Resources. As of one (1) day after the Separation Date, any insurance coverage on behalf of Employee with regard to such automobile shall cease at the Company’s discretion.

          (e) Except as provided in this Agreement, no further payments shall be made to Employee.

          (f) The Company shall withhold such tax, payroll and other amounts from payments under this Agreement as Employee authorizes or the Company reasonably believes to be required by law.

     3. EMPLOYMENT BENEFITS

          (a) Employee agrees and acknowledges that his participation in any 401(k) Plan, short-term and long-term Disability Plans, or any other benefit plans made available to him as a Alion employee, and his participation in and entitlement to any and all other benefits in which he is currently enrolled, but which are not specifically addressed in this Agreement, will terminate on the Separation Date.

2

          (b) Employee’s participation in the Alion medical, dental, vision and other insurance plans shall cease as of the Separation Date, provided that Employee and/or Employee’s eligible dependent(s) remain eligible for such coverage under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”) after the Separation Date, as provided by applicable law. Notwithstanding the foregoing, to the extent that Employee is eligible for and elects COBRA continuation coverage for Employee and any eligible dependent(s), for a period of eighteen (18) months from the Separation Date, the Company will reduce the cost of coverage that Employee is required to pay under such plans as elected by Employee pursuant to COBRA to the then current cost of such benefits to active employees as of the Separation Date; provided, however, that Alion has and reserves the right to amend, modify or replace such plans to provide substantially similar insured coverage.

        (c) Except as otherwise provided in this Agreement, Employee waives any right of participation in, or additional benefits under, the employee benefit, fringe benefit and compensation plans of Alion with respect to any period after the Separation Date.

     4. GENERAL RELEASE BY EMPLOYEE

          (a) Employee hereby releases and forever discharges Alion, its subsidiaries, affiliates, insurers, predecessors, successors, and assigns, and the directors, officers, shareholders, employees, representatives and agents of each of the foregoing (collectively “Releasees”) of and from the following:

          (i) Any and all claims, demands, and liabilities whatsoever of every name and nature (other than those arising directly out of this Agreement), including, without limitation, those with respect to Employee’s employment by Alion, or the terms and conditions of employment, benefits or compensation, or termination of his employment, which Employee has or ever had against Releasees; and

          (ii) Without limitation, any and all claims known or unknown as of the date of execution of this Agreement for tortious injury, breach of contract, and/or wrongful discharge (including, without limitation, any claim for constructive discharge), all claims for infliction of emotional distress, all claims for slander, libel, or defamation of character, and all claims for reinstatement, back pay, front pay, compensatory or punitive damages, severance pay, attorneys’ fees, or costs, as related to Employee’s employment by Alion, or the terms and conditions or termination of his employment, benefits or compensation, or termination of such employment; and

          (iii) Without limitation, any and all claims known or unknown based upon any allegation of employment discrimination, including, without limitation, discrimination on the basis of race, color, sex, sexual orientation, age (including any claim pursuant to the Federal Age Discrimination in Employment Act), religion, disability, national origin or any other classification protected under applicable law.

3

          (b) It is agreed and understood that this release is a GENERAL RELEASE to be construed in the broadest possible manner consistent with applicable law.

          (c) Employee acknowledges and agrees that Employee:

          (i) has not filed or pursued any claim released hereby against any Releasee by filing a lawsuit in any local, state or federal court for or on account of anything which has occurred up to the present time as a result of Employee’s employment or termination of employment, and Employee shall not seek reinstatement with, or damages of any nature, severance pay, attorneys’ fees, or costs from any Releasee; and

          (ii) has been given the opportunity, if he so desires, to consider this Agreement for twenty-one (21) days before executing it. Any change made to the Agreement during the 21-day period, whether material or not, will not restart the running of the 21-day period. In the event that Employee executes this Agreement within twenty-one (21) days of the date of its delivery to him, he acknowledges that such decision was entirely voluntary and that he had the opportunity to consider this Agreement for the entire twenty-one (21) day period. For a period of seven (7) days from the date of the execution of this Agreement, Employee shall retain the right to revoke this Agreement in accordance with 29 U.S.C. § 626 by written notice to Alion, c/o Kathy Madaleno, Director of Human Resources, 1750 Tysons Boulevard, McLean, Virginia 22102. This Agreement shall not become effective or enforceable until the expiration of such revocation period; and

          (iii) has been and is advised to consult an attorney regarding this Agreement prior to executing it and that he has been given sufficient time to do so; and

          (iv) has received full and adequate consideration for this General Release; and

          (v) fully understands and acknowledges the significance and consequences of this Agreement and represents by his signature that the terms of this Agreement are fully understood and voluntarily accepted by him. This Agreement has been individually negotiated by Employee and is not part of a group exit incentive or other group employment termination program.

          (d) Excluded from this General Release are any claims or rights which cannot be waived by law, including the right to challenge the enforceability of this Agreement and the Employee’s right to file a charge with an administrative agency or participate in any agency investigation. However, Employee is waiving his right to recover any money in connection with such a charge or investigation. Employee is also waiving his right to recover money in connection with a charge filed by any other individual or by the Equal Employment Opportunity Commission or any other federal, state or local agency.

4

          (e) This General Release becoming and remaining effective shall be a condition precedent to Employee obtaining any payments or benefits under this Agreement.

     5. NONDISCLOSURE OF INFORMATION; RETURN OF PROPERTY

          (a) Employee shall keep secret and confidential and shall not disclose to any third party, in any fashion or for any purpose whatsoever, any information regarding Alion which is (i) not available to the general public, and/or (ii) not generally known outside the Company, and (iii) is considered proprietary to or a trade secret of the Company, to which he has or will have had access at any time during the course of his employment by the Company, including, without limitation, any information relating to: the Company’s business or operations; its plans, strategies, prospects or objectives; its products, technology, processes or specifications; its research and development operations or plans; its customers and customer lists; its manufacturing, distribution, sales, service, support and marketing practices and operations; its financial condition and results of operations; its operational strengths and weaknesses; and, its personnel and compensation policies and procedures.

          (b) Employee agrees to return to Alion, on the Notification Date or at such later time as Alion may allow in its sole discretion, (i) all documents, data, material, details and copies thereof in any form (electronic or hard copy) that are the property of Alion or were created using Alion resources or during any hours worked for Alion including, without limitation, any data referred to in the immediately preceding Paragraph; and (ii) all other Alion property including, without limitation, all computer equipment (except as otherwise agreed, but including electronic information and/or software on Alion-provided computer equipment to be retained by Employee) and associated passwords, property passes, keys, credit cards, business cards and identification badges.

     6. NO DETRIMENTAL COMMUNICATIONS

          Employee agrees that he will not make, disclose or cause to be disclosed any negative, adverse, false or derogatory comments or statements about Releasees with regard to any product or service provided by Releasees, about Releasees’ prospects for the future, or about Releasees in general. Alion agrees that no authorized officer of Alion will disclose or cause to be disclosed outside of Releasees any negative, adverse, false or derogatory comments or statements about Employee. The parties agree that this provision will not be construed so as to bar any person from providing full and truthful testimony in response to a summons, court or administrative order or subpoena, or as otherwise provided by law. For the limited purposes of this Paragraph only, the term “Releasees” shall mean only the directors, chief executive officer, senior vice presidents and corporate vice presidents of Alion.

5

     7. FUTURE ASSISTANCE

          Alion may seek the assistance and cooperation of Employee in connection with any audit, investigation, litigation or proceeding arising out of matters within the knowledge of Employee and related to his position as an employee of Alion, and in any such instance, Employee shall provide such assistance, cooperation or testimony, and Alion shall pay Employee’s reasonable costs and expenses in connection therewith.

     8. NON-COMPETITION; NON-SOLICITATION

     Employee acknowledges and recognizes the highly competitive nature of the business of Alion and Alion’s subsidiaries and affiliates and, accordingly, agrees as follows:

          (a) As of the Notification Date and for a period of one (1) year after the Separation Date,, Employee agrees that he will not, without the prior written consent of Alion, directly or indirectly, whether as a principal, agent, employee, consultant, contractor, advisor, representative, stockholder (other than as a holder of an interest of five percent (5%) or less in the equity of any corporation whose stock is traded on a public stock exchange), or in any other capacity:

               (i) provide any services, advice or assistance to any business, person or entity which competes with Alion in connection with any contract or other business arrangement in which Employee (1) was involved, directly or indirectly; (2) acquired knowledge through access to confidential information; or (3) had any responsibility or material and direct involvement (except that this restriction shall not apply if Employee provides services, advice or assistance to or within a separate division or operating unit, of any such business, person or entity, that does not itself compete with Alion or any of its subsidiaries or affiliates and Employee has had no involvement with any part of such business, person or entity that competes with Alion);

               (ii) solicit, entice, divert or take away, or attempt to solicit, entice or divert or to take away, the business or patronage of any of the clients, customers or accounts, or prospective clients, customers or accounts, of Alion, or any individual or entity having a business relationship with Alion, in which Employee was involved or acquired knowledge through access to such confidential information, or to induce or attempt to induce, directly or indirectly, any individual or entity having a business relationship with Alion, whether as an employee, consultant, customer or otherwise, to terminate or cease such relationship; or

6

               (iii) (1) solicit or encourage any employee of Alion or any of Alion’s subsidiaries or affiliates to leave the employment of Alion or such subsidiary or affiliate, provided that such employee was employed or had an offer of employment with Alion at the time Employee ceases to be employed by Alion; (2) without Alion’s written permission, hire any such employee who was employed by Alion or Alion’s subsidiaries or affiliates as of the Separation Date or who left employment with Alion or Alion’s subsidiaries or affiliates coincident with, or within three (3) months prior to or after, the Separation Date; or (3) encourage any Alion consultant, vendor or other independent contractor then under contract with Alion or any of its subsidiaries or affiliates to cease work with Alion or any such subsidiary or affiliate.

          (b) The parties represent and agree that any breach of this Paragraph is likely to cause irreparable injury to Alion and that damages for any breach of this Paragraph are difficult to calculate. Therefore, upon breach of this Paragraph, Alion will, at its election, be entitled to injunctive and other equitable relief. However nothing in this Paragraph shall limit Alion’ right to seek any relief or remedies, including damages to which it may be entitled.

          (c) It is the intention of the parties that (i) the restrictions contained in this Paragraph be less restrictive than the restrictions contained in the Employment Agreement; (ii) this Paragraph represents additional valid and good consideration in exchange for Employee executing this Agreement; and (iii) the restrictions contained in this Paragraph are reasonable as to time, geographic scope, and in all other respects.

     9. GOVERNING LAW; SEVERABILITY

          This Agreement is entered into and shall be construed under the laws of the Commonwealth of Virginia. In the event any provision of this Agreement is determined to any extent to be illegal or unenforceable by a duly authorized court of competent jurisdiction, then the illegal or unenforceable provision shall be severed from this Agreement. In the event of such severance, the remainder of this Agreement shall not be affected thereby, and each remaining provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law; provided, however, that the parties expressly acknowledge and agree that the full waiver and release of all claims by Employee is essential to effectuate the parties’ intent in entering into this Agreement and that, in the event the general release of claims set forth in Paragraph 4 is severed, the parties’ remaining obligations under this Agreement shall be deemed waived (other than obligations arising under Paragraphs 5 and 8), and any consideration or value delivered by one party to the other under this Agreement shall constitute a binding obligation by the recipient to the other.

7

     10. WAIVERS

          The failure of either party to require the performance of any term or obligation of this Agreement, or the waiver by either party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation and shall not be deemed a waiver of any subsequent breach.

     11. AMENDMENTS

          This Agreement may be modified or amended, in whole or in part, only by the mutual agreement of the parties in writing.

     12. NO OTHER INDUCEMENTS

          This Agreement sets forth the entire understanding of the parties in connection with the subject matter hereof. Any and all prior negotiations or discussion, either oral or written, are merged into this Agreement. Neither of the parties has made any settlement, representation or warranty in connection herewith (except those expressly set forth in this Agreement) which has been relied upon by the other party, or which acted as an inducement for the other party to enter into this Agreement.

     13. PERSONS BOUND BY AGREEMENT

          This Agreement shall be binding upon and inure to the benefit of Employee and Releasees and their respective successors.

     14. ASSIGNMENT OF INTERESTS

          Employee warrants that he has not assigned, transferred or purported to assign or transfer any claim against Releasees.

     15. PREVAILING PARTY ENTITLED TO FEES

          In the event that any action or proceeding is initiated to enforce or interpret the provisions of this Agreement, or to recover for a violation of the Agreement, the prevailing party in any such action or proceeding shall be entitled to its costs (including reasonable attorneys’ fees). Nothing in this Paragraph is intended to, or shall, place any limitation or condition precedent on Employee’s ability to challenge this Agreement.

     16. CONFIDENTIALITY

          Employee agrees to keep confidential the existence of this Agreement, as well as all of its terms and conditions, and not to disclose to any person or entity the existence, terms or conditions of this Agreement, except to his attorney, financial advisors and members of his immediate family, provided they agree to keep confidential such existence, terms and conditions. In the event that Employee believes he is compelled by law to divulge the existence, terms or conditions of this Agreement, he will notify Alion’s Law Department of the basis for that belief before actually divulging the information. Employee hereby confirms that, as of the date of this Agreement, he has not disclosed the existence, terms or conditions of this Agreement, except as otherwise provided in this Agreement. Alion also agrees to keep confidential the existence of this Agreement and not to disclose its terms and conditions outside of Releasees, its attorneys and consultants, unless Alion is otherwise required to disclose such terms and conditions by operation of law or request by a governmental agency, or as required by any federal or state securities laws or regulations.

8

     IN WITNESS WHEREOF, the parties hereby agree to the terms and conditions of this Agreement as set forth above.

EMPLOYEE:
By:	/s/ Barry S. Watson
	Barry S. Watson	Date
ALION SCIENCE AND TECHNOLOGY CORPORATION:
By:	/s/ Katherine Madaleno
	Katherine Madaleno	Date
	Corporate VP and Director of Human Resources

9

EX-10.74

Exhibit 10.74

SECOND ADDENDUM TO EMPLOYMENT AGREEMENT

     THIS SECOND ADDENDUM TO EMPLOYMENT AGREEMENT (the “Second Addendum”) is made this 21^st day of April, 2006, by and between Alion Science and Technology Corporation, a Delaware corporation (the “Company”) and James C. Fontana (the “Employee”).

     WHEREAS, the Company and Employee entered into an Employment Agreement dated February 2, 2004 (the “Employment Agreement”); and

     WHEREAS, the Company and Employee entered into an Addendum to Employment Agreement dated May 28, 2004 (the “First Addendum”); and

     WHEREAS, the Company and Employee desire to amend the Employment Agreement by extending its term and clarifying eligibility for Change of Control benefits.

     NOW THEREFORE, in consideration of the foregoing recitals and mutual promises and conditions set forth herein, and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Employee agree as follows:

     1. Term of Employment Agreement. The term of the Employment Agreement and First Addendum shall be extended for a period commencing as of February 2, 2006 through December 31, 2007.

     2. Eligibility for Change of Control Benefits. The first paragraph of Section 6 of the Employment Agreement shall be deleted and replace with the following:

     “Eligibility for Change of Control Benefits. If Employee terminates employment (for reasons other than set forth in Section 6D below) with any successor or assign (or any of their respective affiliates) of the Company at any time during the twenty four (24) month period beginning on the effective date of a Change in Control

(the “Protection Period”), he shall be entitled to the Change of Control Benefits described in Section 5. If during the Protection Period, Employee terminates his employment for Good Reason (as defined below) by delivering to the successor or assign of the Company (or its respective affiliate), as applicable, each no later than thirty (30) days after learning of the occurrence of an event constituting Good Reason: (i) a Preliminary Notice of Good Reason (as defined below); and (ii) a Notice of Termination (as defined below); Employee shall have the right, in his sole and reasonable discretion, to receive Change of Control Benefits. For purposes of this Agreement, the following terms shall have the respective meanings:”

     In addition, a new Section 6D shall be inserted as follows:

“D. Notwithstanding any other provision under this Agreement, Employee shall not be entitled to receive Change of Control Benefits in the event that: (i) the Company’s successor or assign (or any of its respective affiliates) terminates Employee’s employment for Cause; (ii) Employee dies (in which case the Company shall pay to Employee’s heir or personal representatives, as the case may be, six (6) monthly payments, each equal to one-twelfth (1/12) of Employee’s then-current salary, commencing with the first calendar month after termination); (iii) Employee is determined to be totally and permanently disabled (in which case the Company shall pay to Employee six (6) monthly payments, each equal to one-twelfth (1/12) of Employee’s then-current salary less any payments under the Company’s long term disability insurance plan that Employee receives or is entitled to receive in each such month, commencing with the first calendar month after termination); (iv) the Company’s successor or assign (or any of its respective affiliates) terminates Employee’s employment without cause (in which case the Company shall make a lump-sum severance payment to Employee equal to one year of Annual Base Salary as of the Date of Termination); or (v) Employee resigns other than for Good Reason (in which case the Company shall have no further obligations to Employee under this Agreement, including without limitation payment of future compensation or benefits). In any such event, Employee, in addition to any benefits payable in accordance with this Agreement.

2

and except as otherwise provided in this Agreement, shall be entitled only to his salary and benefits accrued or earned and vested under other plans, programs, policies, practices and coverage of the Company’s successor or assign (or any of its respective affiliates).”

     3. Other Terms. All other terms and conditions of the Employment Agreement and First Addendum shall remain the same.

ALION SCIENCE AND TECHNOLOGY	EMPLOYEE
CORPORATION
/s/ Stacy Mendler	/s/ James C. Fontana
Signature	James C. Fontana
Stacy Mendler, EVP
Name and Title

3

EX-10.75

Exhibit 10.75

EXECUTION COPY

CREDIT SUISSE SECURITIES (USA) LLC	CREDIT SUISSE
Eleven Madison Avenue	Eleven Madison Avenue
New York, NY 10010	New York, NY 10010

CONFIDENTIAL

May 25, 2006

Alion Science and Technology Corporation
1750 Tysons Boulevard
McLean, VA 22102

Attention: John M. Hughes
Chief Financial Officer

Alion Science and Technology Corporation
$50,000,000 Senior Secured Incremental Term Loan Facility
$175,000,000 Senior Unsecured Increasing Rate Bridge Facility
$310,000,000 Senior Secured Replacement Bank Facilities
Commitment Letter

Ladies and Gentlemen:

     Reference is made to the Credit Agreement dated as of August 2, 2004, as amended (the “Credit Agreement”), among Alion Science and Technology Corporation, a Delaware corporation (the “Borrower” or “you”), the lenders party thereto (the “Lenders”) and Credit Suisse (formerly known as Credit Suisse First Boston, “CS”), as Administrative Agent and Collateral Agent. Terms used but not defined in this commitment letter (including the Exhibits and other attachments hereto, this “Commitment Letter”) shall have the meanings assigned thereto in the Credit Agreement, in the Summary of Principal Terms and Conditions attached hereto as Exhibit A (the “Senior Facilities Term Sheet”) or in the Summary of Principal Terms and Conditions attached hereto as Exhibit B (the “Bridge Facility Term Sheet” and, together with the Senior Facilities Term Sheet, the “Term Sheets”).

     You have informed CS, in its capacity as the Administrative Agent, and Credit Suisse Securities (USA) LLC (“CS Securities” and, together with CS and their respective affiliates, “Credit Suisse”, “we” or “us”) that you intend (a) to acquire (the “Acquisition”) from Anteon Corporation (the “Seller”) all of the Seller’s rights, and to assume the Seller’s obligations, under the Anteon Contracts, (b) pursuant to Section 2.24 of the Credit Agreement, to obtain Incremental Term Loan Commitments for additional Term Loans (or, to the extent contemplated by the sixth paragraph of the fee letter dated the date hereof, among the Borrower, CS and CS Securities (the “Fee Letter”), Other Term Loans) in an aggregate principal amount of $50,000,000 (the “Incremental Term Facility”), (c) to borrow up to $175,000,000 of senior unsecured increasing

 2

rate loans (the “Bridge Loans”) under the senior unsecured credit facility (the “Bridge Facility”) described in the Bride Facility Term Sheet, and (d) to amend certain provisions of the Credit Agreement in order (i) to give effect to the making of loans under the Incremental Term Facility and the treatment of such loans as Term Loans for all purposes of the Credit Agreement and the other Loan Documents, (ii) to permit the Acquisition and the incurrence of the Bridge Loans and (iii) to make certain other changes thereto (the “Proposed Amendment”). If the Proposed Amendment is not obtained, then you would not obtain the Incremental Term Facility, but rather you would terminate the Credit Agreement, prepay all amounts outstanding thereunder and obtain the senior secured replacement credit facilities (the “Replacement Bank Facilities”) described in the Senior Facilities Term Sheet. The Incremental Term Facility, the Replacement Bank Facilities and the Bridge Facility are referred to collectively herein as the “Facilities”.

     In connection with the foregoing, (a) CS is pleased to advise you of its commitment to provide the entire principal amount of the Incremental Term Facility and the Bridge Facility and (b) CS Securities is pleased to advise you of its agreement to use commercially reasonable efforts to arrange the Proposed Amendment, in each case upon the terms and subject to the conditions set forth in this Commitment Letter. In addition, if the Proposed Amendment is not obtained, CS is pleased to advise you of its commitment to provide the entire principal amount of the Replacement Bank Facilities and the Bridge Facility, upon the terms and subject to the conditions set forth or referred to in this Commitment Letter.

     You hereby appoint (a) CS Securities to act, and CS Securities hereby agrees to act, as sole bookrunner and sole lead arranger in respect of the Facilities, and (b) CS to act, and CS hereby agrees to act, as sole administrative agent and sole collateral agent in respect of the Facilities. Each of CS Securities and CS, in such capacities, will perform the duties and exercise the authority customarily performed and exercised by it in such roles. You agree that no other titles will be awarded and no compensation (other than that expressly contemplated by this Commitment Letter and the Fee Letter) will be paid in connection with the Facilities or the Proposed Amendment unless you and we shall so agree.

     We reserve the right, prior to or after the execution of definitive documentation for the Facilities, to syndicate all or a portion of CS’s commitments in respect of the Facilities to a group of banks, financial institutions and other institutional lenders identified by us in consultation with and reasonably acceptable to you (together with CS, the “New Lenders”). We intend to commence syndication efforts promptly upon the execution of this Commitment Letter, and you agree actively to assist us in completing a satisfactory syndication. Such assistance shall include (a) your using commercially reasonable efforts to ensure that any syndication efforts benefit from your existing lending and investment banking relationships, (b) direct contact (at times mutually agreed) between senior management, representatives and advisors of the Borrower and the proposed New Lenders, (c) assistance by you in the preparation of a Confidential Information Memorandum for each of the Facilities and other marketing materials to be used in connection with the syndications, (d) prior to the launch of the syndications, the obtaining of ratings for the Incremental Term Facility or the Replacement Bank Facilities, as applicable, from each of Standard & Poor’s Ratings Service and Moody’s Investors Service, Inc., and (e) the hosting, with CS Securities, of one or more meetings (at times mutually agreed) of prospective New Lenders. You agree, at the request of CS Securities, to assist in the preparation of a version of the Confidential Information Memorandum and other marketing materials and presentations to be used in connection with the syndication of the Facilities, consisting exclusively of information and documentation that is either (i) publicly available or (ii) not material with respect to the

 3

Borrower and its subsidiaries or the Seller and its subsidiaries and any of their respective securities for purposes of United States Federal and state securities laws.

     CS Securities will manage, in consultation with you, all aspects of any syndication, including decisions as to the selection of institutions to be approached and when they will be approached, when their commitments will be accepted, which institutions will participate and the allocation of the commitments among the New Lenders (subject to the institutions which will participate and the commitment allocations being reasonably acceptable to you).

     To assist CS Securities in its syndication efforts, you agree promptly to prepare and provide to Credit Suisse all information with respect to the Borrower and its subsidiaries and the Acquisition, including all financial information and projections (the “Projections”), as we may reasonably request. You hereby represent and covenant that (a) all information other than the Projections and information of a general economic nature (the “Information”), taken as a whole, that has been or will be prepared by or on behalf of you or any of your representatives and that has been or will be made available to Credit Suisse by you or any of your representatives in connection with the transactions contemplated hereby is or will be, when furnished, complete and correct in all material respects and does not or will not, when furnished, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained therein not materially misleading in light of the circumstances under which such statements are made and (b) the Projections that have been or will be prepared by or on behalf of you or any of your representatives and that have been or will be made available to Credit Suisse by you or any of your representatives in connection with the transactions contemplated hereby have been or will be prepared in good faith based upon assumptions that are reasonable at the time made and at the time the related Projections are made available to Credit Suisse (it being understood that the Projections are subject to significant uncertainties and contingencies, many of which are beyond the control of the Borrower, and that no assurance can be given that such Projections will be realized). You agree that if at any time prior to the closing of the Facilities and the effectiveness of the Proposed Amendment any of the representations in the preceding sentence would be incorrect if the Information and Projections were being furnished, and such representations were being made by you, at such time, then you will promptly supplement the Information and the Projections so that such representations will be correct under those circumstances. In arranging and syndicating the Facilities and arranging the Proposed Amendment, we will be entitled to use and rely primarily on the Information and the Projections without responsibility for independent verification thereof.

     As consideration for CS’s commitment hereunder, and Credit Suisse’s agreements to perform the services described herein, you agree to pay to CS Securities the fees set forth in the Fee Letter.

     CS’s commitment hereunder, and Credit Suisse’s agreements to perform the services described herein, are subject to (a) our not having discovered or otherwise become aware of any information not previously disclosed to us that we believe to be inconsistent in a material and adverse manner with our understanding, based on the information, taken as a whole, provided to us prior to the date hereof, of the business, assets, liabilities, operations, financial condition or Projections of the Borrower and its subsidiaries, taken as a whole, after giving effect to the Acquisition, (b) there not having occurred any event, change or condition since September 30, 2005 (the date of the most recent audited financial statements of the Borrower delivered to Credit Suisse as of the date hereof) that, individually or in the aggregate, has caused, or could reasonably

 4

be expected to cause, a material adverse condition in or materially adverse effect on the business, assets, liabilities, operations or financial condition of the Borrower and its subsidiaries, taken as a whole, (c) our satisfaction that, prior to and during the syndication of the Facilities, there shall be no other issues of debt securities or commercial bank or other credit facilities of the Borrower or its subsidiaries being offered, placed or arranged, (d) the negotiation, execution and delivery of definitive documentation with respect to the Facilities reflecting the terms and conditions set forth in this Commitment Letter and in the Credit Agreement and otherwise reasonably satisfactory to Credit Suisse and its counsel, (e) CS Securities having been afforded a period of at least 20 consecutive days following the launch of the general syndication of the Facilities (“launch” being defined as the date of the general meeting with prospective New Lenders) and immediately prior to the closing date to syndicate the Facilities, and (f) your compliance with the terms of the Fee Letter.

     You agree (a) to indemnify and hold harmless Credit Suisse and its officers, directors, employees, agents, controlling persons, members and successors and assigns (each, an “Indemnified Person”) from and against any and all losses, claims, damages, liabilities and expenses, joint or several, to which any such Indemnified Person may become subject arising out of or in connection with this Commitment Letter, the Fee Letter, the Transactions, the Facilities or any related transaction or any claim, litigation, investigation or proceeding relating to any of the foregoing, regardless of whether any such Indemnified Person is a party thereto, and to reimburse each such Indemnified Person upon demand for any reasonable legal or other reasonable expenses incurred in connection with investigating or defending any of the foregoing, provided that the foregoing indemnity will not, as to any Indemnified Person, apply to losses, claims, damages, liabilities or related expenses to the extent they are found in a final, non-appealable judgment of a court of competent jurisdiction to have resulted primarily from the willful misconduct or gross negligence of such Indemnified Person, and (b) to reimburse Credit Suisse, upon presentation of a summary statement, for all reasonable out-of-pocket expenses (including but not limited to expenses of Credit Suisse’s due diligence investigation, consultants’ fees (if such consultants are retained with your prior consent, which consent shall not be unreasonably withheld), syndication expenses, travel expenses and reasonable fees, disbursements and other charges of one counsel (as well as local counsel in each applicable jurisdiction), in each case incurred in connection with the Facilities and the preparation of this Commitment Letter, the Fee Letter, the definitive documentation for the Facilities and any security arrangements in connection therewith. Notwithstanding any other provision of this Commitment Letter, no Indemnified Person shall be liable for any damages arising from the unauthorized use by others of information or other materials obtained through electronic, telecommunications or other information transmission systems or for any indirect, special, punitive or consequential damages in connection with its activities related to the Facilities.

     You acknowledge that Credit Suisse may be providing debt financing, equity capital or other services (including financial advisory services) to other companies in respect of which you may have conflicting interests regarding the transactions described herein and otherwise. Neither we nor any of our affiliates will use confidential information obtained from you by virtue of the transactions contemplated by this Commitment Letter or our other relationships with you in connection with the performance by us of services for other companies, and we will not furnish any such information to other companies. You also acknowledge that neither we nor any of our affiliates has any obligation to use in connection with the transactions contemplated by this Commitment Letter, or to furnish to you, confidential information obtained by us from other companies.

 5

     You further acknowledge and agree that (a) no fiduciary, advisory or agency relationship between you and Credit Suisse is intended to be or has been created in respect of any of the transactions contemplated by this Commitment Letter, irrespective of whether Credit Suisse has advised or is advising you on other matters, (b) Credit Suisse, on the one hand, and you, on the other hand, have an arms-length business relationship that does not directly or indirectly give rise to, nor do you rely on, any fiduciary duty on the part of Credit Suisse, (c) you are capable of evaluating and understanding, and you understand and accept, the terms, risks and conditions of the transactions contemplated by this Commitment Letter, (d) you have been advised that Credit Suisse is engaged in a broad range of transactions that may involve interests that differ from your interests and that Credit Suisse has no obligation to disclose such interests and transactions to you by virtue of any fiduciary, advisory or agency relationship, and (e) you waive, to the fullest extent permitted by law, any claims you may have against Credit Suisse for breach of fiduciary duty or alleged breach of fiduciary duty and agree that Credit Suisse shall have no liability (whether direct or indirect) to you in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on behalf of or in right of you, including your stockholders, employees or creditors.

     This Commitment Letter shall not be assignable by you without the prior written consent of CS and CS Securities (and any attempted assignment without such consent shall be null and void), is intended to be solely for the benefit of the parties hereto (and Indemnitees (as defined below)), and is not intended to confer any benefits upon, or create any rights in favor of, any person other than the parties hereto (and Indemnitees). CS may assign its commitment hereunder to any of its affiliates or, with your consent (which shall not be unreasonably withheld or delayed), to any prospective New Lender. Any such assignment to an affiliate will not relieve CS from any of its obligations hereunder unless and until such affiliate shall have funded the portion of the commitment so assigned (or the commitment of CS hereunder shall have otherwise terminated in accordance with the terms of this Commitment Letter). Any such assignment to a prospective New Lender shall release CS from the portion of its commitment hereunder so assigned. Any and all obligations of, and services to be provided by, CS Securities or CS hereunder may be performed and any and all rights of CS Securities or CS hereunder may be exercised by or through any of their respective affiliates or branches. This Commitment Letter may not be amended or any provision hereof waived or modified except by an instrument in writing signed by CS Securities, CS and you. This Commitment Letter may be executed in any number of counterparts, each of which shall be an original and all of which, when taken together, shall constitute one agreement. Delivery of an executed counterpart of a signature page of this Commitment Letter by facsimile or electronic transmission shall be effective as delivery of a manually executed counterpart hereof. THIS COMMITMENT LETTER SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

     EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM BROUGHT BY OR ON BEHALF OF ANY PARTY RELATED TO OR ARISING OUT OF THIS COMMITMENT LETTER OR THE PERFORMANCE OF SERVICES HEREUNDER.

     Each of the parties hereto hereby irrevocably and unconditionally (a) submits, for itself and its property, to the non-exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in New York City, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Commitment Letter or the

 6

transactions contemplated hereby, or for recognition or enforcement of any judgment, and agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court, (b) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Commitment Letter or the transactions contemplated hereby in any New York State or in any such Federal court and (c) waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.

     This Commitment Letter is delivered to you on the understanding that neither this Commitment Letter nor the Fee Letter nor any of their terms or substance shall be disclosed, directly or indirectly, to any other person except (a) to your affiliates, officers, directors, employees, attorneys, accountants and advisors on a confidential and need-to-know basis or (b) as required by applicable law or compulsory legal process (in which case you agree to inform us promptly thereof); provided that you may disclose this Commitment Letter and the contents hereof (but not the Fee Letter or the contents thereof) to the Seller and its officers, directors, employees, attorneys, accountants and advisors on a confidential and need-to-know basis. Credit Suisse acknowledges and agrees that (i) the Borrower may file this Commitment Letter with the Securities and Exchange Commission as an exhibit to any of its periodic reports and (ii) the provisions of Section 9.16 (Confidentiality) of the Credit Agreement apply to all Information (as defined therein) provided by the Borrower to Credit Suisse hereunder or in connection with the syndication of the Facilities.

     Notwithstanding anything herein to the contrary, any party to this Commitment Letter (and any employee, representative or other agent of such party) may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure of the transactions contemplated by this Commitment Letter and the Fee Letter and all materials of any kind (including opinions or other tax analyses) that are provided to it relating to such tax treatment and tax structure, except that (i) tax treatment and tax structure shall not include the identity of any existing or future party (or any affiliate of such party) to this Commitment Letter or the Fee Letter and (ii) no party shall disclose any information relating to such tax treatment and tax structure to the extent nondisclosure is reasonably necessary in order to comply with applicable securities laws. For this purpose, the tax treatment of the transactions contemplated by this Commitment Letter and the Fee Letter is the purported or claimed U.S. federal income tax treatment of such transactions and the tax structure of such transactions is any fact that may be relevant to understanding the purported or claimed U.S. federal income tax treatment of such transactions.

     The compensation, reimbursement, indemnification, confidentiality, jurisdiction and waiver of jury trial provisions contained herein and in the Fee Letter shall remain in full force and effect regardless of whether definitive financing documentation for the Facilities or the Proposed Amendment shall be executed and delivered and notwithstanding the termination of this Commitment Letter.

     Credit Suisse hereby notifies you that pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law October 26, 2001) (the “PATRIOT Act”), Credit Suisse and each New Lender is required to obtain, verify and record information that identifies the Borrower, which information includes the name, address, tax identification number and other information regarding the Borrower that will allow Credit Suisse or such New Lender to identify

 7

the Borrower in accordance with the PATRIOT Act. This notice is given in accordance with the requirements of the PATRIOT Act and is effective as to Credit Suisse and each New Lender.

     If the foregoing correctly sets forth our agreement, please indicate your acceptance of the terms of this Commitment Letter and of the Fee Letter by returning to us executed counterparts hereof and the Fee Letter by not later than 5:00 p.m. (New York City time) on June 3, 2006. CS’s commitment hereunder, and Credit Suisse’s agreements to perform the services described herein, will expire at such time in the event that Credit Suisse has not received such executed counterparts in accordance with the immediately preceding sentence. In the event the initial borrowing in respect of the Facilities does not occur on or before July 15, 2006, then this Commitment Letter, CS’s commitment and Credit Suisse’s agreements to perform the services described herein shall automatically terminate unless Credit Suisse shall, in its discretion, agree to an extension.

[Remainder of this page intentionally left blank]

8

     Credit Suisse is pleased to have been given the opportunity to assist you in connection with this important financing.

Very truly yours,
CREDIT SUISSE SECURITIES (USA) LLC
	by
		/s/ Christopher G. Cunningham
		Name: Christopher G. Cunningham
		Title: Managing Director
CREDIT SUISSE, CAYMAN ISLANDS BRANCH
	by
		/s/ Robert Hetu
		Name: Robert Hetu
		Title: Managing Director
	By
		/s/ Cassandra Droogan
		Name: Cassandra Droogan
		Title: Vice President

Accepted and agreed as of the date first above written:
ALION SCIENCE AND TECHNOLOGY CORPORATION
	by	/s/ John M. Hughes
		Name: John M. Hughes
		Title: Executive Vice President and CFO

CONFIDENTIAL
May 25, 2006 EXHIBIT A

Alion Science and Technology Corporation
$310,000,000 Senior Secured Replacement Bank Facilities
Summary of Principal Terms and Conditions

Borrower:	Alion Science and Technology Corporation, a Delaware corporation (the “Borrower”).
Transactions:	The Borrower intends to enter into a Purchase Agreement (the “Purchase Agreement”) with Anteon Corporation (the “Seller”), pursuant to which the Borrower will acquire (the “Acquisition”) all of the Seller’s rights, and assume the Seller’s obligations, under certain government contracts (the “Anteon Contracts”) in consideration of the payment by the Borrower to the Seller of approximately $225,000,000 in cash (the “Acquisition Consideration”). In connection with the foregoing, (a) the Borrower will obtain Senior Unsecured Term Loans in an aggregate amount of $175,000,000 (the “Senior Unsecured Term Loans”), (b) either (i) the Borrower’s existing Credit Agreement dated as of August 2, 2004, as amended (the “Existing Credit Agreement”) will be amended to, among other things, permit the Acquisition and the financing therefor and the Borrower will (x) obtain an Incremental Term Facility under the Existing Credit Agreement, as so amended, in the aggregate amount of $50,000,000, and (y) borrow $21,000,000 of delayed draw term loans (the “Delayed Draw Term Loans”) thereunder, or (ii) the Borrower will prepay in full, and terminate, the Existing Credit Agreement, using the proceeds of the Replacement Bank Facilities described below under the caption “Replacement Bank Facilities”, and (c) fees and expenses incurred in connection with the foregoing will be paid. The transactions described in this paragraph are collectively referred to herein as the “Transactions”.
Sources and Uses:	The approximate sources and uses of the funds necessary to consummate the Transactions are set forth on Exhibit C to the Commitment Letter (the “Commitment Letter”) to which this Term Sheet is attached.
Agent:	Credit Suisse, acting through one or more of its branches or affiliates (“CS”), will act as sole and exclusive administrative agent and collateral agent (collectively, the “Agent”) for a syndicate of banks, financial institutions and other institutional lenders

2

		(together with CS, the “Lenders”), and will perform the duties customarily associated with such roles.
Sole Bookrunner and Sole Lead Arranger:		Credit Suisse Securities (USA) LLC will act as sole bookrunner and sole lead arranger for the Senior Facilities described below (the “Arranger”), and will perform the duties customarily associated with such roles.
Syndication Agent:		At the option of the Arranger, a financial institution identified by the Arranger and acceptable to the Borrower (the “Syndication Agent”).
Documentation Agent:		At the option of the Arranger, a financial institution identified by the Arranger and acceptable to the Borrower (the “Documentation Agent”).
Replacement Bank Facilities:	(A)	A senior secured term loan facility in an aggregate principal amount of up to $260,000,000 (the “Term Facility”).
	(B)	A senior secured revolving credit facility in an aggregate principal amount of up to $50,000,000 (the “Revolving Facility” and, together with the Term Facility, the “Senior Facilities”), of which up to $5,000,000 will be available in the form of letters of credit.
		In connection with the Revolving Facility, CSFB (in such capacity, the “Swingline Lender”) will make available to the Borrower a swingline facility under which the Borrower may make short-term borrowings of up to $5,000,000. Except for purposes of calculating the Commitment Fee described below, any such swingline borrowings will reduce availability under the Revolving Facility on a dollar-for-dollar basis. Each Lender under the Revolving Facility shall, promptly upon request by the Swingline Lender, fund to the Swingline Lender its pro rata share of any swingline borrowings.
Purpose:	(A)	The proceeds of the Term Facility will be used by the Borrower on the date of the initial borrowing under the Senior Facilities (the “Closing Date”), solely (a) to refinance the Existing Credit Agreement and (b) together with the proceeds of the Senior Unsecured Term Loans, (i) to finance the Acquisition and (ii) to pay related fees and expenses.

3

	(B)	The proceeds of loans under the Revolving Facility will be used by the Borrower solely for working capital and other general corporate purposes, including for Permitted Acquisitions (as defined below).
	(C)	Letters of credit will be used solely to support payment obligations incurred in the ordinary course of business by the Borrower and its subsidiaries.
Availability:	(A)	The full amount of the Term Facility will be drawn in a single drawing on the Closing Date. Amounts borrowed under the Term Facility that are repaid or prepaid may not be reborrowed.
	(B)	No loans under the Revolving Facility may be made on the Closing Date. Thereafter, loans under the Revolving Facility will be available at any time prior to the final maturity of the Revolving Facility, in minimum principal amounts to be agreed upon. Amounts repaid under the Revolving Facility may be reborrowed.
Incremental Term Facility:		The definitive credit agreement for the Senior Facilities will provide for an uncommitted incremental term loan facility in an aggregate principal amount not to exceed $200,000,000.
Interest Rates and Fees:		As set forth on Annex I hereto.
Default Rate:		The applicable interest rate plus 2.0% per annum.
Letters of Credit:		Letters of credit under the Revolving Facility will be issued by CS or another Lender acceptable to the Borrower and the Agent (the “Issuing Bank”). Each letter of credit shall expire not later than the earlier of (a) 12 months after its date of issuance and (b) the fifth business day prior to the final maturity of the Revolving Facility; provided, however, that any letter of credit may provide for renewal thereof for additional periods of up to 12 months (which in no event shall extend beyond the date referred to in clause (b) above).
		Drawings under any letter of credit shall be reimbursed by the Borrower on the same business day. To the extent that the Borrower does not reimburse the Issuing Bank on the same business day, the Lenders under the Revolving Facility shall be irrevocably obligated to reimburse the Issuing Bank

4

		pro rata based upon their respective Revolving Facility commitments.
		The issuance of all letters of credit shall be subject to the customary procedures of the Issuing Bank.
Final Maturity and Amortization:	(A)	Term Facility
		The Term Facility will mature on the date that is five years after the Closing Date, and will amortize in equal quarterly installments in an aggregate annual amount equal to 1% of the original principal amount of the Term Facility with the balance payable at the Maturity thereof.
	(B)	Revolving Facility
		The Revolving Facility will mature on the date that is five years after the Closing Date.
Guarantees:		All obligations of the Borrower under the Facilities and under any interest rate protection or other hedging arrangements entered into with a Lender or any affiliate thereof (“Hedging Arrangements”) will be unconditionally guaranteed (the “Guarantees”) by each existing and subsequently acquired or organized domestic and, to the extent no adverse tax consequences to the Borrower would result therefrom, foreign subsidiary of the Borrower (the “Subsidiary Guarantors”).
Security:		The Facilities, the Guarantees and any Hedging Arrangements will be secured by substantially all the assets of the Borrower and each Subsidiary Guarantor (collectively, the “Collateral”), including but not limited to: (a) a perfected first-priority pledge of all the capital stock or other equity interests held by the Borrower or any Subsidiary Guarantor (which pledge, in the case of any foreign subsidiary, shall be limited to 100% of the non-voting stock or other equity interests (if any) and 65% of the voting stock or other equity interests of such foreign subsidiary to the extent the pledge of any greater percentage would result in adverse tax consequences to the Borrower) and (b) perfected first-priority security interests in, and mortgages on, substantially all tangible and intangible assets of the Borrower and each Subsidiary Guarantor (including but not limited to accounts receivable, inventory, equipment, general intangibles, investment property, intellectual property, real

5

	property, cash, commercial tort claims, letter of credit rights, intercompany notes and proceeds of the foregoing) except for those assets for which the Agent shall determine, in its reasonable judgment, that the costs of obtaining such security interest are excessive in relation to the value of the security afforded thereby.
	All the above-described pledges, security interests and mortgages shall be created on terms, and pursuant to documentation, consistent with those under the Existing Credit Agreement or otherwise satisfactory to the Borrower and the Lenders, and, subject to customary and limited exceptions to be agreed upon, none of the Collateral shall be subject to any other pledges, security interests or mortgages.
Mandatory Prepayments:	Loans under the Term Facility shall be prepaid with (a) 50% of Excess Cash Flow (as defined in the Existing Credit Agreement) for each fiscal year, reducing to 25% if the Leverage Ratio (as defined in the Existing Credit Agreement) at the end of such fiscal year was less than 2.0 to 1.0, (b) 100% of the net cash proceeds of all non-ordinary course asset sales or other dispositions of property by the Borrower and its subsidiaries (including insurance and condemnation proceeds) (subject to exceptions and reinvestment provisions as provided for in the Existing Credit Agreement), (c) 100% of the net cash proceeds of issuances of debt obligations of the Borrower and its subsidiaries (subject to exceptions as provided for in the Existing Credit Agreement), (d) 50% of the net cash proceeds of issuances of equity securities of the Borrower and its subsidiaries (subject to exceptions as provided for in the Existing Credit Agreement, including an exception for issuances of equity pursuant to the Borrower’s Employee Stock Ownership Plan (the “ESOP”) and reducing to 25% if the Leverage Ratio at the time would be less than 2.0 to 1.0), and (e) 100% of the amount of any purchase price adjustment received by the Borrower or any of its subsidiaries in cash pursuant to the Purchase Agreement.
	The above-described mandatory prepayments shall be applied first to any amortization payments payable in the immediately succeeding 24 months and thereafter, pro rata to the remaining amortization payments thereunder.

6

Voluntary Prepayments and Reductions in Commitments:	Voluntary reductions of the unutilized portion of the Facilities commitments and prepayments of borrowings will be permitted at any time, in minimum principal amounts of $1,000,000, without premium or penalty, subject to reimbursement of the Lenders’ breakage costs in the case of a prepayment of Adjusted LIBOR borrowings other than on the last day of the relevant interest period. All voluntary prepayments of the Term Facility will be applied to the remaining amortization payments thereunder as directed by the Borrower.
Representations and Warranties:	Substantially as provided for in the Existing Credit Agreement, including accuracy of financial statements and other information; no material adverse change; absence of litigation; no violation of material agreements or instruments; compliance with laws (including ERISA, margin regulations and environmental laws); payment of taxes; ownership of properties; inapplicability of the Investment Company Act; solvency; effectiveness of governmental approvals; labor matters; environmental and other regulatory matters; and validity, priority and perfection of security interests in the Collateral.
Conditions Precedent to Initial Borrowing:	Usual for facilities and transactions of this type, including delivery of satisfactory legal opinions; first-priority perfected security interests in the Collateral (free and clear of all liens, other than permitted liens); delivery of Assignment of Claims Act filings; execution of the Guarantees, which shall be in full force and effect; accuracy of representations and warranties; absence of defaults, prepayment events or creation of liens under debt instruments or other agreements; evidence of authority; absence of material adverse change; payment of fees and expenses; and obtaining of satisfactory insurance.
	The initial borrowing under the Senior Facilities will also be subject to the applicable conditions precedent set forth in Exhibit D to the Commitment Letter.
Conditions Precedent to all Borrowings:	Delivery of notice, accuracy of representations and warranties and absence of defaults.
Affirmative Covenants:	Substantially as provided for in the Existing Credit Agreement, including maintenance of corporate existence and rights; performance of material obligations; delivery of annual and quarterly financial statements, other financial information and

7

	information required under the PATRIOT Act; delivery of notices of default, litigation, ERISA events and material adverse change; maintenance of properties in good working order; maintenance of satisfactory insurance; use of commercially reasonable efforts to maintain a rating of the Facilities by each of Standard & Poor’s Ratings Service (“S&P”) and Moody’s Investors Service, Inc. (“Moody’s”); compliance with laws; inspection of books and properties; hedging arrangements; further assurances; and payment of taxes.
Negative Covenants:	Substantially similar to the Existing Credit Agreement (as modified to give effect to the Transactions), including limitations on dividends on, and redemptions and repurchases of, capital stock (except as required pursuant to ERISA, the ESOP and other existing contractual and statutory obligations); limitations on prepayments, redemptions and repurchases of debt (other than loans under the Senior Facilities); limitations on liens and sale-leaseback transactions; limitations on loans and investments; limitations on debt, guarantees and hedging arrangements; limitations on mergers, acquisitions and asset sales; limitations on transactions with affiliates; limitations on changes in business conducted by the Borrower and its subsidiaries; limitations on amendments of debt and other material agreements; and limitations on capital expenditures.
	Notwithstanding the foregoing, the Borrower will be permitted to make “Permitted Acquisitions”, as defined in the Existing Credit Agreement, which includes the following principal elements: (a) the acquired entity is a business unit, or would become a wholly owned subsidiary of the Borrower, and is in a similar line of business; (b) no default or event of default shall have occurred and be continuing and the Borrower would be in pro forma compliance with its covenants; (c) on a pro forma basis, the Borrower’s ratio of Total Debt to EBITDA would be at least 0.25 to 1.00 lower than the required covenant level at the time; and (d) after giving effect to the acquisition and the financing therefor, there would be at least $5,000,000 of available commitments under the Revolving Facility.

8

Selected Financial Covenants:	The definitive credit documentation for the Facilities will contain the following financial covenants (with financial definitions and levels to be agreed upon): (a) maximum ratios of Total Debt to EBITDA and (b) minimum interest coverage ratios.
Events of Default:	Substantially as provided for in the Existing Credit Agreement, including nonpayment of principal, interest or other amounts; violation of covenants; incorrectness of representations and warranties in any material respect; cross default and cross acceleration; bankruptcy; material judgments; ERISA events; actual or asserted invalidity of guarantees or security documents; and Change of Control (as defined in the Existing Credit Agreement).
Voting:	Amendments and waivers of the definitive credit documentation will require the approval of Lenders holding more than 50% of the aggregate amount of the loans and commitments under the Senior Facilities (with certain amendments and waivers also requiring class votes), except that the consent of each Lender directly adversely affected thereby shall be required with respect to, among other things, (a) increases in the commitment of such Lender, (b) reductions of principal, interest or fees, (c) extensions of final maturity or scheduled amortization and (d) releases of guarantors or all or substantially all of the Collateral.
Yield Protection and Illegality:	Substantially as provided for in the Existing Credit Agreement, including protection with respect to breakage costs, changes in capital requirements or their interpretation, changes in circumstances, reserves, illegality and taxes.
Assignments and Participations:	The Lenders will be permitted to assign loans and commitments under the Senior Facilities to other Lenders or their affiliates without the consent of the Borrower and to other persons with the consent of the Borrower (and, if a Revolving Facility commitment is being assigned, the Swingline Lender and the Issuing Bank), in each case not to be unreasonably withheld or delayed; provided that the consent of the Borrower shall not be required after the occurrence and during the continuance of an Event of Default. All assignments will require the consent of the Agent, not to be unreasonably withheld or delayed. Each assignment will be in an amount of an integral multiple of $1,000,000. Assignments will be by

9

	novation and will not be required to be pro rata between the Senior Facilities.
	The Lenders will be permitted to sell participations in loans and commitments without restriction. Voting rights of participants shall be limited to matters in respect of (a) increases in commitments, (b) reductions of principal, interest or fees, (c) extensions of final maturity or scheduled amortization and (d) releases of guarantors or all or substantially all of the Collateral.
Expenses and Indemnification:	The Borrower will indemnify the Arranger, the Agent, the Syndication Agent, the Documentation Agent and the Lenders and hold them harmless from and against all reasonable costs, expenses (including reasonable fees, disbursements and other reasonable charges of counsel) and liabilities of the Arranger, the Agent, the Syndication Agent, the Documentation Agent and the Lenders arising out of or relating to any claim or any litigation or other proceeding (regardless of whether the Arranger, the Agent, the Syndication Agent, the Documentation Agent or any Lender is a party thereto) that relates to the Transactions, including the financing contemplated hereby or any transactions connected therewith, provided that none of the Arranger, the Agent, the Syndication Agent, the Documentation Agent or any Lender will be indemnified for any cost, expense or liability to the extent determined in the final, non-appealable judgment of a court of competent jurisdiction to have resulted from its gross negligence or willful misconduct. In addition, all reasonable out-of-pocket expenses (including, without limitation, reasonable fees, disbursements and other charges of counsel) of the Arranger, the Agent, the Syndication Agent, the Documentation Agent and the Lenders for enforcement costs and documentary taxes associated with the Senior Facilities will be paid by the Borrower.
Governing Law and Forum:	New York.
Counsel to Agent and Arranger:	Cravath, Swaine & Moore LLP.

ANNEX 1

Interest Rates:	The interest rates under the Senior Facilities will be as follows:
	Term Facility
	At the option of the Borrower, Adjusted LIBOR plus 2.50% or ABR plus 1.50%.
	Revolving Facility
	At the option of the Borrower, Adjusted LIBOR plus 2.75% or ABR plus 1.75%
	Both Facilities
	The Borrower may elect interest periods of 1, 2, 3 or 6 months (or, if agreed to by all relevant Lenders, 9 or 12 months) for Adjusted LIBOR borrowings.
	Calculation of interest shall be on the basis of the actual days elapsed in a year of 360 days (or 365 or 366 days, as the case may be, in the case of ABR loans based on the Prime Rate) and interest shall be payable at the end of each interest period and, in any event, at least every 3 months.
	ABR is the Alternate Base Rate, which is the higher of CSFB’s Prime Rate and the Federal Funds Effective Rate plus 1/2 of 1.0%.
	Adjusted LIBOR will at all times include statutory reserves.
Letter of Credit Fee:	A per annum fee equal to the spread over Adjusted LIBOR under the Revolving Facility will accrue on the aggregate face amount of outstanding letters of credit under the Revolving Facility, payable in arrears at the end of each quarter and upon the termination of the Revolving Facility, in each case for the actual number of days elapsed over a 360-day year. Such fees shall be distributed to the Lenders participating in the Revolving Facility pro rata in accordance with the amount of each such Lender’s Revolving Facility commitment. In addition, the Borrower shall pay to the Issuing Bank, for its own account, (a) a fronting fee equal to a percentage per annum to be agreed upon of the aggregate face amount of outstanding letters of credit, payable in arrears at the end of each quarter and upon the termination of the Revolving Facility, calculated based upon the actual number of days elapsed over a 360-day year, and (b) customary issuance and administration fees.
Commitment Fees:	0.50% per annum on the undrawn portion of the commitments in respect of the Senior Facilities, payable

2

quarterly in arrears after the Closing Date and upon the termination of the commitments, calculated based on the number of days elapsed in a 360-day year.

Changes in Interest Rates:

The definitive documentation for the Senior Facilities will contain provisions under which, from and after the date of delivery of the Borrower’s financial statements covering a period of at least six full months after the Closing Date, and so long as no default shall have occurred and be continuing, interest rates under the Revolving Facility will be subject to reduction in increments to be agreed upon based upon performance goals to be agreed upon.

CONFIDENTIAL
May 25, 2006 EXHIBIT B

Alion Science and Technology Corporation
$175,000,000 Senior Unsecured Increasing Rate Bridge Loans
Summary of Principal Terms and Conditions¹

Borrower:	Alion Science and Technology Corporation, a Delaware corporation (the “Borrower”).
Agent:	Credit Suisse, acting through one or more of its branches or affiliates (“CS”), will act as sole administrative agent (in such capacity, the “Agent”) for a syndicate of banks, financial institutions and other institutional lenders (together with CS, the “Lenders”), and will perform the duties customarily associated with such roles.
Sole Bookrunner and Sole Lead Arranger:	Credit Suisse Securities (USA) LLC will act as sole bookrunner and sole lead arranger for the Senior Unsecured Increasing Rate Bridge Facility described below (collectively, in such capacities, the “Arranger”), and will perform the duties customarily associated with such roles.
Syndication Agent:	At the option of the Arranger, one or more financial institutions identified by the Arranger and acceptable to the Borrower (in such capacity, the “Syndication Agent”).
Documentation Agent:	At the option of the Arranger, one or more financial institutions identified by the Arranger and acceptable to the Borrower (in such capacity, the “Documentation Agent”).
Senior Unsecured Bridge Facility:	Senior unsecured increasing rate bridge loans in an aggregate principal amount of up to $175,000,000 (the “Senior Unsecured Term Loans”).
Purpose:	The proceeds of the Senior Unsecured Term Loans will be used by the Borrower on the Closing Date, together with the proceeds of the Incremental Term Facility, solely (a) to pay the Acquisition Consideration, (b) to prepay loans outstanding under the Existing Credit Agreement and (c) to pay related fees and expenses.

¹ All capitalized terms used but not defined herein have the meanings given to them in the Commitment Letter to which this term sheet is attached, including Exhibit A thereto.

2

Availability:	The full amount of the Senior Unsecured Term Loans must be drawn in a single drawing on the date of the borrowing of the Senior Unsecured Term Loans (the “Closing Date”). Senior Unsecured Term Loans that are repaid or prepaid may not be reborrowed.
Guarantees:	Each existing and subsequently acquired or organized subsidiary of the Borrower that is or that is required to be a “Subsidiary Guarantor” under and as defined in the Existing Credit Agreement will guarantee (the “Guarantees”) the Senior Unsecured Term Loans.
Interest Rates:	Interest for the six-month period commencing on the Closing Date shall be paid at the London interbank offered rate for U.S. dollars (for a three-month interest period) (the “LIBO Rate”) plus 550 basis points. Thereafter, interest shall be paid at (a) for the six-month period commencing on the six-month anniversary of the Closing Date, the LIBO Rate plus 625 basis points and (b) for the six-month period commencing on the first anniversary of the Closing Date, the LIBO Rate plus 700 basis points. Any Extended Loans (as defined below) shall bear interest at the LIBO Rate plus 900 basis points; provided that the portion of any interest payment representing a per annum interest rate in excess of the LIBO Rate plus 700 basis points shall be paid by capitalizing such excess portion of interest as additional Extended Loans. All references herein to Extended Loans shall include additional Extended Loans owed and outstanding as a result of the preceding sentence.
Interest Payments:	Interest on the Loans (as defined below) will be payable in cash (except as provided above), quarterly in arrears.
Default Rate:	The applicable interest rate plus 2.0%.
	Notwithstanding anything to the contrary set forth herein, in no event shall any limit upon the amount of interest payable in cash with respect to the Extended Loans affect the payment in cash of any default rate of interest in respect of any Extended Loans.
Initial Maturity Date:	The eighteen-month anniversary of the Closing Date (the “Initial Maturity Date”).
Exchange:	If the Senior Unsecured Term Loans have not been previously repaid or prepaid in full in cash on or prior to the Initial Maturity Date (with such non-payment on such date not being an event of default), the maturity of

3

	the Senior Unsecured Term Loans shall automatically be extended to the date that is five years and six months following the Closing Date (the “Extended Loan Maturity Date”; such extended Senior Unsecured Term Loans, the “Extended Loans” and, together with the Senior Unsecured Term Loans, the “Loans”). Extended Loans will bear interest as described above and will have covenants, events of default and mandatory redemption provisions identical to the Senior Unsecured Term Loans except to the extent set forth herein.
Extended Loan Maturity Date:	The Borrower shall repay the Extended Loans in full in cash on the Extended Loan Maturity Date at a price (expressed as a percentage of the outstanding principal amount of such Extended Loans) of 103%.
Mandatory Prepayments:	The Loans shall be prepaid with, subject to certain exceptions to be agreed upon, (i) the net proceeds from the issuance, offering or placement of any debt obligations or equity securities by the Borrower or any of its subsidiaries, other than borrowings under the Existing Credit Agreement (with such proceeds being applied to repay the Loans prior to the repayment of loans outstanding under the Existing Credit Agreement); and (ii) the net proceeds from any asset sales by the Borrower or any of its subsidiaries (including proceeds from the sale of stock of any subsidiary of the Borrower) in excess of the amount required to be paid to the lenders under the Existing Credit Agreement. Such mandatory prepayments made pursuant to clauses (i) or (ii) of the preceding sentence during the periods set forth below shall be payable at the prices set forth below:

Months after Closing Date	Price2
0-6	100%
7-12	101%
13-18	102%
19-30	101%
31-42	102%
43-Extended Loan Maturity Date	103%

Change of Control: The Borrower will be required to offer to prepay the Loans following the occurrence of a Change of Control (to be defined) at 100% of the outstanding principal

² Price is expressed as a percentage of the aggregate principal amount of Loans being prepaid.

4

	amount thereof (if such Change of Control occurs prior to the Initial Maturity Date) or at 101% of the outstanding principal amount thereof (if such Change of Control occurs on or after the Initial Maturity Date).
Voluntary Prepayments:	The Senior Unsecured Term Loans may be prepaid, in whole or in part, upon not less than 5 days’ prior written notice, at the option of the Borrower at any time during the periods set forth below at the prices set forth below:

Months after Closing Date	Price3
0-6	100%
7-12	101%
13-Initial Maturity Date	102%

The Extended Loans may be prepaid, in whole or in part, upon not less than 5 days’ prior written notice, at the option of the Borrower at any time during the periods set forth below at the prices set forth below:

Months after Closing Date	Price4
19-30	101%
31-42	102%
43-Extended Loan Maturity Date	103%

Assignments and Participations:

Each Lender shall have the absolute and unconditional right to assign or participate the Loans held by it in compliance with applicable law to any third party at any time and shall give notice to the Borrower of any such assignment.

Representations and Warranties:

The definitive documentation relating to the Loans (the “Loan Documents”) will contain representations and warranties relating to the Borrower and its subsidiaries that are usual and customary for transactions of this nature or required by the Agent for this transaction in particular, including but not limited to those set forth in the Existing Credit Agreement, with such changes as are appropriate in connection with the Loans.

3	Price is expressed as a percentage of the aggregate principal amount of Senior Unsecured Term Loans being prepaid.
4	Price is expressed as a percentage of the aggregate principal amount of Senior Unsecured Term Loans being prepaid.

5

Conditions Precedent to Borrowing:	Usual for facilities and transactions of this type and others to be reasonably specified by the Agent, including, without limitation, delivery of satisfactory legal opinions, corporate documents and officers’ and public officials’ certifications; execution of the Guarantees, which shall be in full force and effect; evidence of authority; and payment of fees and expenses.
	The borrowing under the Senior Unsecured Term Facility will also be subject to the applicable conditions precedent set forth in Exhibit D to the Commitment Letter.
Covenants:	The Loan Documents will contain covenants relating to the Borrower and its subsidiaries that are usual and customary for transactions of this nature or required by the Agent for this transaction in particular, including but not limited to those set forth in the Existing Credit Agreement, with such changes as are appropriate in connection with the Loans.
Events of Default:	Customary for the type of transactions proposed and others to be reasonably specified by the Agent relating to the Borrower and its subsidiaries (subject, where appropriate, to thresholds and grace periods to be agreed upon), including, but not limited to, nonpayment of principal, interest or other amounts; violation of covenants; incorrectness of representations and warranties in any material respect; cross default and cross acceleration; bankruptcy; material judgments; ERISA events; or actual or asserted invalidity of guarantees.
Voting:	Amendments and waivers of the Loan Documents will require the approval of Lenders holding more than 50% of the aggregate amount of the Loans, except that the consent of each Lender shall be required with respect to, among other things, (a) reductions of principal, interest or fees payable to such Lender, (b) extensions of the Initial Maturity Date or the Extended Loan Maturity Date, as applicable, and (c) releases of all or substantially all of the value of the Guarantees.
Cost and Yield Protection:	Usual for facilities and transactions of this type, including customary tax gross-up provisions.
Expenses and Indemnification:	The Borrower will indemnify the Arranger, the Agent, the Syndication Agent, the Documentation Agent, the

6

	Lenders, their respective affiliates, successors and assigns and the officers, directors, employees, agents, advisors, controlling persons and members of each of the foregoing (each an “Indemnified Person”) and hold them harmless from and against all costs, expenses (including reasonable fees, disbursements and other charges of counsel) and liabilities of such Indemnified Person arising out of or relating to any claim or any litigation or other proceeding (regardless of whether such Indemnified Person is a party thereto) that relates to the Transactions, including the financing contemplated hereby, the Acquisition or any transactions connected therewith, provided that no Indemnified Person will be indemnified for any cost, expense or liability to the extent determined in the final, non-appealable judgment of a court of competent jurisdiction to have resulted primarily from its gross negligence or willful misconduct. In addition, all out-of-pocket expenses (including, without limitation, fees, disbursements and other charges of counsel) of the Arranger, the Agent, the Syndication Agent, the Documentation Agent and the Lenders for enforcement costs and documentary taxes associated with the Loans will be paid by the Borrower.
Governing Law:	New York.
Counsel to the Agent and the Arranger:	Cravath, Swaine & Moore LLP.

EXHIBIT C

Sources and Uses of Funds
(in millions of dollars)
(all figures are approximate)

Sources of Funds			Uses of Funds
Revolving Facility1	$	0.0	Acquisition Consideration	$	225.0
Delayed Draw Term Loans		21.0
Incremental Term Facility2		50.0	Prepay Existing Revolving Facility		10.0
Senior Unsecured Bridge Facility		175.0	Transaction Costs		11.0
Total Sources	$	246.0	Total Uses	$	246.0

1	Represents amount to be drawn under the $50,000,000 Revolving Facility on the Closing Date.
2	Assumes Proposed Amendment is obtained and Replacement Bank Facilities not provided.

EXHIBIT D

Alion Science and Technology Corporation
$50,000,000 Senior Secured Incremental Term Facility
$175,000,000 Senior Unsecured Increasing Rate Bridge Facility
$310,000,000 Senior Secured Replacement Bank Facilities
Summary of Additional Conditions Precedent¹

     The initial borrowing under the Facilities shall be subject to the following additional conditions precedent:

     1. The Acquisition and the other Transactions shall be consummated simultaneously with the closing under the Facilities in accordance with applicable law and on the terms described in the Term Sheets; the Purchase Agreement and all other related documentation shall be satisfactory to the Agent and no provision thereof shall have been waived, amended, supplemented or otherwise modified in any material respect adverse to the Lenders without the consent of the Agent.

     2. The Agent shall have received a pro forma consolidated balance sheet and related pro forma consolidated statements of income of the Borrower as of and for the twelve-month period ending on the last day of the most recently completed four-fiscal quarter period ended at least 30 days prior to the Closing Date, prepared after giving effect to the Transactions as if the Transactions had occurred as of such date (in the case of such balance sheet) or at the beginning of such period (in the case of such statements of income).

     3. The Agent shall be satisfied that (a) the Borrower’s consolidated pro forma EBITDA for the four-fiscal quarter period most recently ended at least 30 days prior to the Closing Date (prepared on a pro forma basis with stated assumptions and adjustments as shall be reasonably satisfactory to the Agent to give pro forma effect to the Transactions as if they had occurred at the beginning of such four-fiscal quarter period) (such consolidated pro forma EBITDA, “Pro Forma EBITDA”) shall not be less than $71,000,000 and (b) the Borrower’s ratio of Total Debt (as defined in the Existing Credit Agreement) on the Closing Date to Pro Forma EBITDA shall be no more than 6.0 to 1.0.

     4. The Agent shall have received a certificate from the chief financial officer of the Borrower certifying that the Borrower and its subsidiaries, on a consolidated basis after giving effect to the Transactions and the other transactions contemplated hereby, are solvent.

     5. All requisite governmental authorities and material third parties shall have approved or consented to the Transactions and the other transactions contemplated hereby to the extent required, all applicable appeal periods shall have expired and there shall be no litigation, governmental, administrative or judicial action, actual or threatened, that could reasonably be expected to prevent, materially restrain or impose materially burdensome conditions on the Transactions or the other transactions contemplated hereby.

¹ All capitalized terms used but not defined herein have the meanings given to them in the Commitment Letter, including Exhibit A thereto, to which this Exhibit D is attached.

  2

     6. The Agent shall have received, at least five business days prior to the Closing Date, all documentation and other information required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including without limitation the PATRIOT Act.

EX-10.76

Exhibit 10.76

June 6, 2006

Mr. Rob Goff
113 Jerdone Place
Yorktown, VA 23692

Re:	Amendment to Offer of Promotion,
	Dated February 20, 2004 (the “Offer Letter”)

Dear Rob,

This letter amends the above-referenced Offer Letter for the purpose of extending the term of eligibility for severance under Section 1 and clarifying the terms of Section 3. Accordingly, the Offer Letter shall be amended as follows:

1. The first sentence of Section 1 shall be deleted and replaced with the following: “If, from the Effective Date until and including December 20, 2007, the Company terminates Employee’s employment without Cause (as defined below), the Company shall make a lump-sum severance payment to Employee equal to one year of Annual Base Salary as of the Date of Termination as defined below.”

2. The first paragraph of Section 3 shall be deleted and replaced with the following:

“Eligibility for Change of Control Benefits. If Employee terminates employment (for reasons other than set forth in Section 3D below) with any successor or assign (or any of their respective affiliates) of the Company at any time during the twenty four (24) month period beginning on the effective date of a Change in Control (the “Protection Period”), he shall be entitled to the Change of Control Benefits described in Section 2. If during the Protection Period, Employee terminates his employment for Good Reason (as defined below) by delivering to the successor or assign of the Company (or its respective affiliate), as applicable, each no later than thirty (30) days after learning of the occurrence of an event constituting Good Reason: (i) a Preliminary Notice of Good Reason (as defined below); and (ii) a Notice of Termination (as defined below); Employee shall have the right, in his sole and reasonable discretion, to receive the Change of Control Benefits. For purposes of this Agreement, the following terms shall have the respective meanings:”

Mr. Rob Goff
June 6, 2006
Page 2

     In addition, a new Section 3D shall be inserted as follows:

“D. Notwithstanding any other provision under this Agreement, Employee shall not be entitled to receive Change of Control Benefits in the event that: Company’s successor or assign (or any of its respective affiliates) terminates Employee’s employment for Cause (as defined below); (ii) Employee dies (in which case the Company shall pay to Employee’s heir or personal representatives, as the case may be, six (6) monthly payments, each equal to one-twelfth (1/12) of Employee’s then-current salary, commencing with the first calendar month after termination); (iii) Employee is determined to be totally and permanently disabled (in which case the Company shall pay to Employee six (6) monthly payments, each equal to one-twelfth (1/12) of Employee’s then-current salary less any payments under the Company’s long term disability insurance plan that Employee receives or is entitled to receive in each such month, commencing with the first calendar month after termination); (iv) the Company’s successor or assign (or any of its respective affiliates) terminates Employee’s employment without cause (in which case the Company shall make a lump-sum severance payment to Employee equal to one year of Annual Base Salary as of the Date of Termination); or (v) Employee resigns other than for Good Reason (in which case the Company shall have no further obligations to Employee under this Agreement, including without limitation payment of future compensation or benefits). In any such event, Employee, in addition to any benefits payable in accordance with this Agreement, shall be entitled only to his salary and benefits accrued or earned and vested under other plans, programs, policies, practices and coverage of the Company’s successor or assign (or any of its respective affiliates).”

3. All other terms and conditions of the Offer Letter shall remain the same.

By our mutual signatures below, you and the Company agree to the terms of this letter.

We look forward to continue success. If you have any questions, please call me at (703-269-3487).

Yours very truly,

2

Mr. Rob Goff
June 6, 2006
Page 3

/s/ Stacy Mendler

Stacy Mendler

Executive Vice President

I accept this Amendment to Offer of Promotion and agree to the above terms.

/s/ Leroy R. Goff	6/6/06
Signature	Date

3

EX-10.77

Exhibit 10.77

December 16, 2003

Vice Admiral Scott Fry
21946 Sugarland Oaks Square
Sterling, Virginia 20164

Dear Admiral Fry:

We are pleased to offer you a position with Alion Science and Technology Corporation as a Chief Strategist/Director of Program Development in Alion’s System Technology Sector reporting to Barry Watson, Senior Vice President, Sector Manager, with a proposed start date of January 5, 2004. This position is as an exempt employee. Your starting salary for this full-time position will be $6,924 biweekly. In addition, you will receive $15,000 as a sign-on bonus in accordance with the terms outlined in the enclosed Bonus Agreement form. It is company policy that only Senior Vice Presidents and Group Managers receive the use of a company car, but we are making an exception to the policy for you and you will have the use of a 2002 BMW until August 2005. It is our hope and expectation that you will be in a key line management position by that time that would justify continual use of the vehicle.

All full-time employees participate in Alion’s Flexible Employee Benefits program. This program provides you with a base of benefits at no cost to you: group life insurance, short and long term disability insurance, business travel accident insurance, 10 paid holidays, and 15 days personal time off during your first year of service. You are being offered an additional 4 days of PTO for a total of 19 days during your first year of service. After you complete one year of service, Alion will automatically begin contributions to the Alion Science and Technology Corporation Employee Ownership Savings and Investment Plan (KSOP).

Optional benefits, in which you participate in the cost, include: medical, dental, vision, optional life insurance, AD&D, dependent life insurance, health and dependent care flexible spending accounts and Long Term Care insurance. Immediately upon hire, eligible employees may contribute to the Alion Science and Technology Corporation Employee Ownership Savings and Investment Plan (KSOP). The KSOP consists of an ESOP component (Alion stock) and a 401(k) plan. After one year of continuous service, Alion provides matching contributions to the KSOP plan, pursuant and subject to the Plan.

As a new employee, you will have a one-time opportunity to invest in Alion stock. You may rollover monies from any qualified retirement plan that you had prior to employment with Alion and wish to invest in the company stock portion of the Alion KSOP plan. If you elect to participate after the one-time opportunity, you may still rollover monies from prior plans, but only to the 401(k) portion of the plan.

Once you accept this position, you will be required to maintain your current security clearance level.

In addition, you will also be required as a condition of employment to sign Alion’s Code of Ethics, Conduct and Responsibility Acknowledgement Form and Alion’s Intellectual Property Agreement. Copies are enclosed for your review.

Please note that employment offered by Alion is not an offer of continued employment for a definite period, that is, either Alion or you may terminate employment at any time with or without notice, for any reason or no reason.

Please confirm your acceptance decision by signing below and returning a copy of this letter to us by December 23, 2003. We look forward to a pleasant association with you as a member of our staff. If you have any questions, please call me at 703-269-3487.

Sincerely,

/s/ Katherine C. Madaleno
Katherine C. Madaleno
Vice -President, Director of Human Resources

I accept this offer of employment and enclose the required completed and signed Alion Employment Application.

/s/ Scott Fry
Signature	Date

EX-10.78

Exhibit 10.78

June 6, 2006

Mr. Scott A. Fry
6099 Arrington Drive
Fairfax Station, VA 22039

Re:   Addendum to Offer Letter

Dear Scott:

This letter constitutes an addendum to a letter, dated December 16, 2003, to you from Alion Science and Technology Corporation (“Alion” or the “Company”) which constituted our original offer of employment (the “Offer Letter”). This letter provides to you additional benefits in consideration for your continued service to the Company. This letter replaces and supersedes in its entirety the letter to you dated March 7, 2006.

     1. Benefits.

In addition to the benefits set forth in your Offer Letter, you will continue to be eligible to receive a company-leased automobile under our Auto Lease Policy. This is equivalent to a maximum of approximately $1,000 a month. You will also receive 24 personal days off (“PTO”) per year in addition to the current ten paid holidays. You are also eligible to receive other executive benefits under current Alion policies for:

• Tax Preparation Subsidy

• Physical Fitness Membership Subsidy

• Annual Health Physical Subsidy

All other Alion Core and Optional Employee Benefits remain the same. In addition, you and the Company agree to the following additional terms, with any reference to you to mean “Employee”:

     2. Severance. A. If, from the date of this letter until and including December 20, 2007, the Company terminates Employee’s employment without Cause (as defined below), the Company shall make a lump-sum severance payment to Employee equal to one year of Employee’s annual base salary as of the Termination Date

Mr. Scott A. Fry
June 6, 2006
Page 2

as defined in Section 4 below. There will be no further rights to any further compensation. In the event that Employee is terminated for Cause, Employee will not be entitled to any severance or other benefits upon termination other than those accrued benefits provided to employees pursuant to existing Company policies.

          B. For purposes of this letter, “Cause” is defined as the occurrence of one of the following: (i) Employee’s material violation of Company policy or any violation of the Company’s Code of Ethics, Conduct and Responsibility; (ii) any act, failure to act, series of acts or failures to act, or course of conduct on Employee’s part constituting reckless, willful, or criminal misconduct in the performance of your duties; (iii) any failure to perform, or gross negligence or incompetence in the performance of, Employee’s duties; or (iv) Employee’s commission of a crime involving conversion, misappropriation, larceny, theft, fraud, dishonesty, embezzlement, moral turpitude or any other felony, regardless of whether such crime involves the Company.

     3. Change of Control Benefits. In the event of a Change of Control, as defined in Section 5 below, if Employee meets the Eligibility Requirements set forth in Section 4 below, the Company’s successor or assign shall pay Employee, in lieu of any severance benefits described above, a lump sum amount equal to the amount of Employee’s annual base salary as of the Termination Date (the “Change of Control Benefits”). There will be no further rights to any further compensation or benefits.

     4. Eligibility for Change of Control Benefits. If Employee terminates employment (for reasons other than set forth in Section 4D below) with any successor or assign (or any of their respective affiliates) of the Company at any time during the twenty four (24) month period beginning on the effective date of a Change in Control (the “Protection Period”), he shall be entitled to the Change of Control Benefits. If during the Protection Period, Employee terminates his employment for Good Reason (as defined below) by delivering to the successor or assign of the Company (or its respective affiliate), as applicable, each no later than thirty (30) days after learning of the occurrence of an event constituting Good Reason: (i) a Preliminary Notice of Good Reason (as defined below); and (ii) a Notice of Termination (as defined below), Employee shall have the right, in his sole and reasonable discretion, to receive the Change of Control Benefits. For purposes of this letter, the following terms shall have their respective meanings:

          A. “Good Reason” shall result only upon the occurrence, without Employee’s prior written consent, of one or more of the following events, as determined by Employee in good faith, during the Protection Period: (i) Employee’s

Mr. Scott A. Fry
June 6, 2006
Page 3

authority or responsibility has materially diminished as compared to Employee’s authority and responsibility in effect immediately prior to a Change in Control; (ii) Employee has been assigned permanent duties inconsistent with his position, responsibility and status with the Company immediately prior to the Protection Period; (iii) there has been an adverse change in Employee’s title or office as in effect immediately prior to the Protection Period; (iv) Employee’s base pay or incentive compensation has been reduced; or (v) Employee’s principal work location is more than ten (10) miles away from the principal work location as immediately prior to the Protection Period; provided, however, that “Good Reason” shall not include (x) acts not taken in bad faith that are cured by the Company’s successor or assign in all respects, including without limitation restoration of all back pay and incentive compensation through the Termination Date, not later than thirty (30) days from the date of receipt by the successor or assign of the Company (or its respective affiliate), as applicable, of a written notice from Employee identifying in reasonable detail the act or acts constituting “Good Reason” in a “Preliminary Notice of Good Reason”, or (y) acts for which Employee does not provide a Preliminary Notice of Good Reason within thirty (30) days of learning of the occurrence of the event constituting Good Reason.

          B. “Notice of Termination” shall mean a notice that indicates in reasonable detail the facts and circumstances claimed to provide a basis for termination of Employee’s employment.

          C. “Termination Date” shall mean the date specified in the Notice of Termination for termination of Employee’s employment under this Agreement.

          D. Notwithstanding any other provision under this Agreement, Employee shall not be entitled to receive Change of Control Benefits in the event that: Company’s successor or assign (or any of its respective affiliates) terminates Employee’s employment for Cause (as defined below); (ii) Employee dies (in which case the Company shall pay to Employee’s heir or personal representatives, as the case may be, six (6) monthly payments, each equal to one-twelfth (1/12) of Employee’s then-current salary, commencing with the first calendar month after termination); (iii) Employee is determined to be totally and permanently disabled (in which case the Company shall pay to Employee six (6) monthly payments, each equal to one-twelfth (1/12) of Employee’s then-current salary less any payments under the Company’s long term disability insurance plan that Employee receives or is entitled to receive in each such month, commencing with the first calendar month after termination); (iv) the Company’s successor or assign (or any of its respective affiliates) terminates Employee’s employment without cause (in which case the Company shall make a lump-sum severance payment to Employee equal to one year of Annual Base Salary as of the Date of Termination); or (v) Employee resigns other than for Good Reason (in which case the

Mr. Scott A. Fry
June 6, 2006
Page 4

Company shall have no further obligations to Employee under this Agreement, including without limitation payment of future compensation or benefits). In any such event, Employee, in addition to any benefits payable in accordance with this Agreement, shall be entitled only to his salary and benefits accrued or earned and vested under other plans, programs, policies, practices and coverage of the Company’s successor or assign (or any of its respective affiliates).”

     5. Change in Control. For the purposes of this letter, a “Change of Control” shall mean and shall be effective upon the closing date of: (i) the dissolution or liquidation of the Company; (ii) the merger or consolidation of the Company with any other corporation, foundation, association or other entity; (iii) the amendment of the Company’s corporate documents to grant a party other than the Company’s Employee Stock Ownership Plan, the right to designate, elect or remove a majority of the Company’s voting directors; or (iv) the transfer to another corporation, foundation, association or other entity in a sale, lease, exchange or other similar transfer (in a single transaction or in a series of related transactions) of all or substantially all of the assets of the Company.

     6. Other Provisions. All other provisions set forth in the Offer Letter shall remain the same.

By our mutual signatures below, you and the Company agree to the terms of this letter.

We look forward to your continued success with Alion. If you have any questions, please call me at (703-269-3487).

Yours very truly,

/s/ Stacy Mendler

Stacy Mendler

Executive Vice President

I accept this letter and agree to the above terms.

/s/ Scott Fry	6/6/06
Signature	Date

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
FOR THE CHIEF EXECUTIVE OFFICER

I, Bahman Atefi, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Alion Science and Technology Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) [Reserved]

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/  Bahman Atefi

Name: Bahman Atefi

Title: Chief Executive Officer

Date: August 14, 2006

EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
FOR THE CHIEF EXECUTIVE OFFICER

I, John M. Hughes, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Alion Science and Technology Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

e) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

f) [Reserved]

g) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

h) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

c) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

d) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/  John M. Hughes

Name: John M. Hughes

Title: Chief Financial Officer

Date: August 14, 2006

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Alion Science and Technology Corporation (the “Corporation”) on Form 10-Q for the three months and nine months ending June 30, 2006 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bahman Atefi, Chief Executive Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Corporation.

/s/  Bahman Atefi

Name: Bahman Atefi

Title: Chief Executive Officer

Date: August 14, 2006

EX-32.2

EXHIBIT 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Alion Science and Technology Corporation (the “Corporation”) on Form 10-Q for the three months and nine ending June 30, 2006 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John M. Hughes, Chief Financial Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Corporation.

/s/  John M. Hughes

Name: John M. Hughes

Title: Chief Financial Officer

Date: August 14, 2006